Annual Report (2012)

No.24
The NOVARTIS Foundation (Japan)
for the Promotion of Science

平成 24 年度

財団年報 第 24 号

Contents
Ⅰ . Introduction はじめに ............................................................................................ 6
Akimichi Kaneko, MD, PhD
Chairman of the Board of Trustees

Ⅱ . Reports from the Recipients of Novartis Research Grants
研究報告 .................................................................................................................. 8
1. Molecular analysis of human T cell leukemia virus type-1 (HTLV-1) HBZ genein the pathogenesis of HTLV-1 associated myelopathy. ........................................... 9
Mineki Saito
Department of Immunology, University of the Ryukyus

2. The role of SUMOylation in visual phototransduction in the retina .......................... 12
Akishi Onishi
Osaka Bioscience Institute

3. Establishing a new methodology for genome mining and biosynthesis of natural
products and their analogs through a yeast molecular genomics ........................... 15
Kenji Watanabe
University of Shizuoka, School of Pharmaceutical Sciences

4. Application of epigenetics to elucidate molecular mechanism of geneenvironment interaction involving resistin in type 2 diabetes ................................. 18
HARUHIKO OSAWA
Department of Molecular and Genetic Medicine
Ehime University Graduate School of Medicine

5. Targeting at the interface between normal and transformed epithelial cells. .............. 20
Yasuyuki Fujita
Hokkaido University, Institute for Genetic Medicine

6. Experimental verification of the abnormal neurodevelpmental hypothesis of
schizophrenia ........................................................................................................... 23
Koh-ichi Nagata
Institute for Developmental Research, Aichi Human Service Center

7. To detect susceptibility factor for mental disorders
based on genome and mouse ................................................................................... 26
Nakao Iwata
Department of Psychiatry, School of Medicine, Fujita Health University

8. Analysis of role of hypoxia inducible transcription factor in the regulation of
metabolisms in liver and its pathobiological significance for the developmentof metabolic diseases ................................................................................................ 29
Nobuhito Goda
Faculty of Science and Engineering, Waseda University

9. Mechanism of self-recognition regulating the homeostasis of peripheral T cells ........ 32
Kensuke Takada

Institute for Genome Research, University of Tokushima-1-10. In vitro generation mature oocytes through factitious activation of
dormant primordial follicles ..................................................................................... 35
Kazuhiro Kawamura
Akita University School of Medicine

11. Critical molecular mechanisms to determine brain size and neuronal population ....... 38
Yoichi Kosodo
Kawasaki Medical School

12. Development of promising anticancer agents based onpractical total synthesis of marine natural products ................................................. 41
Makoto Sasaki
Graduate School of Life Sciences, Tohoku University

13. Molecular mechanisms of biological signal transduction operated
by gas molecules ....................................................................................................... 43
Shigetoshi Aono
Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences

14. Regulatory mechanism of cell division by telomeres................................................... 46
Junko Kanoh
Osaka University

15. Development of novel strategy for therapeutic angiogenesis....................................... 49
Tohru Minamino
Department of Cardiovascular Science and Medicine
Chiba University Graduate School of Medicine

16. Spatio-temporal regulation of sensory neural circuit formation................................... 52
Hiroshi Kawasaki
The University of Tokyo, Graduate School of Medicine

17. PHD2-inactivation and new strategy for a treatment ofIschemia/Reperfusion Injury .................................................................................... 55
Yoji Andrew Minamishima
School of Medicine, Keio University / Japan Science and Technology Agency

18. Analysis of cell signaling-mediated phosphorylation and regulation of
nucleocytoplasmic transport machinery ................................................................... 58
Hidetaka Kosako
Institute for Enzyme Research, The University of Tokushima

19. Catalytic Asymmetric Synthesis of Tetrahydropyran Derivatives
and Study of Its Quantitative Structure-Activity Relationship ................................. 61
Takeshi Hata
Tokyo Institute of Technology

20. How does energy metabolism affect sex differentiationand stem cell regulation? .......................................................................................... 64
Minoru Tanaka
National Institutes of Natural Sciences, National Institute for Basic Biology, Japan

-2-

21. The role of CD11b ＋ myelomonocyte in tumor vasculature related to cancer
recurrence ................................................................................................................. 67
Mitomu Kioi
Department of Oral and Maxillofacial Surgery,
Yokohama City University Graduate School of Medicine, Japan

22. Analyses of the pathophysiological elements of the deafness underlying disorderof the cochlear endolymph ....................................................................................... 70
Hiroshi Hibino
Division of Organ Physiology, Graduate School of Medical and Dental Sciences,
Niigata University

23. Synthesis of Welwitindolinone A Isonitrile and Its Analogues by
Catalytic Cycloaddition of Allenynes ....................................................................... 73
Nozomi Saito
Faculty of Pharmaceutical Sciences, Hokkaido University

24. Structural Basis for Oxidative Stress Sensing by Keap1-Nrf2
Cytoprotective System. ............................................................................................. 76
Hirofumi Kurokawa
Tohoku University Graduate School of Medicine

25. Pathological roles of a novel macrophage molecule M-mod in type-2 diabetes .......... 78
Hiroshi Kitamura
Nagoya City University

26. Study of Inwardly Rectifying Potassium Ion Channels ............................................... 81
Motohiko Nishida
Riken

27. Regulation of EGFR membrane trafficking by ROCO family kinase LRRK1 ............ 85
Hanafusa Hiroshi
Nagoya University

28. Analysis of the algal circadian clock for revealing the evolutional history ofplant-type circadian clocks ....................................................................................... 88
Takuya Matsuo
Nagoya University

29. The role of Cathepsin C in generating active IL-1 beta in vivo. .................................. 91
Hajime Kono
Teikyo University School of Medicine

30. Functional characterization of NADPH oxidases and their regulators ofendophytic fungus..................................................................................................... 93
Daigo Takemoto
Nagoya University

31. Pharmacological and clinical significance of the enhanced protein farnesylationinduced by the inactivation of retinoblastoma tumor suppressor gene..................... 96
Chiaki Takahashi
Kanazawa University Cancer Research Institute-3-32. Analysis of leukemogenic mechanisms induced by Trib1 ........................................... 99
Takuro Nakamura
Japanese Foundation for Cancer Research

33. The roles of C-type lectin family in the maintenance of
immunological homeostasis. .................................................................................. 102
Shinobu Saijo
Center for Medical Mycology, Chiba University

34. p53 targeted medicine against heart failure ................................................................ 105
Issei Komuro
Osaka University Graduate School of Medicine

35. Investigation on chronic kidney disease through signal transduction between
vascular endothelial cells and podocytes. ............................................................... 108
Noriaki Emoto・ Department of Clinical Pharmacy, Kobe Pharmaceutical University

36. Development of immunotherapy against disseminated Candida infection ................ 111
Yuki Kinjo
National Institute of Infectious Diseases

37. Construction of chemical library of calyculin A and development of subtype
selective phosphatase inhibitor ............................................................................... 114
Toshiyuki Wakimoto
Graduate School of Pharmaceutical Sciences, The University of Tokyo

38. Roles of axon guidance protein, draxin in the corpus callosum formation ................ 117
Yohei Shinmyo
Kumamoto University

Ⅲ . Reports from the Recipients of Grants for International Meetings
研究集会報告 ....................................................................................................... 119
1. The 13th TNF International Conference .................................................................... 120
Shigekazu Nagata
Kyoto University, the Graduate School of Medicine

2. 10th International Family Nursing Conference .......................................................... 121
Kazuko Ishigaki
Japanese Association for Research in Family Nursing

3. XV International Congress of Molecular Plant-Microbe Interactions ....................... 122
Ko Shimamoto
Nara Institute of Science and Technology

4. The 6th International Conference of Neurons and Brain Diseases (ICNBD) ............ 124(by Association for Neuron and Diseases)
Kaoru Inokuchi
University of Toyama, Graduate School of Medicine & Pharmaceutical Sciences-4-5. XXV Symposium of the International Association for Comparative Research on
Leukemia and Related Diseases (IACRLRD) ........................................................ 125
Watanabe Toshiki
The University of Tokyo

6. 8th AFMC International Medicinal Chemistry Symposium (AIMECS11) ................ 126
Masakatsu Shibasaki
Institute of Microbial Chemistry, Tokyo, Japan

Ⅳ . The 25th (fiscal year 2011) Promotion Report
第 25 期 （2011 年度） 助成事業報告 ................................................................ 127
Ⅴ . The 25th (fiscal year 2011) Financial Report
第 25 期 （2011 年度） 財務報告 ........................................................................ 133
Ⅵ . List of the Board Members
役員名簿 ............................................................................................................... 135
Ⅶ . Information from the Secretariat
事務局便り ............................................................................................................ 139-5-

Introduction“New Public Interest Incorporated Foundation”

Akimichi Kaneko, MD, PhD
Chairman of the Board of Trustees
This annual report includes research and meeting reports written by the 2010
grantees. Their tireless effort is the driving force to promote and to keep the highstandard of the Japanese life science. I strongly believe that the aim of the Foundation isto help keeping their activity and we will do our best toward this goal. I sincerely
appreciate the assistance and warm encouragement extended by the members of theBoard of Trustees, the auditors, the Board of Councilors and the Selection Committee.
The powerful support by the Novartis Pharma KK enabled us to sustain our activity
without interruption.
The Foundation was reincarnated as a new public interest incorporated foundation
on April 1, 2012. As you may know, the Foundation was originally established on
September 4, 1987 with basic assets of JPY 1 billion donated by Ciba-Geigy AG,
Switzerland for the purpose of contributing to academic development and thus
improving public health and welfare by means of promoting creative research andinternational exchange in the field of life science and related chemistry. Since then, theFoundation has granted JPY 1.768 billion to 1,460 researches and international
exchange activities.
In December 2008, the new law, “Act on Authorization of Public Interest
Incorporated Associations and Public Interest Incorporated Foundations”, was put inforce, demanding all associations and foundations in Japan to restructure along the newlaw. The Foundation started preparative discussion for the transition in February 2009.
Although it took a longer period to settle arrangements, the Foundation finally applied
to the Cabinet Office for the Public Interest Corporation Authorization on July 26, 2011.
The Office reviewed and approved that the Foundation meets prescribed standards, thensubmitted the report on November 18, 2011. The certificate of authorization was issued
on March 21, 2012 followed by the official registration on April 1, 2012.
Regardless of these organizational changes, the purpose of the Foundation remains
unchanged. The Foundation will continue to support researchers and researchcommunities. I hope that the Foundation’s activity will contribute to the development oflife science in Japan.
-6-

はじめに

「新公益財団法人」
代表理事

金子章道

本年度もここに 2011 年度にノバルティス科学振興財団研究助成金を受けられた方々の研究報告を収録いたしました。受賞者の皆様の素晴らしい研究がまとめられたエッセイ集です。研究者お一人おひとりの努力の結晶は我が国の学術水準を発展させていく原動力です。こうした方々の研究に多少なりとお力添えをすることが本財団の事業の基本と考え、今後も努力を続けて行きたいと思っております。これらの優れた研究を選考していただいた選考委員の皆様をはじめ、財団の活動を支えて下さっている関係者の皆様に深く感謝いたします。とりわけノバルティスファーマ社の継続した強力な経済的支援に御礼申し上げた
いと思います。
さて、2012 年の 4 月をもって、ノバルティス科学振興財団は新たな公益財団法人として生まれ変わりました。ご存じのように当財団は 1987 年 9 月 4 日、スイス、チバガイギー社からの 10 億円のご寄附をもとに、「生物・生命科学および関連する化学の領域において、創造的な研究ならびに国際交流への助成を行うことにより、学術の振興を図り国民の健康と福祉の向上に寄与する」ことを目的に設立されました。爾来 25 年間に 1,460 件、金額にして 17 億 6800 万円の助成を行ってまいりました。
2008 年 12 月に公益法人制度改革に関する新しい法律が施行され、現行のすべての法人が新組織へ移行することが必要となりました。当財団におきましては
2009 年 2 月の理事会・評議員会における審議をもって新組織への移行準備をスタートさせ、体制を整えるため少し時間がかかりましたが、2011 年 7 月末に内閣府へ移行申請を行いました。それに対し内閣府より 11 月 18 日付で公益法人認定の基準を満たしている旨の答申を得、本年 3 月 21 日に正式の認定証が交付され、4 月 1 日付の登記をもって新組織への移行が完了いたしました。
新しい組織になりましたも、当財団の事業の目的は変わることはありません。
多くの研究者の方々のお役にたてる研究助成活動を続けて参ります。私どもの事業が少しでも日本の生命科学の発展に寄与できることを念願しております。

-7-

II.
Reports from the Recipients ofNovartis Research Grants-8-

Molecular analysis of human T cell leukemia virus type-1 (HTLV-1)
HBZ gene in the pathogenesis of HTLV-1 associated myelopathy.
Mineki Saito
Department of Immunology, University of the Ryukyus
mineki@med.u-ryukyu.ac.jp

Abstract
To investigate the pathological role of HBZ expression in HTLV-1 infection, we have generated
monoclonal antibodies against HBZ, and analyzed the expression of HBZ protein and anti-HBZ
antibodies in clinical samples from HTLV-1 infected individuals. Although we successfully detected
HBZ protein in an enforced overexpressed cells and HTLV-1 infected cell lines by flow cytometry,
ELISA, immunofluorescence and immunoblotting, we could not detect any HBZ protein or antiHBZ antibodies in HAM patients and asymptomatic carrires by our system.
Key Words : HTLV-1, HTLV-1 associated myelopathy (HAM), HBZ, Chronic inflammation

Introduction
Human T-cell leukemia virus type 1 (HTLV-1) is a human retrovirus etiologically associatedwith adult T-cell leukemia (ATL) and HTLV-associated myelopathy (HAM). HTLV-1 basic leucine
zipper factor (HBZ), encoded on the negative strand, was suggested to play an important role inboth HTLV-1-induced neoplastic and inflammatory diseases. We have previously reported that the
HBZ gene is expressed in all HAM patients and its expression is strongly correlated with the HTLV1 proviral load in infected individuals and with disease severity in HAM patients. However, there
have been no reports about the relationship between HBZ protein expression and disease status.

Results
We generated rat monoclonal antibody (moAb) against a C-terminal peptide (HBZ193-206 :CVNYWQGRLEAMWLQ) of HBZ (clone 4B12). We also generated human moAbs against
recombinant HBZ protein by a phage display system (clones 13405.1, 13407.1, 13413.1). Then we
have developed the ELISA system for the detectionof HBZ protein and anti-HBZ antibodies. Using
these reagents, we analyzed the expression of HBZprotein in plasma and peripheral blood mononuclear
cells (PBMCs) of HTLV-1 infected individuals
including HAM patients as well as HTLV-1 infected
cell lines. We successfully detected HBZ protein
in an enforced overexpressed cells and HTLV-1
infected cell lines by flow cytometry (Fig.1), ELISA

-9-

Fig.1

(data not shown), immunof luorescence (Fig.2) andimmunoblotting (Fig.3).
However, we could not detect any HBZ protein or antiHBZ antibodies in HAM patients and asymptomatic
carrires (ACs) by our system. In contrast, HBZ mRNAwas significantly elevated in HAM/TSP patients thanACs. Especially, rapidly progressive HAM/TSP patients
showed extremely high expression of HBZ mRNA but
Fig.2

not tax mRNA in their PBMCs (data not shown).

Fig.3

Discussion & Conclusion
For over two decades since the discovery of HTLV-1, the investigation of HTLV-1-mediatedpathogenesis has been focused on Tax, an HTLV-1 encoded viral oncoprotein. Although Tax has
been viewed as critical for leukemogenesis because of its pleiotropic effects on both viral and manycellular genes responsible for cell proliferation, dysregulation of the cell cycle and apoptosis, Tax
expression is not detected in about 60% of freshly isolated samples from ATL cases. In contrast,
the spliced form of HBZ gene is expressed in all ATL and HAM cases, and its expression isstrongly correlated with the HTLV-1 proviral load in HTLV-1 infected individuals and with disease
severity in HAM patients. Since there have been no reports about the relationship between HBZprotein expression and disease status, we generated the moAbs against HBZ and examined the
HBZ protein expression in clinical samples. As a result, we could not detect any HBZ protein or
anti-HBZ antibodies in serum or PBMCs of HAM patients and ACs, indicating that the expressionof HBZ protein was suppressed in vivo in infected individuals. Low protein expression and low
immunogenicity of HBZ may contribute to the low immune selective pressure and the persistence of
HTLV-1.

References
Saito M, Bangham CR. Immunopathogenesis of Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): Recent perspectives. Leukemia
Research and Treatment Article ID 259045 (online journal), 2012.

- 10 -

一般の皆様へ
ヒト T 細胞白血病ウイルス 1 型（HTLV-1) は、HTLV-1 関連脊髄症（HAM）および成人 T 細胞
白血病（ATL）の原因ウイルスである。ATL は死亡者数が年間 1000 人を超え、HAM 患者では約40% が経過中に歩行不能となるため、その制圧は重要である。我々は以前、HBZ 遺伝子（mRNA）
がすべての HTLV-1 感染者のリンパ球に発現し、発現量が HAM の病勢に関連していることを報告した。本研究では、抗 HBZ モノクローナル抗体を作製し、HTLV-1 感染者の血清・リンパ球における HBZ 蛋白、抗 HBZ 抗体の有無を調べたが、いずれも検出できなかった。すなわち、HTLV-1 は生体内での HBZ 蛋白発現を強く抑制して、宿主の免疫から逃避することで持続感染を維持している可能性が示唆された。HAM の治療・発症予防には、HBZ 蛋白でなく mRNA 発現を抑制することがより重要かもしれない。

- 11 -

The role of SUMOylation in visual phototransduction in the retina
Akishi Onishi
Osaka Bioscience Instituteaonishi@obi.or.jp

Abstract
SUMOylation, one of post-translational modifications (PTM), plays a crucial role in switchingactivities of the target proteins. Since we have shown that SUMOylation is responsible forphotoreceptor subtype specification, we studied the functional role of SUMOylation in mature
photoreceptors by using mice in which SUMO E2 ligase was conditionally disrupted. As aresult, these conditional knockout mice were normal in immunohistochemical studies andelectrophysiological recording, suggesting that SUMOylation is less important in phototransduction
and maintenance of mature photoreceptors.
Key Words : Phototransduction, SUMOylation, photoreceptor, retina

Introduction
Vertebrate image-forming retinal photoreceptors are comprised of rod and cone subtypes. Rod
photoreceptors are activated by dim light, whereas cone photoreceptors are activated by bright light.
Correct expression of the subtype-specific genes is critical for normal vision, which is essential formany ecologically important behaviors. We have found that Pias3, a transcriptional coregulator
and E3 SUMO ligase, plays a central role in photoreceptor subtype specification by SUMOylating
a number of photoreceptor-enriched transcription factors. Since Pias3 is expressed in mature
photoreceptors, we studied a role of SUMOylation in phototransduction.

Results
Pias3 (Protein Inhibitor of Activated Stat3) is an E3 SUMO ligase, catalyzing covalent linkage
of SUMO proteins, which are distant homologs of ubiquitin, to specific lysine residues on target
proteins. SUMOylation, which in many ways mechanistically resembles ubiquitination mediatedby E1 (activation), E2 (conjugation) and E3 (ligation) enzymes. While there are a number of E1
and E3 enzymes reported, Ubc9 is the only SUMO E2 enzyme. Thus, we targeted Ubc9 to disrupt
SUMOylation cascades. Since the targeted null mutation die prior to E7.5 due to major chromosome
condensation and segregation defects (Dev Cell. 9:769-979), we created a line of mice in which
loxP sites flank Ubc9 coding sequence (floxed) enable Cre recombinase-mediated disruption of
SUMOylation cascade.
We first disrupt Ubc9 during retinogenesis, since strong inhibition of SUMOylation by injecting
the SUMOylation-deficient Ubc9 resulted in small eyes in Xenopus laevis (Dev Biol. 347:180-194).
We crossed the floxed mice with Chx10-Cre mice in which Cre recombinase is expressed in retinal- 12 -

progenitor cells driven by Chx10 promoter. The conditional knockout mice resulted in small eyes,indicating that Ubc9 is also responsible for retinogenesis in mice.
To study SUMOylation function in phototransduction in photoreceptor cells, we then crossed theflow mice with Crx-CreERT2 (tamoxifen-dependent Cre recombinase fused with the modified
ligand binding domain of the estrogen receptor) in which Cre-ERT2 is expressed in rod and cone
photoreceptor cells. The conditional knockout mice were treated with tamoxifen at the age of
4 weeks and analyzed at 2 and 6 months of age. We first tried to detect immunohistochemical
and morphological difference by section immunohistochemistry using antibodies localized at theouter segments (opsins and transducins) and the synaptic clefts (CtBP2, PSD95 and Pikachurin)of photoreceptors. We did not find significant morphological difference such as the length ofouter segments, the size and localization of somas and the shape of synaptic clefts, while rod
photoreceptor precursors whose SUMOylation activity is inhibited by knocking down of Pias3
at neonatal retinas turned cone photoreceptor cell-like morphology. There was not ectopic
expression of rod or cone-specific genes (e.g. rhodopsin and cone opsins) in other photoreceptor
subtypes. We also visualized synaptic connection between photoreceptor and bipolar cells by
immunostaining mGluR6 and TRPM1 that are localized at dendritic tips of the ON bipolar cells and
PKCα, a rod-bipolar cell-specific marker. But we did not found the significant difference. Next,
we compared electrophysiological response between the conditional knockout and control mice byelectroretinogram (ERG) that records field potentials of retinal neurons. We recorded ERG underscotopic condition (where the response of rod photoreceptors is dominant) and photopic condition(where rod response is saturated, thus cone response is recorded). We did not observe significant
difference in amplitudes of responses of a- and b-waves, components of ERG that are derived
from photoreceptors and ON-bipolar cells, respectively. In addition, since some of photoreceptorenriched proteins (e.g. Phosducin, mGluR8 and Cask) are reported to be SUMOylated, weelectroporated the mutant forms whose SUMOylation motifs are altered, but there were notsignificant immunohistochemical and morphological differences between the conditional knockout
and the control mice.

Discussion & Conclusion
These results indicated that SUMOylation is less significant in phototransduction andmaintenance in mature photoreceptor cells, while it plays a pivotal role in photoreceptor subtype
specification. Since SUMOylation was disrupted after maturation of photoreceptor cells, we needto study SUMOylation focused on maturation period to fully understand SUMOylation in neuraldevelopment and maturation.

一般の皆様へ
ゲノム解析により遺伝子数は予想より少ない事が判明し、遺伝子産物であるタンパク質に多様な機能を持たせる機構の一つとして翻訳後修飾が注目されています。その一つである SUMO 化の機能は- 13 -

細胞増殖から分化・維持と多岐に渡り、近年はアルツハイマー病などの神経変性疾患に関与する事も報告されています。本助成研究では視覚刺激を受容する網膜の視細胞における SUMO 化の機能を解析しました。その結果、SUMO 化は視細胞の発生・分化に重要である一方、成熟後の視覚の情報伝達では SUMO 化の欠損の影響が低いことが示唆されました。今後、分化決定から機能発現に至るまでの成熟（細胞構造の構築や神経回路生成）の過程での SUMO 化の役割の解析を進めたく思います。

- 14 -

Establishing a new methodology for genome mining
and biosynthesis of natural products and their analogs
through a yeast molecular genomics
Kenji Watanabe
University of Shizuoka, School of Pharmaceutical Sciences
kenji55@u-shizuoka-ken.ac.jp

Abstract
Fungal genome sequencing revealed the presence of many genes coding for natural productbiosynthetic enzymes, including polyketide synthases and nonribosomal peptide synthetases.
However, it remains a challenge to characterize these enzymes and identify the compounds they
synthesize, either in their original hosts or more tractable heterologous hosts, such as yeast. Here,
we have developed a streamlined method for isolating biosynthetic genes from fungal sources
and producing bioactive molecules using an engineered Saccharomyces cerevisiae strain as ahost. We used overlap extension PCR and yeast homologous recombination technology to clone
a desired fungal polyketide synthase or nonribosomal peptide synthetase gene (5–20 kb) into ayeast expression vector quickly and efficiently. This approach was used successfully to clone
five polyketide synthases and one nonribosomal peptide synthetase from various fungal species.
Subsequent detailed chemical characterizations of the resulting natural products identified 6
polyketide and 2 nonribosomal peptide products, some of which were new compounds. Our
system should facilitate the efforts in mining the uncharacterized fungal biosynthetic potential
for identifying novel natural products and rationally engineering in the biosynthetic pathways for
production of analogs possessing desired bioactivity.
Key Words : drug discovery • fungal putative gene cluster • polyketide synthase (PKS) •yeast heterologous biosynthesis

Introduction
Polyketides (PKs) and nonribosomal peptides (NRPs) have been isolated from Streptomyces
and many other source organisms. In recent years, numerous biosynthetic gene clusters encoding
enzymes for biosynthesis of those compounds, such as PK synthases (PKSs) and NRP synthetases(NRPSs), have been discovered in fungal genomes. Despite the presence of 30 to 40 gene clusters
in a single Aspergillus genome, only a handful of fungal polyketide, peptide and terpene products
can be isolated from a culture grown under a typical growth condition. Therefore, a simple approach
for activating these cryptic gene clusters is likely ineffective. Recent advancement of spectroscopic
technology permits elucidation of the chemical structures of natural products even at a microgramlevel. Furthermore, recent advancements in high resolution LC–MS and NMR technology
allow determination of the complex structures of these compounds from a very small amount ofsample. However, it is still necessary to be able to activate the cluster to induce biosynthesis of the- 15 -

corresponding compounds, even at a trace level, to be able to take advantage of these techniques.
An alternative approach in mining for novel secondary metabolites is to heterologously express
genes from putative biosynthetic gene clusters that are encoded in the fungal chromosomal DNA.
However, fungal expression systems often cannot accommodate the number of genes present in a
PKS or a NRPS gene cluster. Additionally, heterologous expression of fungal biosynthetic genes
from a 5- to 20-kilobase (kb) genomic DNA fragment using a typical host, such as Aspergillus
oryzae, will require the host transcriptional system to splice together exons correctly for the
production of functional biosynthetic proteins. Extraction of correct protein-coding segments by
PCR is challenging due to inherent difficulty in predicting intron regions accurately. Likewise, there
has been a significant progress made in Escherichia coli-based heterologous gene expression andmetabolite biosynthesis. However, E. coli requires the fungal genes to be synthesized from mRNA
isolated from the original host to allow correct splicing of the genomic copy of the fungal genes, andsuccessful reverse transcription (RT) of full-length mRNAs of PKSs or NRPSs, which can be morethan 20 kb in length, is challenging. Furthermore, difference in the codon usage between fungi andE. coli can also hinder efficient production of fungal enzymes, making reconstitution of fungal
biosynthetic enzymes in E. coli very difficult.

Results
For our heterologous biosynthetic system, we developed an engineered S. cerevisiae strain
SCKW5, whose genome is modified to include a G418 resistance marker kanMX, along with matBand npgA genes encoding for a malonyl-CoA synthetase and a phosphopantetheinyl transferase,
respectively. We then prepared expression vectors carrying the target PKS and NRPS genes andtransformed SCKW5 with these vectors for further studies. Initially, cDNA of each of the putative
genes, namely CHGG_00542, CHGG_10027, CHGG_10128, CC1G_05377 and Afu6g12080, wassynthesized by RT-PCR from the total RNA isolated from the corresponding fungal host. A fulllength cDNA of these genes was assembled from multiple partial amplicons of the cDNA using
the overlap extension PCR technique. Each of the resulting full-length gene was inserted into
pKW1810 using in vivo recombination activity of yeast, yielding a series of five expression vectors,
pKW14050 (CHGG_00542), pKW11002 (CHGG_10027), pKW11001 (CHGG_10128), pKW11000(CC1G_05377) and pKW5022 (Afu6g12080). We introduced each expression vector into SCKW5
to confirm gene expression by western blotting analysis. We then looked for the biosynthesis of thecorresponding polyketide or nonribosomal peptide compounds. Reverse-phase HPLC analysis of thecrude organic extract of the culture revealed the presence of some late-eluting compounds that were
present only in the culture extracts of the transformants. These results gave us a good indicationthat all of the transformants were capable of producing nonpolar metabolites, suggesting successful
biosynthesis of the target compounds.

- 16 -

Discussion & Conclusion
In this study, we established an innovative approach for biosynthesizing bioactive compounds offungal origin by focusing on previously uncharacterized biosynthetic gene clusters and using anengineered S. cerevisiae strain as a surrogate host. We exploited the overlap extension PCR method
to quickly synthesize full-length PKS and NRPS genes, which are usually 5- to 20-kb or longer,
using a pool of cDNA reverse-transcribed from a total RNA isolated from the source fungus. The
amplified gene was subsequently cloned into a yeast expression vector using the recombination
capability of yeast. This series of procedures allowed fast and efficient establishment of a yeast
system for expression of biosynthetic genes of unknown function and production of corresponding
natural products. Our results clearly demonstrated successful expression of four type I iterative PKS
genes and one NRPS gene from three different fungal species in S. cerevisiae, all of which led tothe production of a total of six compounds whose identities were characterized spectroscopicallyand verified the speculated functions of these biosynthetic mega-enzymes. Our plasmid-based
system provides an advantage over fungal systems in terms of ease and speed of cloning the target
genes, and it also tolerates handling of genes up to at least 12 kb in length. Also, the use of aplasmid-borne system simplifies the effort of engineering biosynthetic pathways for production ofvarious analogs using traditional molecular biological techniques. By streamlining the process oftranslating uncharacterized fungal biosynthetic genes into structurally characterized compounds,
our methodology should facilitate the efforts in isolating novel natural products and rationallyengineering in the biosynthetic pathways for production of analogs possessing comparable or evenmore potent bioactivity.

References
1. Ishiuchi, K., Nakazawa, T., Ookuma, T., Sugimoto, T., Sato, M., Tsunematsu, Y., Ishikawa,N., Noguchi, H., Hotta, K., Moriya, H., Watanabe, K., Establishing a new methodology forgenome mining and biosynthesis of polyketides and peptides through yeast molecular genetics.
ChemBioChem, in press.
2. Nakazawa, T., Ishiuchi, K., Praseuth, A., Noguchi, H., Hotta, K., Moriya, H., Watanabe, K.,
Overexpressing transcriptional regulator in Aspergillus oryzae activates a silent biosynthetic
pathway to produce novel polyketide. ChemBioChem, in press.

一般の皆様へ
研究の背景
人類が初めて手にした抗生物質であるペニシリンは人々を感染症から守り、それが発見されるまでは考えられないような膨大な数の生命を救ってきました。しかしながら、ペニシリンのように容易に得られる薬は既に取り尽くされ、今までのように見つけ出すことが難しくなってきました。そこで、解読されてきた様々な生物の遺伝子情報を活用して、新しい薬を見つけ出すことが期待されています。
研究の目標
この研究は、新しい抗ガン剤や新興感染症あるいは患者数の少ない難病治療薬などの薬を効率的に発見し、さらに安い価格で国民に提供することを目的としています。

- 17 -

Application of epigenetics to elucidate molecular mechanism of geneenvironment interaction involving resistin in type 2 diabetes
HARUHIKO OSAWA
Department of Molecular and Genetic Medicine Ehime University Graduate School of Medicine
harosawa@m.ehime-u.ac.jp

Abstract
The G/G genotype of the human resistin gene promoter single nucleotide polymorphism (SNP) at-420 increased type 2 diabetes susceptibility by enhancing promoter activity. We here analyzed
methylation of five cytosines and other SNPs around SNP-420 in the human resistin gene in type2 diabetes. Quantification of cytosine methylation could be useful as a marker for human resistin
gene expression and could be of assistance to the evaluation of gene-environment interaction.
Key Words : resistin, SNP, methylation, epigenetics

Introduction
Resistin is a cytokine secreted from monocytes, which antagonizes insulin action. Previously,
we reported that the G/G genotype of a promoter single nucleotide polymorphism (SNP) at -420
(rs1862513) was associated with type 2 diabetes susceptibility by enhancing promoter activity.
Increasing evidence suggests that epigenetic mechanisms such as DNA methylation, which mightchange in the environmental state, could regulate the gene expression. In this study, we analyzed
cytosine methylation of five cytosines around SNP-420 in human resistin gene.

Results
Genotype of SNP-420 in the promoter region of human resistin gene was strongly associated withplasma resistin level. We selected five cytosines around SNP-420 to analyze cytosine methylation.
Cytosine methylation was assayed quantitively by pyrosequencing after bisulfite treatment ofgenomic DNA. Genomic DNA was obtained from leukocyte of type 2diabete patients. We
quantified methylation of five selected cytosines. The percentage of methylation was different
among these cytosines (20~80% of methylation ratio). Furthermore, the percentage of methylationin each selected cytosine was different among individuals. So the methylation of these fivecytosines could be a marker for evaluating resistin gene expression.
We are now analyzing methylation of these cytosines as well as plasma resistin level in the general
Japanese population aiming for 2500 subjects, of which SNP in the promoter of resistin gene havebeen analyzed before. The resulting information about SNP, methylation ratio, and plasma resistin
level will be helpful for the analysis of gene-environment interaction.

- 18 -

Discussion & Conclusion
We analyzed genotype of SNP-420 and cytosine methylation of five cytosines around SNP-420
in the promoter region of the human resistin gene. Genotype of SNP-420 was strongly associatedwith plasma resistin level and percentage of methylation in five cytosines was variable among thesecytosines as well as among individuals. Quantification of cytosine methylation could be useful asa marker for human resistin gene expression and could be of assistance to the evaluation of geneenvironment interaction.

References
1. Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T,
Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H.
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes
mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.
Am J Hum Genet. 2004 Oct;75(4):678-86.
2. Osawa H, Tabara Y, Kawano R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J,
Kohara K, Miki T, Makino H.
Plasma Resistin, Associated with Single Nucleotide Polymorphism -420, is Correlated with
Insulin Resistance, Lower HDL, and High Sensitivity CRP in the Japanese General Population.
Diabetes Care. 2007 Jun;30:1501-6.
3. Onuma H, Tabara Y, Kawamura R, Tanaka T, Ohashi J, Nishida W, Takata Y, Ochi M, Yamada K,
Kawamoto R, Kohara K, Miki T, Makino H, Osawa H. A at single nucleotide polymorphism-358
is required for G at -420 to confer the highest plasma resistin in the general Japanese population.
PLoS One. 2010 Mar 16;5(3):e9718.

一般の皆様へ
２型糖尿病は、インスリン抵抗性やインスリン分泌不全に関わる遺伝子に、肥満、運動不足といった環境因子が作用して発症すると考えられている。従って、その発症予防やオーダーメイド医療の確立には、原因遺伝子に加え、遺伝子・環境因子相互作用の解明が鍵と考えられる。本研究ではレジスチンという２型糖尿病感受性遺伝子をモデルとして、エピジェネチックス機構の１つである
DNA のメチル化に焦点を当て、遺伝子－環境相互作用の解明を目的に研究を進めている。

- 19 -

Targeting at the interface between normal andtransformed epithelial cells.
Yasuyuki Fujita
Hokkaido University, Institute for Genetic Medicine
yasu@igm.hokudai.ac.jp

Abstract
We have revealed that Scribble-knockdown cells undergo apoptosis and are apically extruded
from the epithelium when surrounded by normal epithelial cells. This is the first demonstration thatan oncogenic transformation within an epithelium induces cell competition in a mammalian cell
culture system.
Key Words : Cell Competition, Scribble, p38MAPK, apoptosis

Introduction
In Drosophila, normal and transformed cells compete with each other for survival, a process called
cell competition. However, it is not known whether comparable phenomena also occur in mammals.
Scribble is a tumor suppressor protein in Drosophila and mammals. In this study we examine theinterface between normal and Scribble-knockdown epithelial cells using Madin-Darby Canine
Kidney (MDCK) cells expressing Scribble short hairpin RNA (shRNA) in a tetracycline-induciblemanner.

Results(Project 1: Demonstration of cell competition in mammalian cell culture systems)
To examine the interaction between normal and Scribble-knockdown epithelial cells, weestablished MDCK epithelial cells stably expressing Scribble shRNA in a tetracycline-induciblemanner. We found that Scribble-knockdown cells undergo apoptosis when surrounded by normal
cells (Figure). Importantly, when Scribble-knockdown cells alone were present, no cell death wasobserved, indicating that the presence of surrounding normal cells induces death of Scribbleknockdown cells. This is the first demonstration that knockdown of a tumor suppressor proteincauses cell competition in mammalian epithelial cells. Bcl-2 homologous antagonist/killer (Bak)and Bcl-2 associated X protein (Bax) are proapoptotic members of the Bcl-2 family and promote
apoptosis through their effect on mitochondria. We found that Bak and Bax were activated in
Figure Knockdown of Scribble expression induces cell competition in
MDCK cells.
MDCK-pTR Scribble shRNA cells were f luorescently labeled with
CMTPX dye (red) and mixed with normal MDCK cells at a ratio of 1:10,
and cultured in the presence of tetracycline for the indicated times. Cells
were incubated with SYTOX Blue to label dead cells.

- 20 -

apically extruded Scribble-knockdown cells, suggesting the involvement of the mitochondrial
apoptosis pathway in their death.
Next we examined which signaling pathways are involved in this cell competition phenotype.
p38MAPK belongs to the MAPK family that is activated by various types of cellular stresses.
Immunofluorescence analyses with anti-phosphorylated p38MAPK antibody demonstrated
that p38MAPK activity was significantly enhanced in Scribble-knockdown cells surroundedby normal cells, but not in normal cells or Scribble-knockdown cells cultured alone. Additionof the p38MAPK inhibitor SB202190 significantly reduced activation of caspase-3 and deathof Scribble-knockdown cells surrounded by normal cells. Furthermore, expression of dominantnegative form of p38MAPK strongly suppressed death of Scribble-knockdown cells surroundedby normal cells. Collectively, these data indicate that p38MAPK plays a crucial role in cellcompetition between normal and Scribble-knockdown MDCK cells. Finally, inhibition of
p38MAPK significantly suppressed activation of Bak in Scribble-knockdown cells surroundedby normal cells, suggesting that the mitochondrial apoptosis pathway is one of the downstream
targets of p38MAPK.
These data were published in Journal of Cell Science (Norman et al., 2012, JCS).
(Project 2: Identification of molecules that specifically function at the interface between normal andtransformed epithelial cells)
To identify molecules that specifically function at the interface between normal and Srctransformed cells, we first cultured cells under three different conditions: i) normal MDCK cells
alone, ii) 1:1 mix culture of normal and Src-transformed MDCK cells, and iii) Src-transformed
MDCK cells alone. We found several molecules that predominantly immunoprecipitated with
anti-phospho-tyrosine antibody under the mix culture condition. Among them, using mass
spectrometry we identified the 280 kDa and 55 kDa proteins as filamin A and vimentin,
respectively. Both filamin A and vimentin were accumulated in the surrounding normal cells
at the interface with Src-transformed cells. In addition, when Src-transformed cells weresurrounded by filamin A-knockdown or vimentin-knockdown cells, apical extrusion of thetransformed cells from the epithelium was significantly suppressed, suggesting a positive role forfilamin and vimentin in the elimination of the transformed cells. Furthermore, we showed thatfilamin acts upstream of vimentin in these processes. This is the first report demonstrating thatneighboring normal epithelial cells are actively involved in the elimination of transformed cells
and that filamin is a key mediator in the interaction between normal and transformed epithelial
cells.
These data are now submitted to Nature (Kajita et al., 2012).

Discussion & Conclusion
In this study, we have shown that Scribble-knockdown MDCK cells and normal MDCK cells- 21 -

compete with each other for cell survival and that the former undergo apoptosis when surroundedby the latter. This is the first demonstration that an oncogenic transformation within an epithelium
induces cell competition in a mammalian cell culture system. The next important question is themolecular mechanisms of how cell death of Scribble-knockdown MDCK cells is induced in theprocess of cell competition. In my laboratory, we are now trying to identify molecules that play a
crucial role in the intercellular recognition between normal and transformed epithelial cells or in thefollowing signal transduction pathways.
Cell competition is a newly emerging field in cancer biology, which sheds light on the interaction
between normal and transformed epithelial cells at the early stage of carcinogenesis. It is hoped that
future studies will lead us to a novel type of cancer prevention and treatment.

References
1. Hogan, C., Kajita, M., Lawrenson, K., and Fujita, Y. (2011) Interactions between normal andtransformed epithelial cells: their contributions to tumourigenesis. Int. J. Biochem. Cell Biol., 43:
496-503.
2. Fujita, Y. (2011) Interface between normal and transformed epithelial cells —A road to a novel
type of cancer prevention and treatment. Cancer Science, 102(10); 1749-1755.
3. Norman, M., Wisniewska, K. A., Lawrenson, K., Garcia-Miranda G., Tada M., Kajita M., Mano,
H., Ishikawa, S., Ikegawa, M., Shimada, T., and Fujita, Y. (2012) Loss of Scribble causes cellcompetition in mammalian cells. Journal of Cell Science, 125(1): 59-66.

一般の皆様へ
がんは正常な細胞のがん遺伝子やがん抑制遺伝子に変異が蓄積することによって生じる。しかし、がんの初期段階において、正常細胞に最初の変異が起こった時に正常細胞と変異細胞の境界でどのような現象が起こるのかは明らかでなく、がん研究のブラックボックスとなっている。最近の我々の研究で正常細胞には変異細胞を認識し、それらを駆逐する能力があることが明らかになってきた。
これらの研究をさらに発展させることにより、「周囲の正常細胞に変異細胞を攻撃させる」というこれまでになかった新規のがん予防 ･ 治療法の開発へつなげていきたいと考えている。

- 22 -

Experimental verification of the abnormal neurodevelpmental
hypothesis of schizophrenia
Koh-ichi Nagata
Institute for Developmental Research, Aichi Human Service Center
knagata@inst-hsc.jp

Abstract
The membrane-associated guanylate kinase with inverted organization (MAGI) proteins consistof three members, MAGI-1, -2 and -3. We here prepared a specific antibody against MAGI1, and carried out biochemical and morphological analyses in rat neuronal tissues. By western
blotting, MAGI-1 was highly detected in nervous tissues, especially in olfactory bulb. Biochemical
fractionation clarified that MAGI-1 was relatively enriched in the synaptosomal vesicle and synaptic
plasma membrane fractions. Immunofluorescent analyses revealed diffuse distribution of MAGI-1
in the cell body and processes of primary cultured rat hippocampal neurons. Immunohistochemistrydemonstrated that MAGI-1 was mainly expressed in Purkinje cells and in hypocampal neurons.
Key Words : MAGI-1, synapses, neuronal development

Introduction
Schizophrenia is a mental disorder featured by various psychotic phenomena. Since schizophrenia
could be regarded as a neurodevelopmental disorder resulting from abnormalities of synaptic
connectivity, we attempted to clarify the function of MAGI-1 possibly involved in neuronaldevelopment. MAGI-1, a member of MAGI family, harbors six PDZ domains, a GUK domain andtwo WW motifs. Physiological functions of MAGI-1 have been investigated mainly in non-neuronaltissues; it is localized at cell-cell contact sites of various cells. MAGI-1 is likely to act as a scaffold
at cell junctions. However, little investigation has been done as for the physiological significanceand characterization of MAGI-1 in neuronal tissues. In the present study, we prepared a specificantibody for MAGI-1 and performed biochemical and morphological characterization of the protein
in neuronal tissues.

Results
Production and characterization of an antibody against MAGI-1.
To characterize the feature of MAGI-1 in neuronal tissues, we attempted to prepare a rabbit
polyclonal antibody for MAGI-1. We used a long fragment of human MAGI-1b (aa194-1256) as an
antigen. The resultant antibody however cross-reacted with MAGI-2 and MAGI-3, maybe due tothe amino acid sequence and structural similarities among MAGI proteins. We named this panMAGI antibody as anti-MAGI-1/2/3. We next affinity-purified a MAGI-1-specific antibody from theanti-MAGI-1/2/3 antiserum using GST-MAGI-1(aa194-295)-bound sepharose beads. The resultant- 23 -

antibody, termed anti-MAGI-1, selectively recognized MAGI-1 as expected, since only 11 aminoacids are shared among MAGI proteins in the 102 amino acids of MAGI-1(aa194-295) .
Biochemical characterization of MAGI-1 in the rat brain.
By western blotting with anti-MAGI-1, we analyzed the expression profile of MAGI-1 in a variety
of rat tissues and compared the results with those obtained with anti-MAGI-1/2/3. MAGI-1 was
expressed abundantly in brain tissues such as cerebrum, hippocampus and cerebellum. AntiMAGI-1 demonstrated specific expression profiles of MAGI-1 in several rat tissues including
liver, adrenal gland, uterus, extensor degitorum longus (EDL), ovary and testis. To characterize
further the expression of MAGI-1 in brain, various brain regions were dissected from adult rats andsubjected to western blotting using anti-MAGI-1. The results clarified that MAGI-1 is abundantin olfactory bulb. Biochemical subcellular fractionation of rat brain demonstrated that MAGI-1
was relatively enriched in the synaptosomal vesicle (LP2) and synaptic plasma membrane (SPM)
fractions, suggestive of MAGI-1 localization at presynaptic vesicles. On the other hand, results with
anti-MAGI-1/2/3 suggest MAGI-2 and/or MAGI-3 are enriched in the postsynaptic fraction.
Immunohistochemical characterization of MAGI-1 in the rat brain.
Sagittal sections stained with anti-MAGI-1 showed the protein localization in Purkinje cells in
cerebellum. In hippocampus, MAGI-1 was enriched in the cytoplasm of pyramidal cells. We further
performed immunohistochemical analyses to examine the MAGI-1 distribution. Consequently,
we found that MAGI-1 is highly expressed in the glomerulus region of olfactory bulb, a sphericalstructure where synapses form between olfactory nerve terminals and dendrites of mitral,
periglomerular and tufted cells. Additionally, MAGI-1 was recognized in a spinal cord in anembryonic rat: strong signal was detected in the dorsal root entry zone. These results imply that
MAGI-1 is involved in the regulation of neurite outgrowth or guidance of peripheral neurons. We
next examined subcellular distribution of MAGI-1 in primary cultured rat hippocampal neurons.
Immunofluoresence analyses with 3 days in vitro (DIV) neurons revealed that MAGI-1 distributes
diffusely in the cell body, axon and dendrites. When anti-MAGI-1/2/3 was used instead of antiMAGI-1, very similar staining pattern was observed. We then looked into the distribution of MAGI1 in 21DIV neurons, and it was distributed diffusely throughout the cell body, axon and dendrites.
Notably, MAGI-1 was localized at synapses. On the other hand, MAGI-1 expression and localization
were also observed at the neurite tip of dorsal root ganglia (peripheral) neurons. These results imply
that MAGI-1 is involved in the regulation of neurite outgrowth or guidance of peripheral neurons.

Discussion & Conclusion
Our present observations suggest that MAGI proteins are expressed in region- and cell typespecific manners in brain tissues. Further investigation with molecular cellular approaches and invivo analyses will be needed to clarify the physiological role of MAGI-1 in neuronal tissues.

- 24 -

References
Ito, Hidenori; Morishita, Rika; Sudo, Kaori; Nishimura, Yoshiaki; Inaguma, Yutaka; Iwamoto,Ikuko; Nagata, Koh-ichi
Biochemical and morphological characterization of MAGI-1 in the neuronal tissue.
Journal of Neuroscience Research in press

一般の皆様へ
統合失調症の発症の背景には神経組織の発達障害が関与するという仮説（発達障害仮説）があります。私共は、発達期の異常によって神経組織の形態形成障害が生じることで、神経細胞同士の情報伝達が阻害されることが統合失調症の病態と関連すると考えています。本研究では、神経細胞の相互作用と形態形成に重要な役割を果たすと考えられる蛋白質 MAGI-1 について解析をしました。

- 25 -

To detect susceptibility factor for mental disorders
based on genome and mouse
Nakao Iwata
Department of Psychiatry, School of Medicine, Fujita Health University
nakao@fujita-hu.ac.jp

Abstract
Genome-wide association studies (GWASs) of schizophrenia have provided a small numberof definitive risk genes, because this method requires very stringent level of significance. This
indicates a large number of subjects is essential for GWASs, the cost being very expensive. Anotherway to solve this problem is to prioritize possible risk genes using different methods, such astranscriptomics. In this study we conducted transcriptomics of mouse model of schizophrenia andcompared the results with those based upon GWASs. We found several risk genes for schizophrenia,
which require further replication study.
Key Words : Schizophrenia, transcriptome, genome-wide association study

Introduction
Several lines of evidence suggest that genetic factor contributes to susceptibility for major
psychiatric disorders, such as schizophrenia and bipolar disorder. Recently genome-wide association
studies (GWASs) detected a small number of risk genes with strong evidence of association forthese disorders. The effect size of such genes is relatively small, the odds ratio (OR) being less than
1.2. Therefore large number of subjects (case and controls, typically more than several thousands)
should be examined to avoid false positive or false negative. Otherwise, another method to enhance
the results by screening GWAS is required to obtain better candidate genes that should be followedup in the independent replication set with larger number of subjects. Transcriptomics, that measuresthe comprehensive expression level of RNA in tissue, is one of the best methods to prioritize
GWAS results. In this study, we conducted transcriptomic study of mouse brain exposed by several
antipsychotics under the hypothesis where the susceptibility genes for psychiatric disorders involvein genes influenced by antipsychotics. Finally we check the GWAS results for the significant genes
we obtained in the current study.

Results
1) Mouse transcriptomics
To generate mouse models of schizophrenia, mice were firstly exposed by methamphetamine(METH: 1mg/kg s.c for 1 week,N=5) a priori and then treated by a second generation
antipsychotics, risperidone (N=5). As a comparison control, saline was treated instead of METH
or antipsychotics (N=5). RNA from frontal cortex was extracted and Mouse Gene ST 1.0 chip

- 26 -

(Affymetrix) was used to evaluate the expression levels of all probes. Student’s t-test was used to
examine the difference of the expression level for each comparison (test1:METH-saline vs salinesaline, test2: METH-saline vs METH-risperidone, Figure1). In this analysis, we used the best P
value of the probes, if multiple probes were examined within a certain gene.
2) Integration of transcriptomics data with GWAS result
We consulted our GWAS data for schizophrenia to check the association of the genes detectedin the current transcriptomics study. We used gene-wide P values (not individual SNP-wise P
value, because gene-wide analysis has more statistical power) by VEGAS software.
283 genes showed significant differences in the comparison both of test1 (METH-Saline vsSaline-Saline) and test2 (METH-saline vs METH-risperidone). 203 out of 283 genes wereannotated to human genes, and SNPs in 15 genes showed significant association in the GWAS ofschizophrenia.
Two genes out of 15 significant ones are histone-related genes, encoding responsible proteins forthe nucleosome structure of the chromosomal fiber. Also it is of note that PTPRN which encodes
protein tyrosine phosphatase, receptor type N is in the same pathway listed as candidate factor
for schizophrenia based upon KO mouse (Takahashi et al, 2011, Biol Psychiatry).
Table1 shows that genes with significant P values in all analysis
Table1. Significant genes based upon transcriptomics and GWAS
Gene
NAV1
TRIM17
HIST3H2A
THBS1KSR2
HERPUD1
SORBS2USP21
GTF2IRD1
CREB3L4
HIST2H2AB
PTPRN
PSMD7
FBXO3

1) METH-saline vssaline-saline
0.03080.017420.014290.02458
0.004110.00364
0.002
0.00856
0.02934
0.04269
0.03449
0.02550.001540.012712) METH-saline vsMETH-risperidone
0.035170.001610.00146
0.03690.007180.01061
0.03905
0.016440.047350.02474
0.02653
0.02286
0.00267
0.0357SCZ GWAS
0.00440.01180.01260.01350.01470.01600.01610.02650.02970.03110.03720.03830.03950.0421

Discussion & Conclusion
In this study, we prioritized possible risk genes for schizophrenia based upon transcriptomic studyof mouse expression analysis and GWAS. Specifically PTPRN is one of the promising candidate
genes for susceptibility of schizophrenia, and further functional study will be essential.

- 27 -

The integration of independent data is one of the promising methods for selecting candidate
genes, because the very stringent level of significance which is normally used in the GWAS
(called genome-wide significant, P<5x10 -8) is not required. Therefore we can enhance the nominal
significant SNPs (e.g. P~10 -5 level) that should follow-up in the different set of samples in the genetic
association study.

References
Takahashi N, Nielsen KS, Aleksic B, Petersen S, Ikeda M, Kushima I, Vacaresse N, Ujike H, Iwata
N, Dubreuil V, Mirza N, Sakurai T, Ozaki N, Buxbaum JD, Sap J. Loss of function studies in miceand genetic association link receptor protein thyrosilne phosphatase alfa to schizophrenia. Biol
Psychiatry, 2011, 626-35

一般の皆様へ
全ゲノムを半網羅的に検証することが可能な全ゲノム関連研究（GWAS）は、疾患のリスク検出に大きな役割を果たした。しかし、精神疾患のリスク同定は、未だ完成したとは言えず、今後も様々な工夫が必要である。一つの理由として、GWAS は大量のサンプルが必要であるが、一つの研究施設などで収集できるサンプル数には限りがあり、どのようにリスク遺伝子の優先順位をつけていくかが課題となっている。本研究では、統合失調症の仮想のマウスモデルを用い、抗精神病薬投与して変化する遺伝子を同定し、これらと GWAS の結果を比較することを行った。このような複数の結果を統合することで、今後新たな統合失調症のリスク遺伝子同定につながると期待される。

- 28 -

Analysis of role of hypoxia inducible transcription factor in theregulation of metabolisms in liver and its pathobiological significancefor the development of metabolic diseases
Nobuhito Goda, MD. PhD.
Faculty of Science and Engineering, Waseda University
goda@waseda.jp

Abstract
Lowered oxygen concentrations often occur in various kinds of metabolic disorders including fatty
liver and diabetes, although its pathological significance remains elusive. To address this question,
we generated mice lacking a gene encoding hypoxia inducible factor (HIF)-α, a master regulatorof hypoxic response, in the liver. When exposed to ethanol, mice lacking HIF-1α, but not HIF-2α,
showed severer fatty infiltration through derepressing lipid synthesis. HIF-1α-deficient mice also
displayed insulin resistance and glucose intolerance to greater extents than control mice in response
to high fat/sucrose diet. These results suggest that HIF-1α serves as a protective mechanism against
fatty liver and diabetes.
Key Words : Hypoxia, liver, metabolism, HIF

Introduction
Liver is a central organ of metabolisms in the body, and its metabolic dysfunctions are associatedwith development of various metabolic diseases including diabetes and fatty liver. In thesemetabolic conditions, excess influx of nutrients disrupts balance of oxygen consumption and supply,
leading to formation of hypoxic conditions in the liver. Metabolic adaptation to hypoxia is largely
mediated by activation of HIFs, key transcription factors of hypoxic responses, and plays criticalroles in the regulation of glucose and lipid metabolisms. Thus, hypoxic remodeling of metabolism
seems to influence metabolic dysfunctions in disease conditions, however, pathological importanceof hypoxia in the development of liver metabolic diseases remains elusive.

Results
To elucidate pathological roles of HIFs in liver-associated metabolic diseases, we inactivated HIFα
gene in a hepatocyte-dependent manner based on Cre-loxP systems, and subjected these mice toeither ethanol-containing diet (ETD) or high fat/sucrose diet (HFSD). When exposed to ETD for 4
weeks, control mice showed modest accumulation of lipids in pericentral hepatocytes, distribution ofwhich were coincident with deposits of pimonidazole-protein adducts, marker of hypoxia. Consistent
with these findings, HIF-1α protein levels as well as its transcriptional activity were substantiallyelevated in the alcoholic fatty liver. On the other hand, loss of HIF-1α gene was found to enhance
lipid accumulation and deteriorate the fatty liver in response to ETD. The aberrant fatty infiltration- 29 -

was associated with increased levels of sterol responsive element binding protein (SREBP)-1c andits downstream target, acetyl CoA carboxylase (ACC) 1. Serum adiponectin levels were compatible
between the mutant and control mice, suggesting that the adiponectin-AMP kinase pathway is not
involved in hyper-activation of SREBP-1c in the mutant mice. Differentiated embryo chondrocyte(DEC) 1, a well-known target gene of HIF-1, was greatly up-regulated by ETD exposure in control
mice, whereas such an induction was completely abolished in the mutant mice. Forced expressionof DEC1 in the mutant liver ameliorated alcoholic fatty liver concomitantly with decreased mRNAlevels of SREBP-1c and ACC1. In addition, dimethyloxallyl glycine (DMOG), a HIFα prolylhydroxylase inhibitor that inhibits oxygen-dependent HIFα degradation and subsequently activates
HIFs transcriptional activity, reduced lipid accumulation by suppressing SREBP-1c expression inlivers of control, but not HIF-1α-deficient mice fed ETD. In a good agreement with these findings,
a lack of HIF-2α gene in the liver did not show any inf luences on the ethanol-induced lipid
accumulation compared to control mice,

Resultsalthough HIF-2α protein was also induced in response to ETD. To further confirm effects of HIF-1
on hepatic lipid metabolism, we treated mice with choline-deficient diet (CDD), an animal model of
non-alcoholic fatty liver disease. CDD induced large amounts of lipid accumulation predominantly
in periportal hepatocytes in control mice, whereas such fatty infiltration was accelerated in HIF-1αdeficient mice, although serum lipid levels did not differ between the two groups.
We next investigated effects of HIF-1α deficiency on liver glucose metabolism. Under normal
conditions, HIF-1α-deficient mice showed no apparent abnormal phenotypes with compatible serum
levels of glucose and insulin compared to control mice. In response to HFSD for 5 weeks, HIF1α expression was greatly induced predominantly in pericentral hepatocytes concomitantly withincreased liver hypoxia. HIF-1α-deficient mice still had compatible levels of glucose and insulin tocontrol mice under both fed and fasted conditions. However, the mutant mice showed modest, but
significant increase in blood glucose after oral glucose challenge without any difference in insulin
resistance and insulin secretion when compared to control mice. Longer exposure to the diet for 20
weeks, substantial glucose intolerance and insulin resistance were observed in both mice, but suchphenotypes were further deteriorated in HIF-1α-deficient mice. Consistent with these alterations,
phosphorylation of Akt was markedly reduced in response to insulin treatment in skeletal muscle
and adipose tissues of the mutant mice compared to that in control mice. In addition, islet area inpancreas was observed to decrease in HIF-1α-deficient mice, although the mice still had compatible
potential to secrete insulin in response to glucose. We also found that hepatic glucokinase (GK)induction was totally abrogated with substantial decrease in hepatic glucose uptake in the mutant
mice fed HFSD. However, other glycolytic and gluconeogenetic enzyme expressions did not differ
between the two groups.

- 30 -

Discussion & Conclusion
Our present study has clearly demonstrated protective roles of HIF-1 induction against alcoholicand non-alcoholic fatty liver. Although aberrant lipid accumulation is a common phenotype, distinct
molecular mechanisms are involved in the fatty liver diseases. Enhanced fatty infiltration in HIF1α-deficient mice fed ETD is caused by DEC1-mediated desuppression of lipogenic transcription
factor, SREBP-1c. In contrast, our data also suggest that HIF-1 activation is a prerequisite forthe maintenance of gene expression involved in fatty acid β-oxidation in CDD-elicited fatty
liver by unknown mechanism. Taken together, HIF-1 serves as a critical determinant for hepatic
lipid metabolism by modulating both lipogenesis and lipolysis in the context-dependent manner.
In addition, our present findings showing effects of a lack of HIF-2 induction on hepatic lipid
metabolism strongly suggest that HIF has isoform-specific roles in the regulation of liver lipid
metabolism. Our present study also sheds light on roles of HIF-1 as an anti-diabetic factor in the
diet-induced metabolic disease. At present, we could not reveal molecular mechanisms of how lossof hepatic HIF-1 disrupts glucose metabolism, but HIF-1-mediated GK induction might serve as aprotective mechanism against the diet-induced impairments of whole-body glucose metabolism.
In conclusion, HIF-1 functions as a critical regulator of glucose and lipid metabolism in the liver.
Furthermore, present findings provide evidence that HIF-1 is a promising therapeutic target against
fatty liver diseases and diabetes.

References
1. Ochiai D, Goda N, Hishiki T, Kanai M, Senoo-Matsuda N, Soga T, Johnson RS, Yoshimura Y,
Suematsu M. Disruption of HIF-1α in hepatocytes impairs glucose metabolism in diet-induced
obesity mice. Biochem Biophys Res Commun, 415(3), 445-9, 2011.
2. Nishiyama Y, Goda N, Kanai M, Niwa D, Osanai K, Yamamoto Y, Senoo-Matsuda N, Johnson
RS, Miura S, Kabe Y, Suematsu M. HIF-1α induction suppresses excessive lipid accumulation inalcoholic fatty liver in mice. J Hepatol, 56(2), 441-447, 2012.
3. Goda N, Kanai M. Hypoxia-inducible factors and their roles in energy metabolism. Int J
Hematol, 95, 457-463, 2012.
4. Goda N. Hypoxia biology in health and disease. Int J Hematol, 95, 455-456, 2012.

一般の皆様へ
本研究では、肝臓における低酸素に応答した糖・脂質代謝リモデリングが、糖尿病・脂肪肝などの
生活習慣病に対して病態抑制機構として機能していることを明らかにした。この知見は、低酸素を病態形成の根底に抱えるがん、動脈硬化、虚血性心疾患などのさまざまな疾患の病態形成メカニズ
ムを、代謝リモデリングの観点から捉え直すことに繋がり、これらの疾患の形成や進展を理解する
上でも新しい概念を生み出す可能性があると期待される重要な研究と言える。

- 31 -

Mechanism of self-recognition regulating the homeostasis ofperipheral T cells
Kensuke Takada
Institute for Genome Research, University of Tokushima
takada@genome.tokushima-u.ac.jp

Abstract
Constitutive recognition of self-peptide-MHC complexes is important for peripheral T cellhomeostasis, but the nature of those self-peptides has been obscure. CD8 T cells are positively
selected through recognition of self-peptides produced by thymoproteasomes. This study showed
thymoproteasomes are not expressed in the peripheral tissues with which T cells can interact for
their homeostasis. In addition, CD8 T cells in beta5t-deficient mice could not retain naïve phenotype
after migration out of the thymus to the periphery. These findings suggested self-peptides used for
CD8 T cell homeostasis may differ from those recognized during positive selection.
Key Words : Lymphocyte, T cell, positive selection, homeostasis

Introduction
Following the development in the thymus, mature T cells are maintained in the peripherydepending on homeostatic cytokine signals and tonic T cell receptor (TCR) signals induced by therecognition of self-peptide-MHC complexes (1). While there is a general belief that self-peptides
used for thymic positive selection and peripheral homeostasis of T cells are identical, it has not been
directly elucidated. Thymoproteasomes are expressed in cortical thymic epithelial cells and playa central role in the production of self-peptides inducing positive selection of CD8 T cells (2,3,4).
Here, we examined how the self-peptides for positive selection and homeostasis of CD8 T cells are
related, using a mouse model deficient of thymoproteasom-specific proteolytic subunit, beta5t.

Results
1. Thymoproteasome is not expressed in the periphery
In the steady state, T cells circulate peripheral lymphoid organs including the spleen and lymph
nodes through the blood and lymph. T cells interact with dendritic cells and stromal cells inthese lymphoid organs to receive the signals for their homeostasis. We initially examined theexpression of beta5t by highly sensitive RT-PCR in the spleens and lymph nodes and various
cell subsets purified from these organs. Contrary to our expectations, the beta5t gene transcripts
were not detected at all in the peripheral organs, whereas expression of beta5t was apparent in thethymus in accordance with earlier studies (2,3).
2. Abnormal phenotype of peripheral CD8 T cells in beta5t-deficient mice- 32 -

In beta5t-deficient mice, CD8 T cells show a reduction (<25% of normal) in number andan alteration of TCR repertoire (2,3,4). In this study, phenotype of CD8 T cells in beta5tdeficient mice was investigated in detail by flow cytometry, and we found that CD8 T cells inthe secondary lymphoid organs of beta5t-deficient mice were enriched with CD44hiCD122hi
cells, which resembles memory T cells. Increased proportion of these memory-like cells was
first observed in mice between 7 and 10 days after birth and gradually enhanced with aging
of mice. This phenotypic abnormality of CD8 T cells was also seen in beta5t-deficient micewith OT-I TCR transgenic background, suggesting memory-like cells appear independently ofexogenous antigen recognition. On the other hand, the proportion of memory-like cells weresignificantly lower in mice bearing T cells with monoclonal TCR than in mice with polyclonal
T cells, presumably because of the competition for specific self-peptides among T cells withidentical TCR (intraclonal competition) (1). Importantly, regression of phenotypic abnormality
in monoclonal T cells in comparison of polyclonal T cells was observed in both beta5t-sufficientand -deficient groups, suggesting the requirement of tonic TCR signals for the emergence ofmemory-like CD8 T cells at high frequencies in beta5t-deficient mice.
3. Peripheral CD8 T cells in beta5t-deficient mice is a stable population
We examined whether increased frequency of memory-like cells in beta5t-deficient mice isattributed to 1) increased development of memory-like cells in the thymus, 2) decreased thymic
egress of naïve cells, 3) differentiation of naïve cells into memory-like cells, 4) impaired survival ofnaïve cells, or 5) increased proliferation of memory-like cells. In beta5t-deficient mice, memorylike cells occupied a very small fraction of (less than 5%) of CD4-CD8+ mature thymocytes asin normal mice. There was no obvious changes in this frequency even after inhibiting thymocyte
migration from the thymus to the periphery by treatment of mice with FTY720, suggesting that
increased proportion of memory-like cells is neither due to increased development of memorylike cells in the thymus nor impaired thymic egress of naïve cells. Then, CD44loCD122lo naïve
CD8 T cells obtained from the peripheral lymphoid organs of beta5t-deficient and -sufficient
mice were adoptively transferred to normal mice and the phenotype and the survival of the donor
cells were examined overtime. Until 4 weeks after transfer, donor cells retained naïve phenotype
in both groups and the recovery of donor cells was similar. Normal survival of naïve cells were
further supported by the results of in vitro culture performed in the presence or absence of IL-7,
a primary survival factor of naïve T cells. In addition, donor cells including CD44hiCD122hi andCD44loCD122lo populations obtained from beta5t-deficient and -sufficient mice were labeledwith carboxyfluorescein succinimidyl ester and were transferred into normal mice to examine
the cell proliferation. In both beta5t-deficient and -sufficient groups, division of donor cells was
not observed or very limited. These results indicated that CD8 T cells, regardless of naïve or
memory-like, in the periphery of beta5t-deficient mice are quite stable in number and phenotype.

- 33 -

Discussion & Conclusion
This study revealed a phenotypic abnormality of peripheral CD8 T cells in beta5t-deficient mice.
In beta5t-deficient mice, immunoproteasomes which are present in cortical thymic epithelial cells
at low levels produce positive selection-inducing self-peptides on behalf of thymoproteasomes(2,4). Differently from thymoproteasomes whose expression is strictly restricted to the thymus,
immunoproteasomes are systemically present in the immune cells. Therefore, in beta5t-deficient
mice, CD8 T cells that have differentiated dependently of immunoproteasomes in the thymus
are again exposed to the self-peptides produced by immunoproteasomes in the periphery. This
recognition of identical self-peptides for positive selection and homeostasis may lead to the failure
to maintain naïve phenotype of CD8 T cells. This hypothesis suggested from the findings in beta5tdeficient mice seems to be against the current T cell homeostasis model that self-peptides used
for T cell homeostasis is identical to those for positive selection. However, the background studies
which support the current homeostasis model were designed to examine CD4 T cells, not CD8
T cells (5,6,7). The further investigation of CD8 T cells in beta5t-deficient mice will reveal thecharacteristics of self-peptides for the development and the maintenance of T cells and lead to thebetter understanding of the mechanism of naïve T cell homeostasis.

References
1. Takada K, Jameson SC. Naïve T cell homeostasis: from awareness of “space” to a sense of “place”.
Nature Reviews Immunology 9: 823-832 (2009).
2. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, Tanaka K. Regulation of
CD8+ T cell development by thymus-specific proteasomes. Science 316: 1349-1353 (2007).
3. Nitta T, Murata S, Sasaki K, Fujii H, Mat Ripen A, Ishimaru N, Koyasu S, Tanaka K, Takahama
Y. Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells. Immunity 32:29-40(2010).
4. Takahama Y, Takada K, Murata S, Tanaka K. β5t-containing thymoproteasome: specificexpression in thymic cortical epithelial cells and role in positive selection of CD8+ T cells. Curr
Opin Immunol 24:92-98 (2012).
5. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selectionin the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity
11:173-181 (1999).
6. Viret C, Wong FS, Janeway CA Jr. Designing and maintaining the mature TCR repertoire: thecontinuum of self-peptide:self-MHC complex recognition Immunity, 10:559-568 (1999).
7. Lo WL, Felix NJ, Walters JJ, Rohrs H, Gross ML, Allen PM. The function of follicular helper T
cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol 10:1155-1161(2009).

一般の皆様へ
免疫系の主役である T 細胞は、体内に侵入した病原体や異物に由来するペプチドを自分の体の成分とは違うもの（非自己）として認識し、排除することで体を守っています。T 細胞がこれらのペプ
チドを非自己として認識するには、自分の体に由来するペプチド（自己ペプチド）を常に認識し続けることで、T 細胞自身が健康な状態に保たれなくてはなりません。私達は、T 細胞を健康に保つために必要な自己ペプチドの正体を解明したいと考えています。このような免疫系を健康に保つ仕組
みを理解することは、免疫の異常に起因する様々な病気の予防や治療に役立つと期待されます。

- 34 -

In vitro generation mature oocytes through factitious activation of
dormant primordial follicles
Kazuhiro Kawamura
Akita University School of Medicine
kawamura@yf7.so-net.ne.jp

Abstract
The goal of this project is to generate mature human oocytes capable for fertilization andsubsequent development from in vitro cultured ovarian tissues. In this project, we identified several
important factors that facilitate early follicle growth. Using these factors, we are trying to optimize
the method for tissue cultures of human ovaries.
Key Words : Primordial follicle, oocyte, PTEN, PI3K

Introduction
Under in vitro culture, a trial to obtain mature oocytes from primordial follicles in cultured ovaries
has only succeeded in mice in mammals. However, it has not established in human, because of lackof knowledge about the mechanisms of activation of dormant ovarian follicles and early folliclular
growth. Recently, we succeeded to activate dormant ovarian follicles by stimulation of the PI3K-Akt
pathway (1). Using this method, we attempted to establish in vitro culture system of human ovarianfollicles to generate mature oocytes.

Results
Although large follicles (antral stage) are known to grow in response to follicle stimulating
hormone (FSH), it is not clear the mechanisms of the development of early stage of small follicles.
Thus, we tried to identify important growth factors to stimulate early follicular growth based on
ovarian microarray analyses (2, 3).
C-type natriuretic peptide (CNP) encoded by the NPPC (Natriuretic Peptide Precursor C) gene
expressed in ovarian granulosa cells inhibits oocyte maturation by activating the natriuretic peptide
receptor (NPR)B (NPRB) in cumulus cells. Real-time RT-PCR analyses indicated increased
expression of NPPC and NPRB transcripts in somatic cells obtained from mice during prepubertal
development (from day 7–19 of age) in an age-dependent manner with negligible levels in oocytes,
associated with increases in ovarian CNP peptides in mice. In cultured somatic cells from infantile
ovaries and granulosa cells from prepubertal animals, treatment with CNP, but not ANP, led todose-dependent increases in media content of cGMP for both cell preparations. In contrast, nochanges in cAMP production after CNP treatment were detected for both types of cells.Also,
treatment with CNP led to dose- and time-dependent increases in follicle size, reaching levels
comparable to those induced by a cGMP analog, 8-bromo-cGMP. In contrast, treatment with ANP- 35 -

was ineffective. Furthermore, combined treatment with CNP and FSH led to further increases infollicle growth. Treatment of cultured ovarian explants from infantile mice with CNP, increased
ovarian weight gain that was associated with the development of primary and early secondary
follicles to the late secondary stage. In in vivo studies, CNP pretreatment led to a 56% increasein ovarian weight. Histological analyses indicated increases in the development of antral follicles
after CNP pretreatment followed by eCG. Some of these eCG-treated animals were further treatedwith an ovulatory dose of human (h) CG to check ovulation efficiency. Higher numbers of ovulated
oocyte were found in the oviducts of CNP-pretreated animals as compared with controls. Thesefindings suggest the ability of CNP to promote the development of secondary/preantral follicles
to the early antral stage, thus allowing efficient induction of ovulation by the subsequent eCGhCG treatment. In prepubertal mice, CNP treatment alone also promoted early antral follicle
growth to the preovulatory stage, leading to efficient ovulation induction by LH/human chorionicgonadotropin. Mature oocytes retrieved after CNP treatment could be fertilized in vitro anddeveloped into blastocysts, allowing the successful pregnancy and delivery of viable offspring.
To further elucidate molecular mechanisms underlying CNP stimulation of the development ofpreovulatory follicles capable of responding to the preovulatory hCG stimulation, we analyzed theexpression of diverse ovarian genes important for follicle maturation, steroidogenesis, and ovulation.
Treatment with CNP increased the expression of transcripts for LH receptor, progesterone receptor,
inhibin-alpha (inhibin-a), IGF-I, tissue plasminogen activator, key transcriptional factors (GATA6,
WT1, and Ccaat/enhancer-binding protein-alpha), and key steroidogenic enzymes (CYP11a1, CYP19,
and steroidogenic acute regulatory protein) in a time-dependent manner.

Discussion & Conclusion
Other than CNP, we identified different factors capable to stimulate early follicle growth (underreview). The stimulatory effects of CNP and other factors on early follicle growth were also
confirmed in human samples obtained from patients (unpublished data). Using these factors incombination with the method for activation of dormant ovarian follicles, we are trying to establishin vitro cultures of human ovaries to generate mature oocytes. We are also trying to find a suitable
method of large follicle culture in human without loosing cell-to-cell (oocyte-to-cumulus cell)communications, which is important for optimal maturation of oocytes.
Some materials and a person who hired to help experiments were also used for other projects toavoid waste and two papers were published (Sato et al. Mol Endocrinol 2012, in press, Kawamura etal. Endocrinology 2012, in press).

References
1. Activation of dormant ovarian follicles to generate mature eggs.,
Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK, Hsueh AJ.
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10280-4. Epub 2010 May 17.

- 36 -

2. C-Type Natriuretic Peptide Stimulates Ovarian Follicle Development.
Sato Y, Cheng Y, Kawamura K, Takae S, Hsueh AJ.
Mol Endocrinol. 2012 May 17. [Epub ahead of print]
3. Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa
cells to promote meiotic resumption of pre-ovulatory oocytes.
Kawamura K, Cheng Y, Kawamura N, Takae S, Okada A, Kawagoe Y, Mulders S, Terada Y,
Hsueh AJ.
Hum Reprod. 2011 Nov;26(11):3094-101. Epub 2011 Aug 23.

一般の皆様へ
本研究では、卵巣内で休眠状態にある原始卵胞を我々の開発した人為的活性化技術を用いて活性化させ、多数の活性化卵胞検体を得た上で、それらを検体として用いて体外培養によりヒト原始卵胞から成熟卵子を作出することを最終目的とした。本年度は初期卵胞発育に必要な新たな因子を見出すことに成功し、完全なる体外培養環境を構築すべく現在検討を進めている。

- 37 -

Critical molecular mechanisms to determine
brain size and neuronal population
Yoichi Kosodo
Kawasaki Medical School
kosodo@med.kawasaki-m.ac.jp

Abstract
A hallmark of neurogenesis in the vertebrate brain is the apical-basal nuclear oscillation inpolarized neural progenitor cells. Known as interkinetic nuclear migration (INM), these movements
are synchronized with the cell cycle such that nuclei move basally during G1-phase and apicallyduring G2-phase. Based on the results of time-lapse analyses and simulation model, I proposethat the basal migration of G1-phase nuclei depends on a displacement effect by G2-phase nuclei
migrating apically. Furthermore, I demonstrated that basal-to-apical active nuclear movement isinhibited by disruption of gene function of microcephaly causative gene.
Key Words : Brain development, Interkinetic nuclear migration, Neurogenesis

Introduction
A fundamental question of brain development is how the appropriate number of neurons, andultimately, the size of brain are determined. This can be re-phrased as, how do neural stem cells
know when to switch their mode of cell division from self-renewal proliferation to neurogenic
differentiation in a coordinated manner within the neuroepithelium, a pseudostratified epithelial
tissue in the developing brain. Dynamic movement of neural stem cells contributes to intermingling
the neuroepithelium, where neural stem cells undergo both self-renewing expansion andcommitment to neuronal differentiation. I propose that neural stem cells receive and exchange
signals for their cell-fate choice through rather “dynamic interactions” during brain formation,
which would ensure the regional homogeneity of the vertebrate brain. To understand how the
dynamic environment is generated, I pursued to unravel the mechanism of the “interkinetic nuclear
migration”, a nuclear migration associated with the cell cycle progression of neural progenitors in
the developing brain.

Results
To analyze nuclear movement during INM, I established a system that enabled to quantitatively
track the motion of individual nuclei in living tissue. Nuclei in the dorsal cortex of an E13.5 mousebrain were labeled by green fluorescent protein (GFP) containing a nuclear localization signal(NLS) using in utero electroporation. Labeled nuclei in cultures of brain slices were tracked using avideo imaging system. First, nuclear “ratcheting,” a forward and backward motion of nuclei, occurs
while the nuclei migrate toward the basal side during G1-phase. Second, during the basal-to-apical- 38 -

migration before mitosis (G2-phase), the nuclei show linear movements and faster kinetics than
nuclei that are moving in the opposite direction. Next, I demonstrated that INM in both directions
is dependent on microtubules, which indicates that microtubule regulation coupled with the cell
cycle might control the timing of nuclear migration. In this study, functions of Tpx2, a microtubule
associated protein, for proper basal-to-apical nuclear migration and for the cell cycle dependent
microtubule organization are determined. Tpx2 localizes on the apical process of G2-phase neuralprogenitor cell, but not on the G1-phase. Knocking-down of Tpx2 slowdowns the basal-to-apical
nuclear movement, and the conformation of microtubule bundling in the apical process is altered.
Next, I found that cell cycle arrest at G1-phase by overexpressing p18Ink4c induces the basal
accumulation of G1-arrested nuclei. This result suggests that nuclei of G1-arrested neural progenitor
cells migrate basally after mitosis at the apical surface under conditions in which surrounding cells
undergo normal INM. This raised the possibility of a specific mechanism that conveys nuclei fromthe apical to the basal region. To test whether the translocation system in the VZ is cell-autonomousor dependent on the activity of surrounding cells, I observed the behavior of fluorescent microbeads
in cultures of brain slices. As a result, beads showed basally-directed translocation. During thetranslocation, beads showed “ratcheting,” back-and-forth movement as observed in the migrationof G1-phase nuclei. I thus conclude that there is a mechanism by which beads translocate from theapical surface to the basal region through intercellular space in the VZ.
Microbead translocation in the brain slice suggests that G1-nuclei are driven in the apical-tobasal direction by a non-autonomous mechanism. However, such a mechanism is not immediately
apparent. One possibility is that active basal-to-apical migration of nuclei increases the nuclear
density high on the apical side of the VZ. The resultant close packing of nuclei may crowd out
free nuclei that have completed mitosis, so that they are pushed further away from the ventricularsurface. If this is the case, apical-to-basal migration should be affected by the acute perturbationof basal-to-apical migration of nuclei in G2-phase. To test this hypothesis, I arrested the cell cycle
at S-phase by drug treatment using hydroxyurea (HU) and performed time-lapse observations of
migrating nuclei. Under this condition, the average velocity of nuclei moving in the basal direction
was significantly decreased. I next tested whether microbead translocation is also perturbed by
the same drug treatment. Indeed, most fluorescent beads incorporated from the apical surface
translocated shorter distances after HU treatment.
Finally, to evaluate the possibility that apical-to-basal nuclear migration occurs as a resultof the displacement of nuclei in the apical VZ, I constructed a computational model for INM,
and qualitatively compared the outcomes predicted by the model with the experimental data (acollaboration with A. Kimura, National Institute of Genomics). This qualitative correlation supports
a model in which apical-to-basal nuclear migration is mainly driven by the displacement of nuclear
migration in the basal-to-apical direction during G2-phase.
From a mechanistic perspective, the role of centrosomes in INM is noteworthy. A close relationshipbetween neurogenesis and centrosomal functions is suggested from the identification of causative
genes of human autosomal-recessive primary microcephaly (MCPH genes). Indeed, knocking down

- 39 -

of one of such gene, CDK5RAP2, resulted in slowing down of basal-to-apical nuclear migration.
Currently, studies how slowing down of basal-to-apical nuclear migration gives rise to impaired
neurogenesis are taken place.

Discussion & Conclusion
The most remarkable finding of this study is that nuclear migration in the apical-to-basal direction
during G1-phase involves a passive, non-autonomous process dependent on the migration of nuclei
during G2-phase, which takes place toward the apical surface and results in a higher nuclear density
in the apical region and a lower nuclear density in the basal region of the VZ. In a packed tissue
such as the VZ of the embryonic brain, free, mobile nuclei redistribute so that the nuclear density
becomes homogeneous. Based on our experimental results and computational modeling, I propose
a displacement model of INM, in which, after mitosis, nuclei on the ventricular surface are driven
away from this surface by a collective displacement effect generated by other nuclei migrating
toward the ventricular surface. The model for INM explains how the dynamics of neural progenitors
harmonize their extensive proliferation with the epithelial architecture in the developing brain.

References
1) Kosodo Y. (2012) Interkinetic nuclear migration: beyond a hallmark of neurogenesis. Cell. Mol.
Lif. Sci. (in press)
2) Kosodo Y, Suetsugu T, Suda M, Mimori-Kiyosue Y, Toida K, Baba SA, Kimura A, andMatsuzaki F. (2011) Regulation of interkinetic nuclear migration by cell cycle-coupled active andpassive mechanisms in the developing brain. EMBO J. 30:1690-1704.

一般の皆様へ
神経前駆細胞の細胞核が細胞周期に従って組織内を往復運動するエレベーター運動は、発見以来 70 年以上その仕組みについて不明であったが、私は、神経管内腔に向かう核移行は微小管細
胞骨格の細胞周期依存的な安定化による「能動的」な運動であることに対し、逆方向の移行は組織内の細胞密度勾配に従った「受動的」な運動であることを示した（Kosodo et al, 2011；Kosodo,2012）。さらに、小脳症原因遺伝子の機能を胎生期マウス脳で阻害することで、エレベーター運動過程に異常が見られることが見出された。

- 40 -

Development of promising anticancer agents based onpractical total synthesis of marine natural products
Makoto Sasaki
Graduate School of Life Sciences, Tohoku University
masasaki@bios.tohoku.ac.jp

Abstract
An improved total synthesis of neopeltolide, a potent anticancer macrolide natural product, wasaccomplished. The newly developed concise route was successfully applied to the synthesis of
8,9-dehydroneopeltolide, a designed analogue with more potent antiproliferative activity than theparent natural product against human cancer cell lines.
Key Words : macrolide, anticancer agents, total synthesis, natural products

Introduction
Marine organisms are an enormously rich source of structurally diverse secondary metabolites ofnovel molecular architecture and potent biological activities. In particular, marine macrolide natural
products represent a rich source of structurally novel and potent anticancer chemotherapeutic agents.
However, many of these promising compounds are available only in extremely limited quantities andthus organic synthesis is the only way to address these problems. Nenpeltolide, a marine macrolide
isolated from a deep-water sponge, exhibits potent in vitro antiproliferative activity against several
cancer cell lines with nanomolar IC50 values and is expected to be a drug candidate for anticancer
agent. We report herein a novel analogue of neopeltolide based on an improved synthetic route.

Results
We have already reported a concise total synthesis of neopeltolide based on strategic applicationof olefin metathesis reactions [1]. In this research, we developed a more efficient route to thekey intermediate in our earlier synthesis, tetrahydropyran-containing fragment. The synthesisfeatures Nagao aldol reaction using a chiral 1,3-thiazolidine-2-thione derivative, Evans–Tishchenko
reduction of a β-hydroxy ketone with SmI 2 to establish 1,3-anti diol, chemoselective crossmetathesis reaction, and constructionof the tetrahydropyran ring throughoxa-Michael react ion u nder
thermodynamic control.
We designed a novel analogue ofneopeltolide, 8,9-dehydroneopeltolide,on the basis of our earlier structureactivity relationship studies [2]. The- 41 -

synthesis of 8,9-dehydroneoeptolide was successfully accomplished by using the synthetic routedescribed above. This dehydro analogue exhibited potent antiproliferative activity against A549
human lung adenocarcinoma and MCF7 breast cancer cell lines with IC50 value of 0.50 nM and 33
nM, respectively. The former activity was more potent than that of the parent compound (IC50 1.50
nM).

Discussion & Conclusion
We have accomplished a concise synthetic route to neopeltolide, an antitumor marine macrolide.
The synthesis features a convergent union of three fragments, of comparable complexity, in latestages of the total synthesis and was successfully applied to the synthesis of 8,9-dehydroneopletolide.
The designed analogue was equipotent or more active than the parent natural product and thus has
potential for further stereostructure-activity relationship studies. Further studies for the design andsynthesis of more potent structural analogues and molecular probes for elucidating the biological
functions of neopeltolide are underway.

References
1) H. Fuwa, A. Saito, and M. Sasaki, Angew. Chem., Int. Ed., 49, 3041–3044 (2010).
2) H. Fuwa, A. Saito, S. Naito, K. Konoki, M. Yotsu-Yamashita, and M. Sasaki, Chem. Eur. J., 15,
12807–12818 (2009).

一般の皆様へ
海洋生物が産生する化合物（海洋天然物）の中には、顕著な抗がん作用を示すものが数多く発見されており、新たな抗がん剤の候補として注目されている。しかし、海洋天然物の多くは微量成分であり、薬剤開発には化学合成による実用的な化合物供給法の開発が必須である。深海に生息する海綿から単離された強力な抗がん活性マクロリド天然物ネオペルトリドの超効率的な化学合成法を開発し、天然物を凌駕する抗がん活性を示す人工類縁体を合成した。今後さらに、化合物の最適化や作用機構の解明により新しい抗がん剤開発に繋がる可能性がある。

- 42 -

Molecular mechanisms of biological signal transduction
operated by gas molecules
Shigetoshi Aono
Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences
aono@ims.ac.jp

Abstract
We have studied the structural and enzymatic properties of a diguanylate cyclase from an
obligatory anaerobic bacterium Desulfotalea psychrophila, which consists of the N-terminal sensor
domain and the C-terminal diguanylate cyclase domain. The sensor domain shows an amino acidsequence homology and spectroscopic properties similar to those of the sensor domains of theglobin-coupled sensor proteins containing a protoheme. This heme-containing diguanylate cyclase
catalyzes the formation of cyclic di-GMP from GTP only when the heme in the sensor domain binds
molecular oxygen. The hydrogen bonding network plays a crucial role for the selective O2 sensing
responsible for the regulation of the enzymatic activity.
Key Words : Oxygen sensor protein, heme-based sensor, diguanylate cyclase

Introduction
Hemeproteins are a typical metalloprotein, which show a variety of function including oxygenstorage/transport, electron transfer, redox catalysis with various substrates. Besides these traditional
functions of hemeproteins, a new function of hemeprotein has been found recently, which is a sensor
of diatomic gas molecules or redox change. In these heme-based sensor proteins, the heme acts as
the active site for sensing the external signal such as gas molecules and redox change. Our researchinterests are focused on the elucidation of the structure-function relationships of these heme-based
sensor proteins.

Results
HemDGC was found to be a novel heme-based sensor protein that has the enzymatic activity of
diguanylate cyclase. The enzymatic activity for the formation of c-di-GMP from GTP was measured
for ferric, cyanomet, deoxy, oxy, CO-bound, and NO-bound HemDGC. Among them, only oxy
HemDGC showed the activity of diguanylate cyclase for the formation of c-di-GMP from GTP, but
ferric, cyanomet, deoxy, CO-bound, and NO-bound HemDGC did not at all. These results indicatethat O2 will be a physiological effector of HemDGC and will regulate the enzymatic activity of
HemDGC via the formation of the oxy-complex of the heme. Thus, the globin domain of HemDGC
acts as a sensor that can strictly discriminate O2 among external ligands capable to bind to the heme.
The specific interaction between the heme-bound O2 and surrounding amino acid residue(s) would
be responsible for the discrimination of O2 against other ligands. To elucidate the mechanisms by- 43 -

which HemDGC discriminate O2 against other ligands to switch on the enzymatic activity, weinvestigated the heme environmental structure of HemDGC by resonance Raman spectroscopy. The
Fe-O (νFe-O) and O-O (νO-O) stretching modes were observed at 566 and 1138 cm-1, respectively. The
νFe-O band is a sensitive marker of the status of hydrogen bonding interaction on the heme-bound O2.
The νFe-O frequency of HemDGC was similar to those of several non-vertebrate hemoglobins (Hbs)such as Ascaris suum Hb (566 cm-1) [1], Mycobacterium tuberculosis HbN (562-566 cm-1) [2-4], andParamecium caudatum Hb (563 cm-1) [5].
The Fe-CO stretching (νFe-CO), C-O stretching (νC-O), and Fe-C-O bending (δFe-C- O) modes wereobserved at 506, 1944, and 579 cm-1, respectively. The νFe-His band was observed at 226 cm-1 in deoxy
HemDGC. These results indicate that a histidine is the proximal ligand of the heme in HemDGC.
We prepared Y55F, Y80F, and Q81A HemDGC and characterized their spectroscopic andenzymatic properties to elucidate the functional roles of these amino residues interacting with theheme-bound ligand in the distal heme pocket.
The spectroscopic and enzymatic properties of Y80F HemDGC were similar to those of wild-type
HemDGC, indicating that the mutation of Tyr80 did not affect these properties. On the other hand,
the mutation of Tyr55 or Gln81 resulted in changes in the stability of the oxy form and the enzymatic
activity of these mutants. Y55F HemDGC did not show any activity at all for the production of c-diGMP, partly because this mutant could not form a stable oxy form. Thus, Tyr55 plays an importantrole for the stabilization of the heme-bound O2 to maintain the stable oxy form.
Though Q81A HemDGC formed a stable oxy form, it changed to the ferric form by autoxidation
rapidly compared with wild-type HemDGC. Though oxy Q81A HemDGC was active for theformation of c-di-GMP, the activity was lower than that of wild-type HemDGC. The reaction
stopped in 20 min due to the conversion of Q81A HemDGC from the oxy form to the ferric form by
autoxidation.
The mutation of Gln81 resulted in a change of the resonance Raman spectrum of the CO-boundform, as shown in Fig. 5. While wild-type and Y55F HemDGCs showed the νFe-CO band at 506 cm-1,
the νFe-CO band of Q81 HemDGC down-shifted to 496 cm-1. Taken together, Tyr55 and Gln81 arethought to form a hydrogen bonding network with the heme-bound O2.

Discussion & Conclusion
HemDGC from Desulfotalea psychrophila has an N-terminal globin domain and a C-terminal
GGDEF domain. In this work, we have showed that the N-terminal globin domain has a b-type
heme with a ferrous heme that can binds external ligands such as O2 , CO, and NO, and that
HemDGC shows the enzymatic activity of diguanylate cyclase that forms c-di-GMP from GTP only
when the heme in the N-terminal globin domain binds O2. These results indicate that HemDGC isa new member of globin-coupled O2 sensor proteins in which O2 regulates the diguanylate cyclase
activity of the C-terminal GGDEF domain. HemDGC shows different hydrogen bonding patterns- 44 -

between the O2- and CO-bound forms. The formation of the hydrogen bond between Tyr55 and theheme-bound O2, but not with CO, will play an important role for the discrimination of O2 against
CO.

References
1. T. K. Das, J. M. Friedman, A. P. Kloek, D. E. Goldberg, D. L. Rousseau. Biochemistry 39, 837842 (2000).
2. M. Couture, S. R. Yeh, B. A. Wittenberg, J. B. Witternberg, Y. Ouellet, D. L. Rousseau, M.
Guertin. Proc. Natl. Acad. Sci. U. S. A. 96, 11223-11228 (1999).
3. S. R. Yeh, M. Couture, Y. Ouellet, M. Guertin, D. L. Rousseau. J. Biol. Chem. 275, 1679-1684(2000).
4. Y. Ouellet, M. Milani, M. Couture, M. Bolognesi, M. Guertin. Biochemistry 45, 8770-8781(2006).
5. T. K. Das, R. E. Weber, S. Dewilde, J. B. Wittenberg, B. A. Wittenberg, K. Yamauchi, M. L. van
Hauwaert, L. Moens, D. L. Rousseau. Biochemistry 39, 14330-14340 (2000).

一般の皆様へ
近年、気体分子が生理的なシグナル分子として機能し、さまざまな生理機能の制御に関与していることが報告され、多くの研究者の注目を集めている。気体分子がシグナル分子として機能するためには、そのレセプター（センサー）タンパク質が必要不可欠である。本研究では、酸素分子のセンサー機能を有する新規なタンパク質 HemDGC を対象として研究を行い、HemDGC がどのようにして酸素分子をセンシングしているか、センシングされた酸素分子により HemDGC の機能がどのように制御されているかを明らかにした。

- 45 -

Regulatory mechanism of cell division by telomeres
Junko Kanoh
Osaka University
jkanoh@protein.osaka-u.ac.jp

Abstract
In Schizosaccharomyces pombe closed mitosis, the telomeres, tethered to the NE during
interphase, are transiently dissociated from the NE during mitosis. This transient dissociation fromthe NE is essential for accurate chromosome segregation, because forced telomere tethering to the
NE caused frequent chromosome loss. We found that the phosphorylation of the telomere protein
Rap1 during mitosis impedes the interaction between Rap1 and Bqt4, a nuclear membrane protein,
thereby inducing telomere dissociation from the NE. We propose that the telomere dissociation fromthe NE promoted by Rap1 phosphorylation is critical for the fidelity of chromosome segregation inclosed mitosis.
Key Words : chromosome, telomere, mitosis

Introduction
Efficient chromosomal movements are important for the fidelity of chromosome segregation;
however, movements are constrained during interphase by the tethering of many domains to the
nuclear envelope (NE). Higher eukaryotes undergo open mitosis accompanied by NE breakdown,
whereas lower eukaryotes undergo closed mitosis in which NE breakdown does not occur. Although
the chromosomal movements in closed mitosis are proposed to be restricted compared to open
mitosis, the cells overcome this problem by an unknown mechanism to segregate the chromosomes
accurately.

Results
To investigate the regulation of the physical interaction between telomeres and the NE during thecell cycle in S. pombe, we measured the distances between telomeres and the NE. Throughout theG2 phase, most distances were <0.2 μm (the diameter of the S. pombe nucleus is 2.0 – 2.5 µm). Thus,
the telomeres are continuously moving within the vicinity of the NE during G2 phase. In contrast to
the G2-phase distance, the distance during M phase was markedly increased (> 0.4 µm). These data
indicated that telomeres are transiently dissociated from the NE in M phase.
To clarify whether transient telomere dissociation from the NE during M phase is required forthe fidelity of chromosome segregation in closed mitosis, we forced the tethering of telomeresto the NE by expressing the Taz1-Bqt4 fusion protein (Taz1 is a telomere DNA-binding protein,
and Bqt4 is a nuclear membrane protein). We found that the Taz1-GFP-Bqt4∆N-expressing strain
lost mini-chromosome Ch16 after cell division at a markedly high frequency. These observations
demonstrated that transient telomere dissociation from the NE during M phase is required for proper- 46 -

chromosomal movements and thus the fidelity of chromosome segregation in closed mitosis.
To investigate the molecular mechanisms of telomere dissociation from the NE during M phase,the nature of Rap1, which binds to both Taz1 and Bqt4 for telomere tethering to the NE during
interphase, was analyzed. We found that Rap1 is highly phosphorylated, particularly during
M phase. Western blot analyses using phospho-specific antibodies have revealed that Rap1 is
phosphorylated at Ser213, Thr378, Ser422, Ser456, and Ser513 during M phase in vivo. The alanine
mutations (rap1-5A) increased the efficiency of the interaction between Rap1 and Bqt4, whereas thephospho-mimic mutations (rap1-5E and rap1-5D) decreased the efficiency, suggesting that Rap1
phosphorylation has an inhibitory effect on the Rap1-Bqt4 association.
Intriguingly, the distance in the rap1-5A mutant during G2 phase was markedly less than that in
the wild type (average, 0.13 μm). In contrast, the distances were clearly greater in the rap1-5E andrap1-5D mutants (average, 0.37 μm and 0.35 μm, respectively) than in the wild type. These datasuggest that Rap1 phosphorylation promotes telomere-NE dissociation by inhibiting the Rap1-Bqt4
interaction.
We investigated the physiological consequences of the abnormal kinetics of telomere-NE
dissociation in the rap1-5A mutant. The rap1-5A mutant lost mini-chromosome Ch16 at a higher
frequency (2.1-fold) than the wild type. Furthermore, the spindle assembly checkpoint, which blocks
metaphase-to-anaphase progression, was hyper-activated in the rap1-5A mutant; a higher proportion(2.6-fold) of the mutant cells showed the kinetochore accumulation of the Bub1 protein, which
recognizes tension-less kinetochores, than that of the wild-type cells. These results suggest thatthe shortened distances between telomeres and the NE by the rap1-5A mutation disturbs M phaseprogression.
We next determined which phosphorylated residue(s) of Rap1 is important for the telomere-NE
dissociation. rap1513A, but not any of the other single-alanine mutants, showed markedly shorter
distances between telomeres and the NE in G2-phase cells (average, 0.11 μm). In contrast, therap1513E mutant showed moderate elongation of the distance (average, 0.30 μm). These results suggestthat phosphorylation at Ser513 is the key for Rap1-Bqt4 dissociation and thereby for telomere
dissociation from the NE during M phase. Consistent with this mechanism, Ser513 phosphorylation
was observed during the early to middle stages of mitosis, a time during which telomeres are
dissociated from the NE. Ser513 is presumably phosphorylated by Cdc2 kinase, because Ser513 wasefficiently phosphorylated by p13suc1-associated kinases (the major kinase is Cdc2) in vitro.

Discussion & Conclusion
In our study, we discovered a novel regulatory mechanism involved in closed mitosis. Upon
entry into mitosis, telomeres are dissociated from the NE. The release of telomeres from the NE isrequired for faithful chromosome segregation. Phosphorylation of the telomere-binding protein Rap1
presumably by Cdc2 kinase induces its detachment from the nuclear membrane protein Bqt4. This
reaction, in collaboration with other unknown mechanisms, promotes telomere dissociation from- 47 -

the NE. Hence, we propose a model in which the telomere plays an important role in the dynamismof chromosomes during M phase. In a sense, the release of chromosomes from the NE may be
the common mechanism that is required for the proper movement of chromosomes in both closed
mitosis and open mitosis. In closed mitosis, cells show breakdown of the tethering of the telomere(and probably other chromosomal regions) to the NE, whereas chromosomes become free in open
mitosis following breakdown of the NE.

一般の皆様へ
生命の維持には、生命活動の司令塔である染色体（DNA がまとまって形作る構造体）が安定に維持されることが必要です。染色体が分配される細胞分裂期において、染色体の末端にあるテロメアという構造体が染色体の安定性において重要な役割を果たしていることを明らかにしました。
（テロ
メアは、細胞の老化に関与することがよく知られています。）- 48 -

Development of novel strategy for therapeutic angiogenesis
Tohru Minamino
Department of Cardiovascular Science and Medicine
Chiba University Graduate School of Medicine
t_minamino@yahoo.co.jp

Abstract
In this study, we performed both in vivo and in vitro investigations into the role of Sema3E/
plexinD1 in postnatal angiogenesis, and we found that these two molecules inhibit angiogenesis by
suppressing the vascular endothelial growth factor (VEGF) signaling pathway.
Key Words : angiogenesis, semaphorins, p53, diabetes

Introduction
The axon-guiding molecules known as semaphorins and their receptors (plexins) regulate
the vascular pattern and play an important role in the development of vascular network during
embryogenesis1, 2. Semaphorin3E (Sema3E) is one of the class 3 semaphorins, and plexinD1 isknown to be its receptor3. While these molecules have a role in embryonic vascular development,
it remains unclear whether the Sema3E/plexinD1 axis is involved in postnatal angiogenesis. The
objective of this study is to elucidate the role of Sema3E/plexinD1 in postnatal angiogenesis.

Results
Sema3E inhibited cell growth and tube formation by suppressing the vascular endothelial growth
factor (VEGF) signaling pathway. Sema3E suppressed VEGF-induced phosphorylation of ERK and
Akt. It is well accepted that both ERK and Akt are crucial for the intracellular signaling pathways
stimulated by hepatocyte growth factor (HGF) or basic fibroblast growth factor basic (bFGF) to
induce angiogenesis. Interestingly, Sema3E also inhibited bFGF or HGF-induced tube formation ina dose dependent manner. Moreover, Sema3E significantly inhibited bFGF-induced tube formationeven in the presence of the anti-VEGF antibody, whereas it did not inhibit HGF-induced tube
formation. These results suggest that besides the suppression of VEGF-induced angiogenesis, theanti-angiogenic effect of Sema3E was partially mediated by VEGF-independent mechanisms.
Expression of Sema3E and plexinD1 was markedly up-regulated in ischemic limbs of mice (2.5fold and 4.5 fold increase for Sema3E and plexinD1, respectively), and inhibition of this pathway
by introduction of the plexinD1-Fc gene or disruption of Sema3E led to a significant increase ofblood flow recovery (1.6 fold and 1.5 fold increase for the plexinD1-Fc gene treatment and Sema3E
disruption, respectively). Hypoxia activated the tumor suppressor protein p53, thereby up-regulating
Sema3E expression. Expression of p53 and Sema3E was enhanced in diabetic mice comparedwith normal mice (2 fold and 1.3 fold increase for p53 and Sema3E, respectively). Consequently,- 49 -

neovascularization after VEGF treatment was poor in the ischemic tissues of diabetic mice, while
treatment with VEGF plus plexinD1-Fc markedly improved neovascularization.

Discussion & Conclusion
The present study demonstrated that the Sema3E/plexinD1 axis inhibits postnatal angiogenesis ina murine model of hindlimb ischemia. Our results suggested that Sema3E inhibits angiogenesis byblocking activation of the VEGFR-2 and its downstream signaling pathway. Our results also suggestthat p53 has a crucial role in the induction of Sema3E expression in ischemic tissue, although theprecise mechanism of how p53 regulates Sema3E expression remains unknown. Since the antiangiogenic activity of p53 is important for tumor suppression, Sema3E/plexinD1 could be a potential
target for the treatment of malignancies with p53 mutations. It has been reported that hyperglycemia
activates p53 by increasing the production of reactive oxygen species. Thus, p53-induced upregulation of anti-angiogenic factors (including Sema3E) is likely to account for the impairment ofangiogenesis in patients with diabetes. Therefore, Sema3E/plexinD1 could also be a target for thetreatment of ischemic cardiovascular disease in diabetic patients because conventional therapeutic
angiogenesis is not very efficient in this patient population4, 5.

References
1. Eichmann A, Le Noble F, Autiero M, Carmeliet P. Guidance of vascular and neural network
formation. Curr Opin Neurobiol. 2005;15:108-115.
2. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour
angiogenesis. Nat Rev Cancer. 2008;8:632-645.
3. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol.
2005;6:789-800.
4. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease.
Part I: angiogenic cytokines. Circulation. 2004;109:2487-2491.
5. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease:part II: cell-based therapies. Circulation. 2004;109:2692-2697.

- 50 -

一般の皆様へ
セマフォリンは元々神経ガイダンス分子として発見された分子であるが、最近胎児期における血管形成にも重要な分子であることがわかってきた。そこで本研究では、成人期のセマフォリンの血管新生に対する作用を明らかにすることによって、次世代の血管新生治療を開発することを目的とした。
培養細胞やマウスモデルを用いた検討では、セマフォリンは血管内皮増殖因子の作用を抑制することによって、血管新生を負に制御していることがわかった。セマフォリンの発現は、老化分子 p53
によって正に制御されており、特に糖尿病マウスモデルなどでその発現の亢進がみられた。糖尿病
モデルにおいては、血管増殖因子などによる血管新生治療効果は著しく障害されていたが、セマフ
ォリンを併用することによって、その治療効果は著しく改善された。以上より、セマフォリンを用いた血管新生治療は、これまでの血管新生治療に抵抗性であった糖尿病患者などにおいて有効である
可能性が示唆され、次世代の血管新生治療の標的となりうると考えられた。

- 51 -

Spatio-temporal regulation of sensory neural circuit formation
Hiroshi Kawasaki
The University of Tokyo, Graduate School of Medicine
kawasaki@m.u-tokyo.ac.jp

Abstract
Elucidating the fundamental principles in the development of sensory neuronal circuits is oneof the important questions in neuroscience. Here, we selectively visualized layer 2/3 neurons andexamined their axonal organizations in the somatosensory cortex. We found that the axons oflayer 2/3 neurons run preferentially in septal regions of layer 4. Immunohistochemical analyses
revealed that at least two distinct steps are involved. Our results suggest that distinct developmental
principles mediate the formation of axonal organizations of layer 2/3 neurons in the somatosensory
cortex.
Key Words : somatosensory system, development

Introduction
Elucidating the fundamental principles in the development of sensory neuronal circuits is oneof the important questions in neuroscience. Although the mechanisms underlying the formationof neuronal circuits between the sensory periphery and the cerebral cortex have been extensively
examined, those of intracortical circuitries still remain elusive. To examine intracortical circuitries,
here we selectively visualized layer 2/3 neurons and examined their axonal trajectories in thesomatosensory cortex. We found a novel intracortical circuitry and developmental principles
underlying the formation of the intracortical circuitry.

Results
To elucidate the intracortical axonal trajectories of layer 2/3 neurons, we selectively expressed GFP
in layer 2/3 neurons of the mouse somatosensory cortex using in utero electroporation. Consistent
with previous reports, when in utero electroporation was performed at E15.5, GFP-positive neurons
were selectively located in layer 2/3.
Then we examined the axonal trajectories of layer 2/3 neurons in the somatosensory cortex. We
found that the axons of layer 2/3 neurons preferentially located in the septal regions of layer 4. GFP
signal intensities were significantly higher in the septal regions compared with barrel hollows. We
then examined the distribution patterns of GFP-positive axons in tangential sections of flattened
cortices. We found that GFP-positive axons were predominantly distributed all around barrel
hollows in a whisker-related pattern in layer 4. Our confocal microscopic analyses demonstrated that
there was a much higher density of GFP-positive axons in the septal regions. GFP-positive axons
formed mesh-like structures, with the majority of axons running radially and the remainder running- 52 -

obliquely.
It seemed possible that the axons of layer 2/3 neurons were just passing through the septal regions
without making any synaptic contacts. Conversely, it also seemed possible that the axons of layer 2/3
neurons could make synaptic contacts in the septal region of layer 4. To address these possibilities,
we examined the distribution pattern of a presynaptic marker protein. Using in utero electroporation,
we transfected layer 2/3 neurons with GFP-tagged synaptophysin, which accumulates at presynaptic
terminals when exogenously expressed. Intriguingly, we found a number of GFP-positive puncta,
suggesting that the axons of layer 2/3 neurons in the septal regions contain presynaptic structures.
This is indicative of a possibility that the spatial patterns of the axons of layer 2/3 neurons are
involved in the functioning of the neuronal circuitry in the somatosensory cortex.
Next, we examined the developmental processes of the axonal trajectories of layer 2/3 neurons.
We performed in utero electroporation at E15.5 and examined the distribution pattern of GFPpositive axons of layer 2/3 neurons at various time points during development. GFP-positiveaxons were distributed evenly without any specific preference until P6, and were found to bepreferentially located in the septal regions at P10 and thereafter. This suggests that the formationof the axonal trajectories of layer 2/3 neurons consists of two distinct steps: initial axon projection
without distinction of the septal and barrel regions, followed by the formation of axonal projections
preferentially located in the septal regions. To further uncover the detailed processes underlying theformation of the axonal trajectories of layer 2/3 neurons, it would be interesting to investigate threedimensional reconstruction images of single axon arbors derived from single layer 2/3 neurons.
To investigate the fine-scale structures of individual neurons in vivo, we developed and validated a
rapid genetic technique that enables simultaneous investigation of multiple neuronal properties withsingle-cell resolution in the living rodent brain. Our technique PASME targets specific small subsets
of sparse neurons in layer 2/3, layer 5 of the cerebral cortex and in the hippocampus with multiple
fluorescent reporter proteins such as PSD-95-GFP and GFP-gephyrin. This technique, broadly
applicable for probing and manipulating neurons with single-cell resolution in vivo, should provide
robust means to uncover the basic mechanisms employed by the brain, especially when combinedwith in vivo two-photon imaging and/or optogenetic technologies.

Discussion & Conclusion
We identified the novel intracortical axonal trajectories of layer 2/3 neurons in the somatosensory
cortex. The axons of layer 2/3 neurons were preferentially located in the septal region of layer 4.
It would be intriguing to search for similar axonal trajectories in other cortical regions containingcolumn-like structures such as ocular dominance columns. Because previous studies reported thatrats do not have column-like structures in the visual cortex, higher mammals such as carnivores andprimates might be appropriate for addressing this point.
It would be interesting to uncover the mechanisms underlying formation of the axonal trajectories
we found during development. At P6 the axons of layer 2/3 neurons ran radially regardless of- 53 -

barrels and septa. At P10, the axons started to locate preferentially in septa. This suggests that theformation of the axonal trajectories of layer 2/3 neurons may consist of two steps. It seems likelythat each step requires distinct molecular mechanisms regulating axon pathfinding. Pinning downmechanisms underlying the formation of axonal trajectories of layer 2/3 neurons would lead tobetter understanding of the general principles of intracortical axonal development.

References
1) Kawasaki H., Molecular signatures of parallel pathways in the visual thalamus, Visual Cortex,
Nova Science, in press
2) Yamasaki T., Kawasaki H. and Nishina H., Diverse roles of JNK and MKK pathways in the brain,
Journal of Signal Transduction, 459265, 2012.
3) Yamasaki T., Kawasaki H. (co-corresponding author), Arakawa S., Shimizu K., Shimizu S.,
Reiner O., Okano H., Nishina S., Azuma N., Penninger J. M., Katada T. and Nishina H., Stressactivated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex,
Journal of Neuroscience, 31, 16872-16883, 2011.
4) Ako R., Wakimoto M., Ebisu H., Tanno K., Hira R., Kasai H., Matsuzaki M. and Kawasaki H.,
Simultaneous visualization of multiple neuronal properties with single-cell resolution in theliving rodent brain, Molecular and Cellular Neuroscience, 48, 246-257, 2011.
5) Sehara K. and Kawasaki H., Neuronal circuits with whisker-related patterns, Molecular
Neurobiology, 43, 155-162, 2011.

一般の皆様へ脳神経系を理解することは、ヒトを理解することと言っても過言ではありません。従って、高次脳機能の基盤となる複雑かつ精緻な脳神経回路の情報処理機構や形成メカニズムの解明は、神経科学の最重要課題の一つです。我々は、視覚や体性感覚（触覚）などの感覚系神経回路を用いて、この課題に挑んでいます。これまでに新たな神経回路の同定、神経回路形成メカニズムに２段階ある
こと、さらには生体脳内で神経回路を可視化するための技術開発を行ってきました。今後は回路形成異常がもたらす病態についても解析していきたいと思っています。

- 54 -

PHD2-inactivation and new strategy for a treatment of Ischemia/
Reperfusion Injury
Yoji Andrew Minamishima, M.D., Ph.D.
School of Medicine, Keio University / Japan Science and Technology Agency
yoji_andrew_minamishima@a7.keio.jp

Abstract
Prolyl-hydroxylase PHD1~3, also known as the “oxygen sensor”, negatively regulate hypoxic
response via transcriptional factor hypoxia-inducible factor (HIF), a master regulator of hypoxic
responses. PHDs are inactivated when oxygen is limited, which stabilizes HIF and turns on various
hypoxic response. Among three PHDs, PHD2 is known to be a dominant hydroxylase for HIF in
vivo. Therefore, inactivation of PHD2 is supposed to be protective against hypoxia and here we’ve
hypothesized that PHD-inactivation might bring beneficial outcomes on ischemia/reperfusion (I/R)injuries including myocardial infarction.
Key Words : Ischemia-reperfusion injury, PHD, HIF, Hypoxia

Introduction
Inactivating PHD2 shifts cellular metabolism toward “hypoxic mode” HIF-dependent manner,which enables cells to be survived in hypoxic environment. The purpose of this study is to test thepotential beneficial effect of PHD2-inactivation in ischemia-reperfusion injuries, such as myocardial
infarction, using PHD2 knockout mice that we’ve established recently.

Results
As a mouse I/R-injury model (acute myocardial infarction model), left anterior descending(LAD) artery was clamped for 15 minutes before reperfusion (LAD-ligation assay) in Wt or PHD2
conditional knockout mice (PHD2 KO). PHD2 was inactivated by orally given tamoxifen 72 hours
prior to the surgery. Size of the infarction was significantly smaller in PHD2 KO mice than Wt
mice. Left ventricular end-diastolic pressure (LVEDP) was elevated in both Wt and PHD2 KO mice
during LAD-ligation, but rapidly decreased in PHD2 KO mice, suggesting cardiac function wasmaintained upon PHD2-inactivation. Taken together, inactivation PHD2 might be beneficial against
I/R injuries including myocardial infarction. However, mechanism of this cardio-protective effectupon PHD2-inactivation was still unclear.
We have focused on cellular metabolism in PHD2-defficient heart and revealed these findings;(1) ATP levels of PHD2-KO hearts were significantly higher than Wt mice.
(2) Oxygen consumption rate (OCR) of the isolated cardiomyocytes was significantly lower in
PHD2 KO cardiomyocytes.
(3) Mitochondrial mass is smaller in PHD2-KO hearts and copy number of mitochondrial DNA- 55 -

was also significantly lower in PHD2 KO hearts.
(4) Metabolome analysis revealed that glycolysis was activated and mitochondrial respiration was
suppressed in PHD2 KO hearts.
(5) Long term inactivation of PHD2 in cardiomyocytes failed to maintain cardiac function
possibly due to remodeling of heart tissue, at least partially.
These data suggest that maintaining higher ATP levels with lower oxygen consumption and lessmitochondria via anaerobic glycolysis in cardiomyocytes might contribute to better outcomes upon
I/R-injuries upon PHD2-inactivation.
However, inactivation of PHD2 on I/R-injury must be limited to short term to avoid detrimental
effect, such as cardiac failure.

Discussion & Conclusion
Here we showed the beneficial effect of hypoxic responses by PHD2-inactivation in mouse LADligation model. This suggests that PHD2-inactivation might have global tissue protection effectagainst I/R-injuries.
I/R-injuries could be an issue not only in ischemic diseases including myocardial infarction orbrain stroke, but in organ transplantation, as well. It is still critical how to maintain the organfunction from the blockade of blood flow until the reperfusion. ATP-levels in the grafts havebeen a marker of tissue preservation. Our data showed that PHD2-inactivation can maintain thehigher tissue ATP levels, at least in hearts. Also, as already reported, treating donor with PHDinhibitor has better outcomes in rat kidney transplantation model. This could raise the possibility
that PHD-inactivation is also tissue-protective in other organ transplantation including liver, islet
or heart, where the long-term tissue preservation is difficult and donor is limited. Our mice modelof PHD-inactivation would be a powerful tool to study the mechanism of tissue protection in organtransplantation, as well.

References
1. Moslehi J, Minamishima YA, Shi J, Neuberg D, Charytan DM, Padera RF, Signoretti S, Liao R,
Kaelin WG Jr.
Circulation. 2010 Sep 7;122(10):1004-16.
2. Minamishima YA, Kaelin WG Jr.
Science. 2010 Jul 23;329(5990):407.
3. Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG Jr.
Mol Cell Biol. 2009 Nov;29(21):5729-41.
4. Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG Jr.
Blood. 2008 Mar 15;111(6):3236-44.
5. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schödel J, 5. Reisenbuechler A,
Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU.
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21276-81- 56 -

一般の皆様へ水酸化酵素 PHD は、我々の細胞内で “ 低酸素センサー ” として機能している。この低酸素センサ
ーが失活すると、細胞は自らが低酸素環境に陥ったものと勘違いして、低酸素環境でも生き延びることができるように、エネルギー代謝を低酸素モードに切り替える。この生理現象を逆手にとって、心筋梗塞などの虚血が関与する疾患の治療時に PHD を阻害する薬剤を使用すると、心筋梗塞サイズの縮小・心筋脳定価の抑制など、生体にとって有利な結果を導くことができるかもしれない。また、臓器移植など、血流の遮断と再灌流が関与する治療への応用、なかでも、ドナー不足や臓器保護時間が限られている心移植への応用が期待される。

- 57 -

Analysis of cell signaling-mediated phosphorylation and regulation of
nucleocytoplasmic transport machinery
Hidetaka Kosako
Institute for Enzyme Research, The University of Tokushima
kosako@ier.tokushima-u.ac.jp

Abstract
The nuclear pore complex (NPC) is composed of ~30 different nucleoporins (Nups), and about 10
Nups contain phenylalanine-glycine (FG) repeats that form a meshwork or brushwork barrier in thecentral channel of the NPC. We revealed that ERK and p38 MAP kinases efficiently phosphorylate
various FG and non-FG Nups in vitro and in vivo. The phosphorylation of FG Nups by MAP kinases
does not affect the overall architecture of the NPC but directly inhibits their interactions with NTRs
and regulates the permeability properties of the NPC.
Key Words : signal transduction, phosphorylation, nuclear transport, nuclear pore complex

Introduction
In eukaryotes, the nuclear pore complex (NPC) is a highly selective, bidirectional transporter fora wide range of material between the nucleus and cytoplasm. It is composed of about 30 uniqueproteins, collectively referred to as nucleoporins (Nups). Approximately a third of these Nups areclassified as FG Nups due to their content of phenylalanine-glycine (FG) repeat region, which
provides hydrophobic binding sites for nuclear transport receptors (NTRs) during the NPC passage.

Results
Recently, our multi-step phosphoproteomic approach combining IMAC (immobilized metal ion
affinity chromatography) and 2D-DIGE (fluorescent two-dimensional difference gel electrophoresis)
revealed a number of new ERK MAP kinase targets including Nup50 (also called Npap60).
ERK phosphorylation of the FG repeat region of Nup50 specifically reduced its interaction with
importin-β family proteins and regulated the permeability properties of the NPC in in vitro nuclear
transport assays (Kosako et al., Nat. Struct. Mol. Biol., 2009).
In this research, we have shown that both ERK and p38 MAP kinases efficiently phosphorylate
multiple FG and non-FG Nups in vitro. Phosphate-affinity SDS-PAGE using the Phos-tag
ligand followed by Western blotting (Kosako, Nat. Protoc., 2009) revealed that these Nups
are stoichiometrically phosphorylated by ERK and p38 in vivo. By preparing phospho-specificantibodies to several Nups, we have detected the spatiotemporal changes in phosphorylation ofthese Nups in cells (Kosako and Imamoto, Nucleus, 2010). Quantitative phosphoproteomic analysis
using phosphopeptide enrichment, chemical labeling with different stable isotopes, and LC-MS/MS(liquid chromatography-tandem mass spectrometry) was developed for simultaneous identification- 58 -

and quantitation of individual phosphorylation sites (Kosako and Nagano, Expert Rev. Proteomics,
2011). As a result, we detected and quantified over 100 phosphorylation sites of all Nups in control,
ERK-activated, and ERK-inhibited cell lysates. Then effects of phosphorylation of each FG repeat
region on interaction with different NTRs (such as importins, Tap/NXF1, NTF2, and Hikeshi) wereanalyzed qualitatively and quantitatively. Affinity capture experiments from total cell lysates showedthat interactions of FG Nups with various NTRs but
not with other Nups are sensitive to phosphorylationof FG Nups. Finally, MAP kinase activation has beenshown to inhibit nucleocytoplasmic translocation offluorescent reporters in digitonin-permeabilized cells.
These results suggest that MAP kinase signaling
pathways phosphorylate multiple nucleoporins in the
NPC to regulate nuclear transport.

Discussion & Conclusion
In higher eukaryotes, it has been well known that the phosphorylation of Nups causes thedisassembly of the NPC during mitosis. However, its roles in interphase were ill defined. Ourstudies suggest that signal transduction-mediated phosphorylation and regulation of nuclear
transport machinery may have a broad impact on cellular physiology. Until recently, many studies
have focused on phosphorylation of individual cargo proteins, such as transcription factors. There isincreasing evidence that Nups have multiple functions, some independent of their roles in transport
processes such as gene expression, mitotic progression, differentiation, and aging. An understandingof the effects of signaling pathways on nuclear transport machinery is only beginning to emerge,
and Nups and NTRs may function as molecular hubs for various signal transduction pathways.

References
1. Chow, K.-H., Factor, R. E. and Ullman, K. S. (2012) The nuclear envelope environment and its
cancer connections. Nature Rev. Cancer, 12(3), 196-209.
2. Grunwald, D., Singer, R. H. and Rout, M. (2011) Nuclear export dynamics of RNA-protein
complexes. Nature, 475(7356), 333-341.
3. Kosako, H. and Nagano, K. (2011) Quantitative phosphoproteomics strategies for understanding
protein kinase-mediated signal transduction pathways. Expert Rev. Proteomics, 8(1), 81-94.
4. Kosako, H. and Imamoto, N. (2010) Phosphorylation of nucleoporins: signal transductionmediated regulation of their interaction with nuclear transport receptors. Nucleus, 1(4), 309-313.
5. Kosako, H. (2009) Phos-tag Western blotting for detecting stoichiometric protein phosphorylationin cells. Nature Protoc. (Protocol Exchange), doi:10.1038/ nprot.2009.170
6. Kosako, H., Yamaguchi, N., Aranami, C., Ushiyama, M., Kose, S., Imamoto, N., Taniguchi, H.,
Nishida, E. and Hattori, S. (2009) Nature Struct. Mol. Biol., 16(10), 1026-1035.

- 59 -

一般の皆様へヒトなどの真核生物において多くの生命現象に関わる重要な細胞内での出来事の一つに、核膜孔と輸送運搬体との結合を介した、核と細胞質の間の選択的な物質輸送があります。私たちは細胞内での情報伝達に重要な MAP キナーゼという酵素が核膜孔タンパク質をリン酸化することにより、輸送運搬体との結合を抑制することを見出しました。細胞内情報伝達による核膜孔や輸送運搬体の調節の仕組みを明らかにすることは、核膜の突破が必要な遺伝子治療薬の開発などに役立つと考えられます。

- 60 -

Catalytic Asymmetric Synthesis of Tetrahydropyran Derivatives andStudy of Its Quantitative Structure-Activity Relationship
Takeshi Hata
Tokyo Institute of Technology
thata@bio.titech.ac.jp

Abstract
We reported that Rh-catalyzed cyclization of alkynyl benzyl ethers via C–H bond activation
afforded 2,6-cis-disubstituted dihydropyrans with high diastereoselectivity. This reaction wasapplied to syntheses of (–)-calyxin L (anti-cancer) and (±)-diospongin A (anti-osteoporosis).
Key Words : Asymmetric Synthesis, C–H Bond Activation, Rhodium Catalyst, Tetrahydropyran

Introduction
Transition-metal-catalyzed C–H bond activation is one of useful synthetic methods in organic
chemistry. We previously reported that Rh-catalyzed alkynyl benzyl ethers via C–H bondactivation affording dihydropyrans (eq 1).[1] As shown in eq 2, diastereoselective ring closure is also
viable and a substituent at the homopropargyl position controls the stereoselection to yield 2,6-cisdisubstituted dihydropyrans. Based on these findings, we examined the syntheses of (–)-calyxin L
and (±)-diospongin A by the above Rh-catalyzed C–H bond activation.

Results
Chiral alkynyl sulfone 3 (>99.9% ee) was readily prepared from commercially available (S)-malic
acid by several steps via diol 1 and propargyl alcohol 2 (Scheme 1).
Scheme 1. Preparation of Chiral Alkynyl Sulfone 3.

- 61 -

Treatment of 3 with a catalytic amount of the Rh catalyst gave the corresponding dihydropyran
4 with high diastereoselectivity. After the sulfone moiety in 4 was removed, epoxidation of theolefin and the treatment with DIBAL afforded the desired alcohol 6 as a single isomer via 5. Chiralalcohol 6 was converted to ketone 7 by Swern oxidation, which was followed by hydrogenolysis andbenzenesulfonylation to give an enantiomerically pure 8, a known intermediate of chiral (–)-calyxin
L[2] (Scheme 2).
Scheme 2. Formal Total Synthesis of (–)-calyxin L.

As the above synthesis of (–)-calyxin L, alkynyl benzyl ether 9 by the Rh-catalyzed reaction,
desulfonylation, epoxidation, and reduction afforded the desired alcohol 10 as a single isomer. Afterthe hydroxyl group of 10 was protected with triethylsilyl group, hydrogenation and Swern oxidation
provided the aldehyde 10, a known intermediate of (±)-diospongin A.[3] Actually, aldehyde 11 wastransformed into (±)-diospongin A by a three-step sequence (Scheme 3).
Scheme 3. Total Synthesis of (±)-Diospongin A.

- 62 -

Discussion & Conclusion
In conclusion, we reported a formal total synthesis of (–)-calyxin L from chiral alkynyl sulfone 3
catalyzed by a rhodium salt without lost of ee value. Similarly, a total synthesis of (±)-diospongin
A was completed by the above mentioned Rh-catalyzed C–H bond activation and cyclization.
Further investigations on developing of chiral Rh-catalysts for asymmetric C–H bond activationand synthesis of their derivatives for researching quantitative structure-activity relationships are in
progress.

References[1] Shikanai, D.; Murase, H.; Hata, T.; Urabe, H. J. Am. Chem. Soc. 2009, 131, 3166-3167.
[2] Washio, T.; Nambu, H.; Anada, M.; Hashimoto, S. Tetrahedron: Asymmetry 2007, 18, 26062612.
[3] Sawant, K. B.; Jennings, M. P. J. Org. Chem. 2006, 71, 7911-7914.

一般の皆様へ
炭素—水素結合 (C-H 結合 ) の活性化を用いる炭素—炭素結合形成反応は、反応基質を事前に官能基化する必要がなく、これまで官能基変換に要していた工程を削減できるため、天然有機化合物
合成の効率化に有効である。我々は置換ベンジルアルキニルエーテルにロジウム触媒を作用させると、その C-H 結合活性化を経て環化し、ビニルスルホン部位を有する 2,6- ジ置換ジヒドロピランを立体選択的に与えることを既に報告している（Journal of the American Chemical Society、2009 年）。
本研究では、この知見に基づき種々検討した結果、カリキシン L（抗ガン作用）の形式的不斉合成
およびディオスポンジン A（抗骨粗鬆作用）のラセミ体全合成を達成した。

- 63 -

How does energy metabolism affect sex differentiationand stem cell regulation?
Minoru Tanaka
National Institutes of Natural Sciences,
National Institute for Basic Biology, Japanmtanaka@nibb.ac.jp

Abstract
Early gametogenesis, especially the number of germ cells, was regulated cell-autonomously
through stem-like germ cells by energy conditions. Interestingly it was found that these conditions
affect proper sex differentiation. We also establish the transgenic medaka that could monitor an ATP
amount in germ cells. These studies will collectively enhance the cellular and molecular studies ofthe effect of energy levels on the germline stem cell regulation.
Key Words : medaka, mutant, lipid, metabolism

Introduction
Using a model vertebrate, teleost fish, medaka, we have isolated mutants which shows the defectin gonadogenesis. One of the mutants, called zenzai, exhibits a phenotype of a gradual loss of stemtype germ cells and subsequently becomes sterile by a loss of germ cells. This suggests that energy
metabolism is associated with stem cell regulation. Therefore we have analyzed how stem-likegerm cells are regulated at molecular and cellular levels during the course of gametogenesis.

Results
In order to assess possible relations between germ cell regulation and energy levels, we haveaddressed the following four aspects.
1. First, we investigated if the developing gonad has germ cells that exhibit the character similar
to germline stem cells identified in medaka ovary (ref.1). Incorporation of BrdU indicated thepresence of quiescent type of germ cells, suggesting the presence of germ cells with the similar
character of germline stem cells. We revealed that the proliferating type of stem-like germ
cells, but not a quiescent type, was regulated by an ancient type of TGFβ family, amh (antiMullerian hormone) (ref.2). The AMH system functions in an interfollicular manner but does notdirectly act on germ cells. Our result indicates that the activity of the AMH system modulates
somatic cells and the unknown factor secreted from the somatic cells functions to attenuate theproliferation of mitotically active stem-type germ cells.
2. Next we examined how stem like germ cells were affected by an energy level. Using transgenic- 64 -

medaka allowing us to observe germ cells and gonadal somatic cells by fluorescence (sox9bDsRed/olvas-EGFP), the transgenic larva were left in the starved conditions without feeding after
hatching. Gonadal development was then monitored for a month. Contrary to our anticipation,a preliminary result shows that the proliferation of stem-like germ cells was not severely
impaired in the starved conditions but the germ cell number was reduced. This implies that notproliferation of stem-type germ cells but some subsequent process in gametogenesis is regulatedwith an energy level. Loss of germ cells lead to the sex reversal to male phenotype, which isconsistent with our recent findings that germ cells are critical for proper manifestation of sex
directed by sex determination gene (ref.3-5).
3. As described in Introduction, zenzai mutant gradually decreases the germ cell number. We have
tried addressing the cellular mechanism affecting the mutant phenotype. In situ hybridization
analysis demonstrated that the gene is expressed in both the germ cells and the surrounding
somatic cells. We next generated chimera between wild-type and mutant medaka. Interestingly
the mutant germ cells in the wild-type somatic environment were decreased gradually in number,recapitulating the mutant phenotype, while the wild-type germ cells surrounded by mutant
somatic cells did not exhibit any phenotype found in the mutant. This clearly indicates that thegene functions germ cell-autonomously. Currently we are investigating if the mutant phenotype
is rescued with some pharmaceutical activators and/or inhibitors, thus trying to identify themolecular pathway regulating stem-like germ cells. In addition, we are examining the change of
expression levels of the genes at RNA and protein levels in the candidate pathway. The same typeof experiment is also ongoing for the starved medaka (mentioned in above 2).
4. Lastly we are developing the transgenic medaka that senses and indicates an intracellular ATP
level by fluoresncence. For this purpose, we established medaka lines that express ATeamfluorescent protein in germ cells. In the gonad of the transgenic medaka, CFP fluorescence is
detected in the germ cells. We are now examining if the fluorescence shifts from short to longwavelength by FRET in vivo. Also we have successfully established the method where germ cells
were isolated from the developing gonads with more than 98 % purity by FACS, which allows us
to evaluate the correlation of fluorescence with an ATP levels in the culture system.

Discussion & Conclusion
We have demonstrated the presence of stem-like germ cells in the developing medaka gonads.
The stem-like germ cells fall into two types, a quiescent type and mitotically active type. The
mitotically active type is regulated by the activity of anti-Müllerian hormone and loss of this signal
causes hyperproliferation of germ cells. The systemic energy levels do not seem to make a direct
effect on proliferation but regulate some subsequent process. This results in a gradual loss of germ
cells and the sex reversal to male phenotype, which is consistent with the analysis of zenzai mutant- 65 -

where lipid metabolism is impaired in the germ cells. These analyses collectively indicate thatgametogenesis is regulated by the systemic energy levels and the control of germ cells is necessary
for proper manifesation of sex.
For the direct assessment to energy levels, we have established transgenic lines which express
ATeam fluorescent protein (ATP sensing protein).

References
1. Nakamura, S., Watanabe, I., Nishimura, T., Toyoda, A., Taniguchi, Y. and Tanaka, M.
Identification of germline stem cells in the ovary of the teleost medaka. Science (2010) 328 15611563.
2. Nakamura, S., Watanabe, I., Nishimura, T., Picard, J-Y., Toyoda, A., Taniguchi, Y., di Clemente,
N. and Tanaka, M. Hyperproliferation of mitotically active germ cells dues todefective antiMüllerian hormone signaling mediates sex reversal in medaka. Development (2012) 139, 22832287.
3. Kurokawa, H., Saito, D., Ohta, K., Aoki, Y., Baba, T., Morohashi, K. and Tanaka, M. Germ cells
are essential for sexual dimorphism in the medaka gonad. Proc. Natl. Acad. Sci. USA (2007)
104, 16958-16963.
4. Saito, D. and Tanaka, M. Comparative aspects of gonadal differentiation in medaka: a conservedrole of developing oocytes in sexual canalization. Sex. Dev. (2009) 3, 99-107. (Invited Review).
5. Nakamura, S., Watanabe, I., Nishimura, T., Toyoda, A., Taniguchi, Y. and Tanaka, M. Analysis of
medaka sox9 orthologue reveals a concerved role in germ cell maintenance. PLoS ONE (2012)
7(1), e29982.

一般の皆様へ生き物にとって卵や精子産生のタイミングやその量など適切に制御することは、次世代を作り出す
ためには重要なことである。今回、メダカを用いた研究により、身体のエネルギーレベルが卵や精子を生み出す元の細胞（生殖細胞）を制御していることが明らかとなった。そしてその制御が適切でないと性転換を引き起こすことも示された。今後、エネルギーとして作用する物質を同定するとともに、その分子機構のより詳細な機構を明らかにし、生殖とエネルギーとの関係を解析していく予定である。

- 66 -

The role of CD11b+myelomonocyte in tumor vasculature related tocancer recurrence
Mitomu Kioi
Department of Oral and Maxillofacial Surgery,
Yokohama City University Graduate School of Medicine, Japan
kioi@yokohama-cu.ac.jp

Abstract
Radiotherapy and chemotherapy play a major role in the treatment of oral cancer as conservative
therapy. However, tumors recur or grow after those treatments in many cases. In this study, weinvestigated if the irradiation and chemo drug affect the tumor vasculature using human oral cancer
clinical samples and a xenograft mouse model. We found that irradiation induced recruitment ofbone marrow-derived CD11b+cells into tumors. This data suggests that recruited CD11b+ cells has amajor role for restoring tumor vasculature in irradiated oral cancer cells.
Key Words : CD11b+ bone marrow-derived cells(BMDCs) vasculogenesis

Introduction
In past several decades, oral cancer patients have been continuously increased, and it will be
estimated approximately 7800 in 2015, which accounts for 1~2% of all cancers or 40% of all headand neck cancers in Japan. Standard treatments for the patients with oral cancer are radiotherapy,
chemotherapy, and surgery. To prevent the functional and sensuousness disorder such as chewing,
swallowing, and articulator, social need of the conservative therapy has been growing. Despite theadvances of radiotherapy and development of anti-cancer drug, tumors invaluably recur within theradiation field, resulting in poor prognosis. Therefore, the local control of the primary tumor is very
important.
Tumor vasculature is required for tumor relapse and growth. The tumor vasculature can arise fromsprouting and proliferation of endothelial cells from local vessels (angiogenesis) or by colonizationof circulating endothelial or other cells, primarily derived from bone-marrow (vasculogenesis).
In this study, we explored if the tumor vasculature after irradiation depends on vasculogenesis
because tumor endothelial cells are not likely to survive the large doses of radiation.

Results
To investigate strong association between recurrence of oral cancers after chemo-radio treatment
and bone-marrow derived CD11b+ cells, we demonstrated following experiments.
We first examined to see if the chemo-radio treatment induces the recruitment of CD11b +cells in tumor recurrences using human clinical samples from the patients with oral cancer byimmunohistochemistry (IHC). We determined the levels of CD11b +cells in human oral cancers- 67 -

both prior to therapy and when the tumors had recurred in the same patients. We observed higher
levels of CD11b+cells in recurrent tumors compared with those in the untreated tumors in 8 out of 11
paired samples. (Fig.1A,B)
Next, we examined human oral cancer xenograft
mice models with immunof luorescent staining.
OSC-19 (human oral squamous cell carcinoma cellline) cells were inoculated s.c. at 1×107 cells/mouseon the back of the 6 weeks old, ♀, BALB/c nu/nu
mouse approximately 1cm proximal to the base of
the tail. Anesthetized mice were placed under thelead plate through which the established tumors(approximately 200 mm 3 in volume) protruded
for irradiation 15 Gy or 25 Gy. Tumor volume
was calculated using the formula: V=0.5 × width× length × depth. Irradiation of 25 Gy eradicatedthe established tumors completely. The tumors
irradiated 15 Gy were shrunk at once and thenshowed the regrowth. When 15Gy-irradiated tumors reached approximately 200 mm3 again, tumors
were collected by cardiac perfusion with 4% paraformaldehyde. As shown in Fig 2, we found thathigh levels of CD11b+cells in irradiated tumors compared with untreated tumors.
In addition, we investigated if anti-cancer drugs also induce the recruitment of bone marrowderived CD11b + cells into tumor in a mouse xenograft model. When tumors had reachedapproximately 200mm3 in volumes, docetaxel (20mg/kg, 40mg/kg) or cisplatin (5mg/kg, 10mg/kg)
were administered two times once a week. Currently these tumors have been underwent analyses.

Discussion & Conclusion
In this study, we showed that CD11b recruitment into tumor after irradiation was associatedwith tumor recurrence. CD11b expressing myelomonocytes are known to be associated withimmunosuppressant and secret inflammatory cytokines. In recent years, it is reported that thesecells have an important role on vasculogenesis in ischemic tissue, wound healing, and cancer, but
the detailed mechanism of tumor vasculogenesis has not been understood. Our data suggest that
irradiation induces recruitment of BMDCs into tumors, restoring the radiation-damaged vasculature
by vasculogenesis and thereby allowing the growth of surviving tumor cells in oral cancer.

References
1) Kioi M, et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of
glioblastoma after irradiation in mice. J Clin Invest.2010; 120(3):694-705.
2) Kerbel RS, et al. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
Science.2006; 312:1171-5.

- 68 -

3) De Palma M, et al. Tie2 identifies a hematopoietic linage of proangiogenic monocytes required
for tumor vessel formation and mesenchymal population of pericyte progenitors. Cancer
Cell.2005; 8(3):211-226.
4) K Zaleska , et al. Tumor-infiltrating CD11b+myelomonocytes and response to fractionatedirradiation of human squamous cell carcinoma(hSCC)xenografts. Radiotherapy and Oncology.
2011; 101(1):80-85.

- 69 -

Analyses of the pathophysiological elements of the deafness underlying
disorder of the cochlear endolymph
Hiroshi Hibino
Division of Organ Physiology, Graduate School of Medical and Dental Sciences,
Niigata University
hibinoh@med.niigata-u.ac.jp

Abstract
Hearing loss caused by damage of cochlea in inner ear affects many people in the world but its
pathophysiological sources remain largely unknown. To overcome such disease in the future,basis research that clarifies the mechanisms underlying sound-transduction in the cochlea isof importance. We have focused on the cochlear endolymph, an unusual extracellular solution
essential for hearing, and analyzed its functional roles and properties. In this study, we have utilized
theoretical approach and for the first time found that the circulation current, a continuous ionflux that unidirectionally flows throughout the cochlea, plays key roles in formation of uniqueelectrochemical environments of the endolymph. （30-100 語程度）
Key Words :（1-5 語程度）Hearing, inner ear, ion transport, deafness, computer simulation

Introduction
Sound-evoked mechanical stimuli permit endolymphatic K+ to enter sensory hair cells. Thistransduction is sensitized by an endocochlear potential (EP) of +80 mV in endolymph. After
depolarizing the cells, K+ is secreted into perilymph and then circulated back to endolymph acrossthe lateral cochlear wall. In theory, this entails a continuous and unidirectional current carried by
apical K+ channels and basolateral K+-uptake transporters in both the marginal cell and syncytial
layers of the lateral cochlear wall. The transporters regulate intracellular and extracellular [K+],allowing the channels to form K+ diffusion potentials across each of the two layers. These potentials
govern the EP. What remains uncertain is how this current might affect the characteristics of theendolymph. To address this question, we developed an electrophysiological model that incorporates
channels and transporters of the lateral wall and channels of hair cells that derive a circulation
current.

Results
In our model, the circulation current and the concentrations of ions in lateral wall compartments
were inferred from the function of ion channels and transporters as well as morphological featuresof the cochlea, which included three layers, i.e., the marginal cell and syncytial layers of the lateralwall and hair cell layer, and three extracellular spaces between these layers. We assumed that (1)ion transport apparatus interplay on each of the membranes of the lateral wall and hair cells andthese components are serially connected in a closed-loop circuit to represent the circulation current,- 70 -

and (2) the circulation current is coupled to all of the elements responsible for the EP including
the membrane potentials of the lateral wall and its spatial ionic concentrations. By using thiscomputational model, we calculated ionic concentrations and potential of intra/extracellular spacesin the lateral wall and the EP.
The simulation replicated normal experimental EP values. Therefore, the principle elements andconcepts underlying the model would seem to be valid. We previously found by the experimental
approach that, when basolateral K+-uptake transporters of marginal cells were blocked, intra/
extracellular [K+] in the lateral wall were drastically changed. This process modulated K+-diffusion
potentials of the lateral wall and reduced the EP. Our computational model reasonably reproduced
these experimentally-measured changes in the EP and intra/extracellular [K+] in the lateral wall.
Furthermore, the simulation revealed that, in such condition, the predominant carrier of thecirculation current switched from K+ to Na+ and Cl- at the basolateral membranes of marginal cell.
These additional ionic fluxes directly contributed to the change of ionic environment of the lateralwall. On the other hand, when K+ channels at the apical membranes of syncytial layers of the lateralwall are inhibited, the situation is completely different. In the experiments, this perturbation reduced
the EP with minimum alternation of the ionic milieu of the lateral wall. Our model successfully
mimicked such electrochemical properties in the cochlea. Of importance, when the K+ channels’
activity was reduced, the circulation current was immediately decreased but continued to be
dominated by K+. These two lines of in silico simulation imply that the circulation current associates
closely with the electrochemical properties of the lateral wall and the EP and affect them differently
in different conditions. We further simulated the process underlying the EP loss in a mouse model ofa chloride channelopathy called “Bartter syndrome” that is accompanied with deafness. The chloride
channels are expressed at the basolateral membrane of marginal cell layer and known to dysfunctionin the disease. Unexpectedly, in our model, strong blockage of the channels evoked additional
flux of Na+ through the concomitant non-selective cation channels at the basolateral membrane of
marginal cells and thus enlarged the potential difference across this membrane compartment. Thisabnormality of electrical profile is likely to underlie the loss of the EP in the mouse model and could
be responsible for the deafness of Bartter syndrome.

Discussion & Conclusion
In this simulation study, we demonstrated that the circulation current is closely correlated withformation of the EP in the cochlea. Also, our model showed how the EP would be reduced inchloride-channel null mice, which mimic Bartter syndrome associated with deafness. Theseobservations were achieved only by analyzing the circulation current and membrane currents withthe present computer-simulation approach, because these currents cannot be measured in vivo by
the current experimental protocol. Therefore, the findings are striking. Simultaneously, the basic ion
homeostasis and the main machineries establishing the endolymphatic properties including the EP
have been successfully reproduced and theoretically understood. With our computational model, the- 71 -

pathophysiological processes and mechanisms underlying other hearing disorders may be analyzed
and clarified in the future. Such endeavors could open an approach to develop new drugs for deaf
diseases.

References
Nin F, #Hibino H, Murakami S, Suzuki T, Hisa Y, #Kurachi Y. Computational model of a circulation
current that controls electrochemical properties in the mammalian cochlea. Proc Natl Acad Sci
USA, in press. (#equal corresponding authors)

一般の皆様へ音は外耳 • 中耳を経由して、内耳に到達します。我々は、内耳が原因で起こる難聴を克服するため、内耳の基礎的な研究を行っています。その中心として、内リンパ液という内耳を満たす体液を対象にしています。この液体は、他の体液には見られない電気現象があり、その成立の仕組みを、コンピューターシミュレーションを駆使して検討しました。すると、内耳全体を巡る「循環電流」という電流が内リンパ液の電気現象に重要であることが分かりました。また、循環電流を支えている普段は目立たない小さな電流が止まることで、遺伝性難聴が起こることも理論的に理解できました。この研究により、内耳が音を処理する仕組みがより深く解明されたのみならず、色々な難聴の病態理解や治療法開発に繋がると期待されます。

- 72 -

Synthesis of Welwitindolinone A Isonitrile and Its Analogues by
Catalytic Cycloaddition of Allenynes
Nozomi Saito
Faculty of Pharmaceutical Sciences, Hokkaido University
nozomi-s@pharm.hokudai.ac.jp

Abstract
Synthetic studies of welwitindolinone A isonitrile, belonging to oxyindole alkaloid
Key Words : welwitindolinone A isonitrile, ruthenium, allene, alkyne, [2 + 2] cycloaddition

Introduction
Welwitindolinone A isonitrile (1), isolated from blue-green algae, exerts fungicidal activity and isa densely functionalized oxindole including three all-carbon quaternary centers and a spiro-fused
cyclobutane1). Total synthesis of 1 was reported by Baran group2) and Wood group3) to date. On theother hand, we recently reported ruthenium-catalyzed [2 + 2] cyclization of 1,7-allenyne leading tobicyclo[4.2.0]octa-1(8),5-diene skeleton4), found in 1 as core-structure. With this as a background,
we planned total synthesis of 1 via our ruthenium-catalyzed [2 + 2] cyclization as a key step.

Results
Wood demonstrated that bicyclic compound 2 could
be converted into 1 in 7 steps (Scheme 1) 3). Thus,
we planned to synthesize 2 by our methodology. To
examine the feasibility of our plan, we conducted model
study first (Scheme 2). When allenyne 3a having asilyloxy group at propargylic position was treated withruthenium catalyst in methanol, desired product 4a was
not obtained, but triene
derivative 5a was producedin 75% yield. On the other
hand, the reaction of 3b
having hydroxy group gave
desired bicyclic compound
4b in 73% yield as a sole product.
Encouraged by this result, the reactionof 6 having a quater nar y carbon
center was conducted in the presenceof ruthenium catalyst (Scheme 3). As- 73 -

a result, desired bicyclic compound 7 was obtained in good yield.
Next, we conducted further transformation of 7 into synthetic intermediate 2. In order to install
oxygen functionality into allylic positionof six-membered ring, we examined allylic
oxydation of compound 8 under various
conditions. However, in all cases, thereaction gave complex mixture, and nodesired product 9 was produced.

Discussion & Conclusion
Based on above results, we decided to change the synthetic route. Thus, allenynes 10a-c having
an oxygen functionality on the allylic position were applied to [2 + 2] cyclization (Scheme 5). The
reaction of 10a bearing a silyloxy group did not give the desired product 11a but complex mixture.
On the other hand, allenyne 10b having a smaller SEM group gave 11b in 46% yield. Furthermore,diol 10c was also applicable to the cyclization, desired 11c was produced in 66% yield. These
results indicated that size of the oxygen functionality at allylic position was crucial to progress ofcyclization.
In conclusion, we conducted synthetic study of (+)-welwitindolione A isonitrile by rutheniumc a t a l y z e d [ 2 + 2] c y c l i z a t i o n o f
1,7-allenyne. In the course of the study,
we found that hydroxy groups in a chain
remarkably affected on the progress ofthe cyclization. Further studies along
this line are in progress.

References
1) Stratmann, K.; Moore, R. E.; Bonjouklian, R.; Deeter, J. B.; Patterson, G. M. L.; Shaffer, S.;
Smith, C. D.; Smitka, T. A. J. Am. Chem. Soc. 1994, 116, 9935.
2) Baran, P. S.; Richter, J. M. J. Am. Chem. Soc. 2005, 127, 15394.
3) Reisman, S. E.; Ready, J. M.; Hasuoka, A.; Smith, C. J.; Wood, J. L. J. Am. Chem. Soc. 2006, 128,
1448.
4) Saito, N.; Tanaka, Y.; Sato, Y. Org. Lett. 2009, 11, 4124.

一般の皆様へWelwitindolione A isonitrile（1）は天然からはごく少量しか得られないため、生物活性評価のために必要な十分量のサンプルを確保することが困難でした。従って 1 の効率的な全合成法の開発を通じ、1 の大量供給が可能となると考えられ、未だ見出されていない薬理作用を探索する道を拓くことができると期待されます。一方、確立した 1 の合成法を応用することにより、1 を基本骨格とした多様な誘導体を合成できると考えられます。これにより、全く新しい生理作用を示す誘導体を見出- 74 -

すことができる可能性があります。従って、本研究を進めることにより新規医薬品リード化合物や新しいバイオツールの創製に繋がると期待されます。

- 75 -

Structural Basis for Oxidative Stress Sensing by Keap1-Nrf2
Cytoprotective System.
Hirofumi Kurokawa
Tohoku University Graduate School of Medicine
hkuro@med.tohoku.ac.jp

Abstract
Keap1 is a substrate adaptor of a Cullin 3-based E3 ubiquitin ligase complex that recognizes
Nrf2, and also acts as a cellular sensor for xenobiotics and oxidative stresses. We have succeeded
crystallizing Keap1. X-ray data collection and structure determination are currently underway. We
also analyzed interactions of Keap1 and Nrf2 by Surface Plasmon resonance method.
Key Words : X-ray structure

Introduction
The up-regulation of detoxifying enzyme reduces the risks of cancer and other life-style-relateddiseases caused by reactive oxygen species and electrophiles. The oxidative-stress sensor protein
Kelch-like ECH-associated protein 1 (Keap1) and the transcription factor NF-E2-related factor
2 (Nrf2) play a major role for the induction of these protective enzymes through the antioxidant
response element (ARE). In order to clarify the oxidative stress sensing mechanism, structural andbiochemical analyses of Keap1 were performed.

Results
Upon exposure to oxidative and electrophilic stress, reactive cysteine residues in intervening
region (IVR) and Broad complex, Tramtrack, and Bric-à-Brac (BTB) domains of Keap1 aremodified by electrophiles. Previous reports suggest that cysteine residue 151 in BTB domain andcysteine residues 273 and 288 in IVR domain are important for the stress sensing by Keap1. Here
we focused on the reactive cysteine 151 in BTB domain. Keap1 BTB domain forms homodimer andinteracts with Cul3 protein. Biological function of Keap1 BTB is poorly understood due to the lackof structural information.
In order to obtain Keap1 fragment including BTB domain, we prepared various truncation mutant
of mouse Keap1. 6x His-tagged protein was successfully expressed in E. coli and purified by using
Ni-NTA column, and further purified by size exclusion chromatography. SDS-PAGE showed that the
purity of resulting protein sample is >90%. We performed crystal screening by using TOPAZ 1.96
Chip (Fluidigm Corporation) and found that two deletion mutants were successfully crystallized(Fig. 1a). Initial crystallization conditions, obtained by using Free Interface Diffusion (FID) method,were further optimized for vapor diffusion methods. X-ray data was collected at beamline BL-1A
at PhotonFactory Tsukuba (Fig. 1b). Using HKL2000 the data was processed. Structure solution- 76 -

was obtained by using molecular replacement methods by program Molrep. Further refinement andmodel building are currently underway by using program Coot.
In addition to the structure analysis of Keap1 BTB domain, we analyzed interactions of Keap1 DC
domain and Nrf2. Nrf2 has two Keap1 binding site. Our single particle electron microscopy analysis
showed that dimeric Keap1 binds monomeric Nrf2 at two sites. Somatic mutations were exclusively
found in these two sites of Nrf2 in cancer patients. Roles of each Keap1 binding site in Nrf2 are,however, largely unknown.
In order to analyze binding mode of Nrf2 and Keap1, 6x His- and GST-tagged Nrf2 fragments
including each Keap1 binding site were prepared. The His-GST-tagged Nrf2 samples were purified
by using Ni-NTA column. The purified proteins were immobilized to the sensor chip. Purified
Keap1 was used as analyte for Surface Plasmon resonance analysis by using Biacore X100 (GEhealthcare). The kinetic analyses of Keap1 and Nrf2 binding showed distinct binding parameter of
two sites.

Discussion & Conclusion
Cancer and other life-style-related diseases caused by reactive oxygen species and electrophiles
can be prevented by the up-regulation of detoxifying enzymes. Nrf2 is a transcription factor
controlling the inducible expression of these cytoprotective enzymes. Keap1, a regulator of Nrf2, isemerging drug target for various diseases including multiple sclerosis and chronic kidney disease(CKD) in type 2 diabetes. Small molecules, which inhibit Keap1-Cul3 E3 ligase, are potential drugs
for these diseases. Lack of the structure data of Keap1, however, prevents us from understanding theinhibition mechanism of these small molecule against Keap1. Our structural analysis of Keap1 may
offer an important insight of oxidative stress sensing mechanism as well as rational design of theinhibitors.

一般の皆様へ酸化ストレスや親電子性分子と総称される毒性物質は癌や生活習慣病を引き起こすことが知られています。一方、生体にはこれを解毒・排出する生体防御システムが存在します。その中心が Keap1と呼ばれるストレスを感知する生体分子で、近年、新たな創薬ターゲットとして注目されています。
本研究では、Keap1 分子の詳細な三次元構造を明らかにします。本研究によって酸化ストレスを感知する分子機構が解明されれば、将来、Keap1 を標的とした生活習慣病の新たな予防薬開発が加速することが期待されます。

- 77 -

Pathological roles of a novel macrophage molecule M-mod
in type-2 diabetes
Hiroshi Kitamura
Nagoya City University
ktmr@med.nagoya-cu.ac.jp

Abstract
We investigated anti-diabetes function of M-mod (Macrophage-modulator) using gene-engineered
cells and mice. M-mod knockdown macrophage-like cells hampered insulin signaling of 3T3-L1
adipocytes accompanied by robust induction of type2 diabetes-deterioration molecules such as aP2
and PAI-1. On the other hand, macrophages from adipose tissues of obese M-mod transgenic mice
produced less amount of aP2 and PAI-1 compared from control mice. In agreement, composition of
immune cells in adipose tissues was dramatically affected in M-mod TG mice. Thus, M-mod seems
to modulate progression of type2 diabetes.
Key Words : macrophage, type2 diabetes, gene-engineered mouse, obesity

Introduction
M-mod is a novel molecule whose expression is dramatically repressed during the macrophage-like
differentiation of the leukemia cell lines. Our previous cell culture study indicated that M-mod isdispensable for macrophage-like differentiation. On the other hand, M-mod knockdown (KD) cells
indicated selective increase of various type2 diabetes-deterioration molecules such as aP2 and PAI1, indicating potential anti-diabetic effects of M-mod. In this study, we attempt to clarify roles ofM-mod as an individual level, and also molecular mechanisms underlying function of M-mod.

Results
1. At first, we performed some experiments strengthening involvement of M-mod in pathogenesis of
type2 diabetes.
A) Supernatant from HL-60 derivatives extensively expressing M-mod shRNA (M-mod KD
cells) remarkably suppressed insulin sensitivity of 3T3-L1 adipocytes.
B) Macrophages isolated from obese ob/ob mice show lower expression of M-mod compared with
control lean C57BL/6 mice.
2. To clarify roles of M-mod at an individual level, we assessed phenotypic changes of M-mod geneengineered mice.
C) We generated several lines of mice having M-mod transgene linked to a macrophage specificpromoter. Peritoneal macrophages isolated from these mice markedly expressed M-mod
compared with non-transgenic litter mates, indicating M-mod transgenic (TG) mice were

- 78 -

successfully generated.
D) M-mod TG mice did not exhibit any obvious changes in fertilization, growth, and feedingunder a normal feeding condition at least by 20 weeks.
E) When we gave high fat diet to M-mod TG mice, they increased body weight at the almost
same degree as their litter mate control mice. Similarly, soft tissue masses of liver, visceral(omental and epididymal) and subcutaneous adipose tissue of M-mod TG mice wascomparable to those of the control mice by 15 weeks.
F) M-mod TG mice did not display any decrease or increase in blood glucose, triglyceride, andcholesterol on both normal chow and high fat diet.
G) Fluorescence Activated Cell Sorting (FACS) analysis indicated that macrophage and otherimmune components in adipose tissues showed a unique pattern in M-mod TG mice.
H) Macrophages from adipose tissues of obese M-mod TG mice produced less amount of thetype2 diabetes deleterious molecules such as aP2 and PAI-1
I) Taking advantage of homologous recombination, we established more than 10 lines ofrecombinant mouse embryonic stem (ES) cells for generation of M-mod flox mice.
3. We also explore molecular mechanisms underlying function of M-mod.
J) We monitored total and phosphorylated several protein kinases in M-mod KD cells byWestern blotting analysis. We could not distinguished amount of phospho-MAPKs such as
ERK, p38 and JNK between the control and KD cells both before and after differentiation
stimuli. Moreover, M-mod KD cells did not modulated the PI3K cascade, verified by ratios ofphospho-PI3K/total PI3K as well as phospho-Akt/total Akt. Similarly, M-mod KD cells failed
to affect nuclear contents of PPARs (PPAR-alpha, gamma, and delta) and their binding partner
RXR.
K) Intracellular FACS analysis represented that cellular contents of phospho-STATs andphospho-p65 NF-kappaB subunit in M-mod KD cells were almost identical to those of control
cells.
L) Suspension arrays reproducibly indicated that knock down of M-mod did not affect binding
activities of >80 transcription factors including PPAR and NF-κB.
M) Comprehensive chromatin-immunoprecipitation (ChIP)-PCR analysis revealed that lysine
4 residue of H3 histone was hypermethylated in M-mod KD cells at aP2 locus. In contrast,
lysine 9 residue was ignorably affected by M-mod KD cells. On the other hand, M-mod KD
promoted acetylation of H4 histone at lysine 5 and 8.

Discussion & Conclusion
So far, we found M-mod KD promoted expression of some type2 diabetes exacerbation molecules,
suggesting roles of M-mod in pathogenesis of type2 diabetes. In this study, we performed extensive
experiments to validate this idea. As we expected, M-mod KD cells are capable to inhibit insulin- 79 -

signaling in cultured adipocytes reinforcing the suppressor function of M-mod. In addition, M-mod
TG mice slightly modulate accumulation of immune cells in adipose tissues accompanied byproduction of aP2 and PAI-1. In combination with the observation that macrophage from obese
individuals expressed M-mod at a low level, expressional changes of M-mod is one of the major
causes of pathogenesis of type2 diabetes.
In addition to verify pathophysiological roles of M-mod, we also attempt to uncover molecularmechanisms underlying function of M-mod in this study. We could found neither protein kinases
nor transcription factors affected by M-mod KD, indicating M-mod did not employ these signaling
molecules to regulate expression of type2 diabetes exacerbation molecules. On the other hand,
M-mod KD cells show remarkable changes in histone H3 methylation as well as H4 acetylation.
Thus, M-mod seems to be a novel epigenetic regulator affecting pathogenesis of type2 diabetes.
Further studies are needed to clarify molecular events controlled by M-mod.

References
1. Furuhashi M, Fucho R et al. Adipocyte/macrophage fatty acid-binding proteins contribute tometabolic deterioration through actions in both macrophages and adipocytes in mice. J. Clin.
Invest. 118(7), 26540-2650, 2008.
2. Kishore P, Li W et al. Adipocyte-derived factors potentiate nutrient-induced production ofplasminogen activator inhibitor-1 by macrophages. Sci. Transl. Med. 2(20), 20ra15, 2010
3. Sun K, Kusminski CM, Scherer PE Adipose tissue remodeling and obesity. J. Clin. Invest. 121(6),2094-2101, 2011.

一般の皆様へ
本研究では、マウスモデルを用いて、新たなマクロファージ分子 M-mod が２型糖尿病に特徴的な病変を軽減する知見を得た。細胞レベルの解析で、M-mod が２型糖尿病の進行に関わる分子の発現を抑えることを考え合わせると、M-mod が２型糖尿病治療の全く新たな抑制分子であることがより明らかになった。しかし M-mod が如何なる分子を介して標的分子の発現を制御しているのかな
ど依然課題は残る。ヒトでの M-mod の役割解明も合わせ研究を進め、抗２型糖尿病治療の分子標的としての M-mod の可能性をさらに探りたいと考えている。

- 80 -

Study of Inwardly Rectifying Potassium Ion Channels
Dr. Motohiko NishidaRikennishidamotohiko@gmail.com

Abstract
The interaction of Kir3 channels with G proteins was analyzed with surface plasmon resonance.
Key Words : ion channel, membrane protein, structural biology, surface plasmon resonanceIntroduction
Inwardly rectifying channels (Kir channels) are a family of potassium ion channels consisting of atetrameric assembly of homologous subunits. There are seven subfamilies of Kir channels (Kir1-7).
The activity of each subfamily is controlled by specific intracellular components. For instance, Kir3
opens in response to the release of G protein subunits Gβγ upon stimulation of G protein-coupled
receptors.
The ion conduction pathway of these channels is formed at the center of the tetrameric assembly
and is structurally divided into two parts, the cytoplasmic pore and the transmembrane pore.
Especially, the cytoplasmic pore is important for regulation of Kir channels. In order to understandthe mechanism of channel gating, it is necessary to obtain their structure in complex with regulatory
factors. As an initial step toward this goal, it is worth characterizing their interaction with regulatory
factors by employing other techniques besides electrophysiology.

Results
To begin with, I need to mention that some parts of the experimental result obtained from my study
can not be described here in detail since they are yet to be published.
The Kir3 channels are activated by the binding of Gβγ subunits and phosphatidylinositol
4,5-bisphosphate (Logothetis et al, 1987; Huang et al, 1998). The binding site of G proteins has
been proposed to reside primarily in their cytoplasmic portion and their dissociation constantfor Gβγ has been reported in the order of nanomolar (Ivanova-Nikolova et al, 1998). However, it
should be kept in mind that such information has been derived exclusively from experiments using
electrophysiological techniques in which binding parameters were estimated indirectly by recording
channel conductance. That means that, in such an experimental setting, it is unable to discern
whether mutations introduced to the channel affect directly the interaction with G proteins or gatingof the channel without impairing its association with G proteins.
Therefore, it is helpful to establish an experimental system in which physical association of Kir3
with G proteins or phosphatidylinositol 4,5-bisphosphate can be recorded directly. For this purpose,
I have employed surface plasmon resonance. There are four subtypes of Kir3 that have been

- 81 -

identified so far in mammals (Kir3.1-4). I have analyzed the interaction of some of them with G
proteins using their cytoplasmic portion. These were expressed in large quantity in Escherichia coli
cells and purified to homogeneity with a combination of affinity and gel-filtration chromatography.
Interestingly, some of these were purified as a tetramer that is a biological unit, whereas others
were not stable in the tetrameric form and instead appeared to dissociate into monomers, dimers or
trimmers in the course of preparation. Accordingly, the inner surface of these channels, which ismostly hydrophobic and normally buried inside the intact tetramer, was exposed to solvent. As for
G proteins, the dimeric Gβγ subunits were expressed in Spodoptera frugiperda cells and purified
to homogeneity with a combination of affinity, ion-exchange and gel-filtration chromatography as
well. The finally purified products were employed for the surface plasmon resonance experiment,
in which the interaction between the channels and Gβγ subunits has been detected. Next, I willsummarize how I interpret experimental sensorgrams of surface plasmon resonance.
Through the experiment, the proteins used as an analyte had been immobilized to a sensor chipby amine coupling. It is of notice that lysine residues are scattered broadly on the protein surface
of both the channels and Gβγ subunits. Therefore, I do not exclude the possibility that the binding
observed by surface plasmon resonance was caused in part by non-specific interactions between
them. Even though, I suppose that the binding of a subtype that retains the tetrameric structure toGβγ reflects physiological association inside cells upon stimulation of G protein-coupled receptors.
In this case, the sensorgram indicates that the association kinetic of the channel with Gβγ ismonophasic whereas the dissociation kinetic is biphasic. Obviously, the dissociation kinetic could
be resolved into two contributions from fast and slow rates. At this stage, it is not clear whether thisbiphasic nature of dissociation was brought about by multiple conformations of the channel structureor the involvement of non-specific interactions.
On the contrary, the interaction of channel subtypes that had dissociated into monomers, dimers
or trimers with Gβγ did not show this kind of property. In their sensorgrams, only a slow phase
was observed during dissociation. Therefore, in these cases, I suppose that this slow process of
dissociation is due mainly to non-specific interactions between the channels and Gβγ.

Discussion & Conclusion
The dissociation constant of the channel for Gβγ estimated by this study is in the order ofmicromolar, which is weaker than that estimated by electrophysiological studies (Ivanova-Nikolova
et al, 1998). It may be due to the absence of the transmembrane portion of the channel used for thesurface plasmon resonance experiment. Considering this situation, it is important to employ infuture experiments a full-length channel so as to evaluate the contribution of the transmembrane
portion to binding to G proteins (Nishida & MacKinnon, 2007). It is also important to performbinding experiments in the presence of phosphatidylinositol 4,5-bisphosphate, which is an essential
component for activation of Kir3 along with Gβγ. In order to exclude the effect of non-specificinteractions and enhance the contribution of physiological interactions in measurements, instead of- 82 -

immobilizing the channel or G proteins to the sensor chip by amine coupling, they must be attachedto the sensor chip via an antibody that recognizes epitope-tagged analytes. The understanding of
biophysical characteristics of this protein-protein interaction should be improved significantly bytaking these kinds of approach.
A lt houg h t he i nter act ion of K i r3 w it h G protei ns ha s been a nalyzed mai n ly w it helectrophysiological techniques so far, some reports included biochemical experiments in order tocomplement the information derived from electrophysiological studies. In some of these reports,
the interaction was analyzed by pull-down assay in which the cytoplasmic portion of the channel
had been fused to glutathione S-transferase so that they can be immobilized to glutathione agarose
beads without covalent reaction (Lei et al, 2000). However, for this assay, the channel seemed tohave been prepared not as a tetramer that is physiologically relevant but as a monomer. My study
suggests that the information obtained from such experiments should be interpreted very carefully
since they might just detect hydrophobic interactions between the inner surface of the channel and
G proteins.

References
1) Huang CL, Feng S, Hilgemann DW
Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gβγ.
Nature 391: 803-806 (1998)
2) Ivanova-Nikolova TT, Nikolov EN, Hansen C, Robishaw JD
Muscarinic K+ channel in the heart: modal regulation by G protein βγ subunits. J Gen Physiol
112: 199-210 (1998)
3) Lei Q, Jones MB, Talley EM, Schrier AD, McIntire WE, Garrison JC, Bayliss DA
Activation and inhibition of G protein-coupled inwardly rectifying potassium (Kir3) channels by
G protein βγ subunits. PNAS 97: 9771-9776 (2000)
4) Logothetis DE, Kurachi Y, Galper J, Neer EJ, Clapham DE
The βγ subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 325:
321-326 (1987)
5) Nishida M, Cadene M, Chait BT, MacKinnon R
Crystal structure of a GIRK1-prokaryotic Kir chanel chimera. EMBO J 26: 4005-4015 (2007)

一般の皆様へ
本書類に述べた蛋白質間相互作用の解析手法を更に発展させ、これを参考としつつ、医療において重要な意義のあるチャンネル蛋白質の制御の機構を、X 線結晶構造学的手法を用いて明らかとしたい。
また、本助成に採択される方々の研究は重要であり、そういった方々は関連した研究で他の助成団
体や国からの研究費を複数得ている場合が多いと推察する。そういった場合、本助成の研究費はこれのみで大型の研究を推進するほど多額ではないので、おそらく他からの資金源より、本人を含む
人件費や設備費等を支出しつつ、消耗品や旅費等に本助成金を使用するという場合が多いのではないだろうか。その場合、本助成による研究費は１年で使い切るというより、例えば、全額使用するのは５年間以内と延長するか、もしくは研究代表者を信頼し、思い切って無期限としてしまえば、大変使い勝手がよくなると私は思う。基礎研究は本来数年で完成する性質のものではない。従ってこれを長年かけて遂行する必要があるが、その際、諸事情によって、研究代表者が、必要な資金をど- 83 -

こからも得られなくなる年度も生じる可能性は充分ある。そこで研究を中断しなければならないとなると、これは非常に残念な事である。そういった際、もし本助成の期間が延長されており、これによる予算を随時使用できれば、例えば年度によって必要な消耗品が購入できなくなるといった事態が避けられる。あるいは、諸事情により本人を含む人件費すら捻出できない年度が生じた場合でも、予算をある程度額使わずにこれを保持しておけば、研究再開が可能となった年度より、ただちにこれを使用する事が可能となる。このような諸状況を想定すれば、私立の助成金で、たとえ小額であったとしても使い勝手の良い制度のものがあれば大変に便利であると私は思う。

- 84 -

Regulation of EGFR membrane trafficking
by ROCO family kinase LRRK1
Hanafusa Hiroshi
Nagoya University
q47371a@nucc.cc.nagoya-u.ac.jp

Abstract
Key Words : EGFR, LRRK1, membrane trafficking, phosphorylation

Introduction
Endocytosis and subsequent delivery of EGFR to lysosomes are essential for the degradationof many membrane-associated proteins. This process is crucial for determining the amplitudeof EGFR signaling, and is therefore tightly regulated. In spite of considerable effort researching
EGFR intracellular transport, the detailed mechanisms underlying endosomal trafficking of EGFR
is still not well understood. We have recently reported that Leucine-rich repeat kinase 1 (LRRK1)
is involved in the trafficking of activated EGFR, specifically in the progression from early to lateendosomes. In this study, we show that the EGFR-mediated tyrosine phosphorylation of LRRK1
plays an important role in the proper endosomal trafficking of EGFR.

Results
LRRK1 is phosphorylated at the Tyr-944 residue in response to EGF
We have recently shown that LRRK1 forms a complex with activated EGFR through a mutualinteraction with Grb2. We further observed that EGFR is co-immunoprecipitated with LRRK1
and is tyrosine phosphorylated in cells stimulated by EGF. So, we attempted to identify the sites in
LRRK1 that are tyrosine phosphorylated in an EGFR-dependent manner. The ROC-COR domain of
LRRK1 contains one EGFR tyrosine kinase consensus site (Glu-Glu-Glu-Tyr-Phe) at residue 944. To
examine whether this site is responsible for EGFR-mediated tyrosine phosphorylation, we generated
a polyclonal antibody against a peptide encompassing phospho-Tyr-944. As a result, phosphorylationof LRRK1 Tyr-944 was detected by this antibody upon EGF stimulation.
Phosphorylation of LRRK1 at Tyr-944 negatively regulates its kinase activity
Since phosphorylation represents an important posttranslational modification that regulates kinase
activities, we examined the effect of the non-phosphorylatable LRRK1(Y944F) mutation on these
activities. We found that compared to wild-type LRRK1, LRRK1(Y944F) showed much higher
autophosphorylation activity. We next examined the effect of EGF stimulation on LRRK1 kinase
activity. Cos7 cells were transfected with wild-type GFP-LRRK1 and then treated with EGF forvarious times. LRRK1 proteins were immunoprecipitated and assayed for autophosphorylation
activity. LRRK1 kinase activity was transiently activated by EGF stimulation, peaked at 10 min,- 85 -

and then declined. In contrast, the kinase activity of the LRRK1(Y944F) mutant was more enhanced
and was sustained for up to 120 min after EGF stimulation. These results suggest that LRRK1 isactivated in response to EGF stimulation and subsequently inactivated by EGFR-mediated Tyr-944
phosphorylation in a negative feedback fashion.
LRRK1 kinase activity regulates the motility of EGF-containing endosomes
Since the kinase activity of LRRK1 is required for motility of EGF-containing endosomes, we
examined the effect of LRRK1 hyper-activation on the dynamics of EGF movement in vivo using
time-lapse confocal fluorescence microscopy. The movement of EGF-containing endosomes wasfollowed in HeLa cells expressing GFP-LRRK1 at 15 min after a brief pulse of fluorescent EGF(Alexa 647-EGF). In addition to short-range movement, long-range rapid movement of GFP-LRRK1and Alexa 647-EGF-double-positive endosomes was frequently observed. When HeLa cells weretransfected with GFP-LRRK1(Y944F) and treated with Alexa 647-EGF, the frequency of EGF longrange movement was remarkably increased. These results suggest that hyper-activation of LRRK1
kinase activity enhances the long-range rapid movement of EGF-containing endosomes.
Hyper-activation of LRRK1 causes EGF/EGFR accumulation in perinuclear endosomes
Next, we investigated the effect of the LRRK1(Y944F) mutation on the intracellular distribution of
EGF/EGFR after EGF stimulation. We expressed GFP-LRRK1 in HeLa S3 cells and assessed EGF
localization by immunofluorescence using a fluorescently-labeled rhodamine-conjugated EGF (RhEGF) Cells expressing wild-type GFP-LRRK1 were briefly stimulated with Rh-EGF. By 10 min
post-stimulation, Rh-EGF was distributed in a fine, punctate pattern that co-localized with GFPLRRK1. After 30 min, weak punctate staining of Rh-EGF was co-localized with GFP-LRRK1
in the perinuclear region, suggesting that transport of EGF/EGFR from early to late endosomes.
After 60 min, most of the Rh-EGF signal had disappeared and GFP-LRRK1 was diffusely
distributed, suggesting that EGF/EGFR had been degraded in lysosomes and/or recycled. In GFPLRRK1(Y944F)-expressing cells briefly stimulated with EGF, the distribution of Rh-EGF at 10
min was similar to that observed in cells expressing wild-type LRRK1. However, at 30 min, both
Rh-EGF and GFP-LRRK1(Y944F) had accumulated in compartments in the perinuclear area andremained there up to 60 min after EGF stimulation. Thus, EGFR degradation appears to be impairedin these cells.

Discussion & Conclusion
Following clathrin-mediated endocytosis, activated EGFR is delivered to the lysosome fordegradation. This transport and lysosomal degradation of activated EGFR occurs rapidly,
presumably to limit excessive mitogenic EGFR signaling. The rapid kinetics of this process led us
to postulate the existence of a more specific mechanism that regulates EGFR endosomal trafficking.
Our findings here indicate that LRRK1 kinase activity plays a role in EGFR intracellular trafficking
as a cargo-specific regulator of EGFR endosomal transport.
In this study, we find that LRRK1 is phosphorylated at Tyr-944 in response to EGF stimulation- 86 -

and negatively regulated its kinase activity. Recent studies have shown that early endosomes movetowards the cell center as they mature. The process of endosomal maturation is coordinated with the
movement of endosomes along microtubules. This coordination appears to be disrupted by hyperactivation of LRRK1, as expression of LRRK1(Y944F) inappropriately promotes the motility of
EGF-containing endosomes. Therefore, the regulation of LRRK1 kinase activity might be important
to ensure the orderly and timely trafficking of endosomes containing EGFR.

References
Ishikawa, K., Nara, A., Matsumoto K., and Hanafusa, H.
EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper
endosomal trafficking of EGFR. Mol. Biol. Cell, 23:1294-1306 (2012).

一般の皆様へ活性化した上皮成長因子受容体（EGFR）は、細胞増殖シグナルを発信します。過剰な EGFR シグ
ナルは細胞の癌化を引き起こすことから、細胞は EGFR シグナルを素早く止める仕組みを備えています。リン酸化酵素 LRRK1 は、酵素活性依存的に EGFR の細胞内トラフィックを制御し、EGFR シ
グナルの抑制に機能していることを明らかにしました。

- 87 -

Analysis of the algal circadian clock for revealing
the evolutional history of plant-type circadian clocks
Takuya Matsuo
Nagoya University
t-matsuo@gene.nagoya-u.ac.jp

Abstract
We investigated the molecular mechanisms of the circadian clock in the green alga
Chlamydomonas reinhardtii. This study revealed that ROC75, a Chlamydomonas circadian clock
protein, is a transcriptional repressor functioning as a generator of circadian oscillation and as
mediator for the timing information of the clock to many cellular biological processes.
Key Words : Circadian rhythm, Green alga, Clock gene, Plant

Introduction
Circadian clocks are self-sustained molecular machinery to generate 24-h rhythm (circadianrhythm) and control timing of various biological processes to adapt the organisms to daily
environmental cycles. We identified the clock genes, which are core components of the molecularmachinery of clock, in the green alga Chlamydomonas reinhardtii. In this study, we investigated themolecular mechanisms of the Chlamydomonas circadian clock and compared them with those ofhigher plants circadian clocks.

Results
At first, we analyzed the mRNA expression patterns of six clock genes of Chlamydomonas in theclock mutant genetic backgrounds, and found that the clock gene mutations affect expressions ofother clock gene expressions. Especially, a mutation of a clock gene termed ROC75 was strongly
affect the expression of another clock gene ROC40. The ROC40 mRNA level was constantly
elevated in roc75 mutant throughout the circadian cycles. Since ROC75 encodes a protein having
the GARP DNA-binding motif, it was expected to be a transcription factor controlling ROC40
expression. Thus, in this study, we focused on
ROC75.
To analyze the ROC75 protein expression,
we introduced a hemagglutinin (HA) tag justprior to the stop codon of the ROC75 gene on a
genomic DNA fragment, and introduced it into
roc75 mutant. Since the tagged-ROC75 fullycomplemented the roc75 mutant phenotypes,
the ROC75-HA f usion protein would be- 88 -

functional in the Chlamydomonas circadian system. We analyzed circadian expression profileof the ROC75-HA protein by western blot. The ROC75 mRNA has been known to be expressedcircadianly peaking at the subjective early-mid day. ROC75-HA protein level also showed strong
circadian rhythm peaking at mid to late subjective day, which is slightly delayed from its mRNA
oscillation. The ROC75-HA rhythm was clearly antiphase to the mRNA oscillation of ROC40 gene,suggesting ROC75 is a repressor for ROC40.
Immunocytochemical staining using a HA antibody
indicated that this protein is a nuclear protein. Doublestaining with SYBR Green I or an antibody for the
nuclear pore complex revealed that ROC75-HA islocalized to the nuclear periphery. No obvious changesof localization were detected throughout the circadiancycles.
To investigate direct interaction of ROC75 with
ROC40 gene, we purified the DNA-binding motif of
ROC75 expressed in E. coli and analyzed binding to the
DNA fragment of the ROC40 promoter region by theelectrophoresis mobility shift assay. The DNA-binding motif clearly bound to the ROC40 promoter.
By analyzing binding to a series of DNA fragments of ROC40 promoter region, we identified
binding site of ROC75. In addition, we analyzed in vivo binding sites of ROC75 by the chromatin
immunoprecipitation combined to deep sequencing (ChIP-Seq). ChIP-Seq analysis revealed ROC75
binding sites more than one thousand, including not only ROC40 but also other clock genes (ROC15,
ROC66) and genes related to various biological processes. This result suggests that ROC75 regulates
not only clock oscillation itself but also many biological processes to output the timing informationof the circadian clock.

Discussion & Conclusion
Our results suggest that ROC75 is a transcriptional repressor functioning as a generator of
circadian oscillation and as mediator for the timing information of clock to many cellular biologicalprocesses. The expression profile and the target DNA motif of ROC75 suggest a part of molecularmechanisms of circadian clock is conserved between green algae and land plants. The large datasetof ChIP-Seq analysis will be useful for further investigation of the circadian-clock-regulation forvarious cellular physiological pathways, including growth, photosynthesis, lipid metabolism, which
will be involved in creation of basic technology for new bioenergy production.

References
1. T. Iida, T. Matsuo, and M. Ishiura: Role of ROC75 in the circadian oscillatory mechanisms in
Chlamydomonas. 発表予定

- 89 -

2. Y. Niwa, T. Matsuo, K. Onai, and M. Ishiura: Role of ROC15 in the circadian oscillatory
mechanisms in Chlamydomonas. 発表予定

一般の皆様へ
本研究では、これまでよく解っていなかった緑藻の生物時計の分子機構に関する新たな知見を多数得ることに成功しました。この成果は植物の生物時計の進化の過程を解明する手がかりとなります。また、近年盛んに研究が進められている緑藻を使ったバイオエネルギー生産の効率を高める手がかりにもなると期待されます。

- 90 -

The role of Cathepsin C in generating active IL-1 beta in vivo.
Hajime Kono
Teikyo University School of Medicine
kono@med.teikyo-u.ac.jp

Abstract
The aim of this study is to reveal how the active IL-1β is produced in vivo. IL-1β is transcribed
as an inactive pro protein and cleaved to become active form which can transmit signal via IL-1
receptor. Here we identified Cathepsin C is responsible for generating active IL-1β in vivo inaccordance with Caspase-1.
Key Words : cell death, inflammasome, IL-1, NLRP

Introduction
The sterile inflammatory response to cell death and irritant crystals is medically important because
it causes disease. Although these stimuli are structurally distinct, they cause inflammation througha common pathway that requires the cytokine IL-1. In vitro the inflammasome, and in particular its
generation of active caspase 1, is absolutely required to produce bioactive IL-1β. However, here we
report that caspase 1 is not required in vivo for much of the IL-1β-dependent sterile inflammatory
response.

Results
We find that cathepsin C, which controls the activity of a number of leukocyte serine proteases
capable of processing IL-1β, plays a major role in this caspase 1-independent pathway. Mice that are
deficient in cathepsin C have reduced inflammatory responses to dying cells and silica crystals. In
the absence of cathepsin C, caspase 1 becomes rate limiting so that mice that are doubly deficientin both of these proteases make little IL-1β in vivo and have markedly attenuated inflammatory
responses to the sterile stimuli. In contrast, these mutant mice generate normal inflammation in
response to exogenous IL-1β, indicating that cathepsin C and caspase 1 function upstream of IL-1β,
and in their absence, all components of the pathway downstream of mature IL-1β are intact.

Discussion & Conclusion
We believe that understanding how IL-1β is produced during sterile inflammation is importantbecause this process underlies a number of diseases. The inflammation that occurs in response tocell death can cause tissue damage and disease. Sterile inflammation to crystals underlies a numberof diseases including silicosis, gout, pseudogout, asbestosis and possibly also even atherosclerosis.
IL-1β has also been implicated in metabolic syndrome and type II diabetes among other diseases.
Our findings have implications for potential therapeutic targets to block IL-1 production and may
help to explain why caspase 1 inhibitors were not effective in clinical trials.

- 91 -

References
1. Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat Rev
Immunol 8:279-289.
2. Rock, K. L., and H. Kono. 2008. The inflammatory response to cell death. Annu Rev Pathol 3:99126.
3. Rock, K. L., E. Latz, F. Ontiveros, and H. Kono. 2010. The sterile inflammatory response. Annu
Rev Immunol 28:321-342.
4. Rock, K. L., J. J. Lai, and H. Kono. 2011. Innate and adaptive immune responses to cell death.
Immunol Rev 243:191-205.

一般の皆様へ
痛風や関節リウマチなどの熱や痛みを伴ういわゆる炎症性の病気に、サイトカイン IL-1βが重要な役割を果たしていることは知られていました。これまで代謝性疾患と考えられてきた動脈硬化や糖尿病も実は炎症性の病態が重要な役割を果たしており、IL-1βが重要な役割を果たしていることが最近判明しました。IL-1βの活性化機構についてはよく知られていませんでしたが、本研究においてこれまで知られていた caspase-1 に加えて cathepsin C という分子が IL-1βの活性化に必要と判明しました。

- 92 -

Functional characterization of NADPH oxidases andtheir regulators of endophytic fungus
Daigo Takemoto
Nagoya University
dtakemo@agr.nagoya-u.ac.jp

Abstract
We investigated morphological characteristics of knockout mutants of NoxA, NoxB and theirregulators, NoxR, RacA and BemA. On water agar, noxA, noxB and noxR mutants showed increased
hyphal branching and irregular curving, indicated that Noxs and regulators are involved in polarized
growth under starvation condition. In noxA mutant, formation of asexual conidia was increased.
Interestingly, mutation of regulators has no effect on conidiation. Hyphae of noxA, noxB, noxRand racA mutants lost the ability to form hyphal fusion. These results indicated that NoxA, NoxBand their regulators have distinct or overlapping functions for the regulation of different hyphalmorphogenesis.
Key Words : Conidiation, Endophyte, Hyphal fusion, NADPH oxidase, Reactive oxygen species.

Introduction
The endophytic fungus Epichloë festucae systemically colonizes the intercellular spaces ofhost grass to establish a mutualistic symbiotic association. We have previously shown thatreactive oxygen species produced by a specific NADPH oxidase isoform, NoxA, and associatedregulators, NoxR and RacA, have a critical role in regulating hyphal growth in the host plant tomaintain symbiotic infection. We also have identified BemA and Cdc24, homologues of polarity
establishment proteins of yeast, as interactors of NoxR. In this study, we further investigated themorphological characteristics of knockout mutants of NoxA, NoxB and their regulators, NoxR, RacA
and BemA.

Results
E. festucae wild type (WT), noxA, noxB, noxA/noxB, noxR, racA and bemA deletion mutants weregrown on PDA or water agar, and hyphal growth of these strains were observed. On nutrient richmedium, most of tested mutants showed normal growth like WT expect racA mutant, which showedhyphal swelling and increased branching. On water agar, noxA, noxB and noxR mutants showed
increased hyphal branching and irregular curving, indicated that both Noxs and regulators are
involved in polarized growth under starvation condition.
Epichloё endophyte WT grown on PDA hardly produced conidia, but a few conidia were observed
when it was grown on thin-layer PDA.
In noxA mutant, formation of asexual conidia was significantly increased, and noxA/noxB double- 93 -

mutant showed further increase of conidiation. Interestingly, mutation of regulators, NoxR and
BemA, has no effect on conidiation (Fig. 1).
Hyphae of wild type E. festucae showed frequent hyphal fusion. noxA, noxB, noxR and racAmutants lost the ability to form hyphal fusion. bemA mutant showed significant reduction on thefrequency of cell fusion. These results indicated that NoxA, NoxB and their regulators have distinct
or overlapping functions for the regulation of different hyphal morpho- genesis (Fig. 2).

Fig. 1. Conidiation of nox mutants

Fig. 2. Models of involvement of Noxs and theirregulators in hyphal differentiations.

Discussion & Conclusion
It was found that NoxA, NoxB, NoxR and RacA are essential for polarity related events, such as
establishment of polarized growth and apical dominance under starvation condition and formation ofhyphal cell fusion. BemA would have supportive role in ROS production for polarity establishment.
Phenotype of these mutants in symbiotic infection might be related to the phenotype observed
on water agar, as intercellular space of plant cells, where endophyte is growing, is generally poorin nutrient, and hyphal growth and branching of endophyte is restrictedly controlled to establish
symbiosis.
Interestingly, noxA/noxB mutant showed significant increase of conidiation, whereas knockout of
E. festucae noxR have no effect on productivity of conidia, despite the previous reports indicatingthat NoxR is required for the function of both NoxA and NoxB. Therefore, alternative mechanisms
or unknown regulator might be involved in NoxR-independent regulation of E. festucae NoxA
and NoxB for control of conidiation. Altogether, Nox activity for polarity establishment require
regulators like NoxR, whereas role of Nox for priming or suppression of differentiation might beregulated by another mechanism (Fig. 2).

References
1) Takemoto D., Kamakura S., Saikia S., Becker Y., Wrenn R., Tanaka A., Sumimoto H. and Scott
B. (2011) Polarity proteins Bem1 and Cdc24 are components of the filamentous fungal NADPH
oxidase complex. Proceedings of the National Academy of Sciences of the United States ofAmerica 108: 2861-2866.
2) Kayano Y., Tanaka A., Scott B. and Takemoto D. Differential roles of NADPH oxidases and- 94 -

their regulators in polarized growth, conidiation and hyphal fusion of symbiotic fungus Epichloë
festucae. (Submitted).

一般の皆様へ
共生糸状菌 Epichloë festucae は牧草、芝草の地上部組織の細胞間隙で伸長し、共生関係を保っている。この共生菌は植物内で種々の生理活性物質を生成し、植物に動物や昆虫による補食の抑制、耐乾性、耐病性などの効果をもたらすことが知られている。本研究では、共生菌が植物と共生するために必須な活性酸素生成酵素（Nox）とその制御因子の機能解明を進めた。NoxA 、NoxB および制御因子（NoxR 、RacA 、BemA ）の遺伝子を欠損した変異株を詳細に観察したところ、これら因子が、植物との共生確立、胞子の形成、菌糸の極性伸張および菌糸融合において異なる組み合
わせで機能していることが解った。

- 95 -

Pharmacological and clinical significance of the enhanced protein
farnesylation induced by the inactivation ofretinoblastoma tumor suppressor gene
Chiaki Takahashi
Kanazawa University Cancer Research Institutechtakaha@staff.kanazawa-u.ac.jp

Abstract
DNA microarray and subsequent gene ontology analysis indicated pRB targets many genes
involved in the mevalonate pathway. Further analysis indicated pRB plays crucial roles in tumor
progression by affecting farnesylation, geranylgeranylation or synthesis of cholesterol and its
derivatives. Our studies suggested that pRB affects tumor cell differentiation and DNA damage
response via regulating farnesylation, tumor cell invasion via geranylgeranylation and cancer stem
cells via cholesterol synthesis.
Key Words : cancer, farnesylation, geranylgeranylation, cholesterol, cancer stem cell

Introduction
RB mutation is frequently found in the initiation of retinoblastoma, osteosarcoma or small cell lungcarcinoma. However, in majority of cancers, pRB inactivation is found during cancer progression.
This implicates that beyond its previously appreciated functions in cell cycle control or terminal
differentiation, pRB plays many more functions during tumor progression. We in this study focus
on the novel transcriptional targets of pRB, which contains many of genes involved in mevalonate
pathway. Findings obtained by our current study indicate that pRB affects malignant behaviors ofcancer cells through regulating lipid metabolism.

Results
We previously reported that Rb status affects Ras activation status through regulation of protein
farnesylation. We then determined pRB transcriptional targets in cells in which the presence of pRB
does not affect cell proliferation, and found many of genes involved in mevalonate pathway as novel
pRB transcriptional targets. pRB via E2F family transcription factors targets SREBP transcription
factors or SREBP targeted genes. Protein farnesyl ation, geranylgeranylation and cholesterolsynthesis and subsequent steroidgenesis and other pathways are innervated by mevalonate pathway.
We first observed increased level of total protein farnesylation in Rb-negative cells. In addition, we
recently observed that pRB depletion in mouse cells lead to increased level of fatty acid synthesis.
All these observation supported that pRB targets mevalonate pathway. In the current study, we
focused on the effect of pRB inactivation on the cancer stem-cell-like behaviors seen in cancer
cells. We found that in cells in particular genetic background, pRb depletion efficiently induces- 96 -

sphere formation which is thought to be relevant to self-renewal activity exhibited by cancer stem
cells. First, we tested whether total shut-down of mevalonate pathway by statins antagonizes
pRb depletion-induced sphere formation. The result was positive. Then we determined which
downstream event of mevalonate pathway is critical for pRb depletion-induced sphere formation.
Our current results suggest that cholesterol synthesis pathway is the most critical in pRb depletioninduced sphere formation. Accordingly, we are currently trying to determine which cholesterol
derivate is critical in this pathway. Oxy-LDL which exogenously supplies cells with oxy-sterols havebeen implicated in cell transformation. Elevated serum cholesterol level is known to higher risk
and worsen prognosis in various cancers. We also determined the effect of geranylgeranylation andfarnesylation in other facets of malignant behaviors of cancer cells. Geranylgeranylation mediates
pRB to affect Rho family members thus this interaction is implicated in tumor cell invasion andmetastasis. As we reported previously, farnesylation mediates pRB to affect Ras protein maturation,
thus this interaction appeared to be implicated in cell differentiation, DNA damage, DNA damage
response, cellular senescence, etc.
In addition, these studies disclosed a novel mode of cooperation between p53 and pRB. Currently
p53 is implicated in the control of aerobic glycolysis. We found pRB controls the expression ofmany genes involved in lipidogenesis. Aerobic glycolysis and enhanced lipidogenesis consist two
major metabolic perturbations featured in cancer cells. Therefore, inactivation of both p53 and pRB,
which is frequently observed in human cancers, efficiently couples these two metabolic disorders
by promoting production and consumption of NADPH. Indeed, we observed a dramatic “metabolic
reprogramming” occurs in cells lacking both p53 and pRb. These cells exhibited increased levelsof lipid anabolism and catabolism; the latter was indirectly proved by the increased expression of
UCP1 in these cells. UCP1 is also known to frequently predict poor prognosis in prostate cancers.
These observations suggest that inactivation of p53 and pRB contributes to malignant behavior ofcancer cells through regulating cell metabolism. We are currently confirming these hypothesis byusing Rb-p53 DKO mice simultaneously lacking one of genes involved in cholesterol synthesis orother pathways for example SREBP1.

Discussion & Conclusion
25 years have passed since the first molecular cloning of human RB tumor suppressor gene. The
functions of pRB have been implicated in cell cycle control and terminal differentiation. However,researchers predicted more multi-faceted functions of pRB based on pathological and biologicalstudies. Our study revealed that pRB inactivation contributes to carcinogenesis via perturbing lipid
metabolism, and further that this role is more critical in the absence of p53 function which controls
aerobic glycolysis. Our studies provide strong genetic evidence that metabolic perturbation incancers is bona fide malignant phenotypes linked from tumor suppressor inactivation. Our studies
also have shown that malignant phenotypes induced by inactivation of such tumor suppressors
can be pharmacologically targeted. Based on findings accumulated in the current research, we are- 97 -

establishing in vitro cancer stem cell models that are optimized for unbiased and high-throughput
siRNA, drug or chemical screening. Our future study will identify more number of possible targets
in cancer therapy.

References
C. Takahashi et al., Nat Genet. 2006 Jan;38(1):118-23.
A. Shamma et al., Cancer Cell. 2009 Apr 7;15(4):255-69.
T. Miki et al., Mol. Cancer Res. 2010 May;8(5):665-76.
F. Loayza-Puch et al., Oncogene. 2010 May 6;29(18):2638-48.
E. P. Candana et al., BMC Dev Biol. 2010 Aug 6;10:84.
S. Kitajima et al., Oncogene. 2011 Feb 10;30(6):737-50.
M. Taura et al., Mol Cell Biol. 2012 Feb 6. [Epub ahead of print]

一般の皆様へ
RB という古くから知られているがん抑制遺伝子の新規標的がファルネシル化経路を含むメバロン
酸経路であることを突き止めました。これは、脂肪合成やコレステロール合成も司る代謝経路です。
がん抑制遺伝子が、脂肪代謝の経路を制御するという働きによって、発がんやがんの悪性化を抑制する可能性があるわけです。近年、脂質異常と様々な疾病の関連に注目が集まっておりますが、この研究を契機に、がんとの関連も今後重要視されていくと考えます。

- 98 -

Analysis of leukemogenic mechanisms induced by Trib1
Takuro Nakamura
Japanese Foundation for Cancer Research
takuro-ind@umin.net

Abstract
RAS/MAPK signaling and C/EBPα are important in myeloid leukemogenesis. Trib1 interacts with
MEK1, enhances MEK1-dependent ERK phosphorylation and promotes degradation of C/EBPα.
The Trib1 function in C/EBPα regulation has been also evident in bone marrow of Trib1 knockout
mouse where significant increase of mature granulocytes and accumulation of the C/EBPα protein
was observed. We have identified TRIB1 point mutation in a human case of Down syndrome-related
acute megakaryocytic leukemia, and found that the mutation R107L enhanced Trib1 function on
both ERK phosphorylation and C/EBPα degradation. These studies suggest that Trib1 is a goodcandidate of a novel molecular targeted therapy for cancer.
Key Words : Trib1, leukemia, oncogene, signal transduction, C/EBPα

Introduction
Intracellular signal transduction is important for regulating proliferation, survival anddifferentiation, and the dysregulated signaling is an important hallmark of cancer. Mutations within
the Ras/mitogen activated kinase (MAPK) pathway have been identified in human leukemias.
Dysregulated transcriptional control is another important mechanism in leukemogenesis. C/EBPα
acts as an anti-proliferative molecule and a tumor suppressor in myeloid cells. In human AML
patients, loss-of-function mutations of C/EBPα are frequently observed. The tribbles family ofproteins, Trib1 and Trib2, are adaptors that link the MAPK pathway and C/EBP transcriptional
regulation, and affect hematopoietic cell growth and leukemogenesis.

Results
1. Analysis of tribbles mutant mice
In tribbles family genes Trib1 and Trib2 are expressed in bone marrow while Trib3 is not.
Bone marrow fractionation revealed that both Trib1 and Trib2 are expressed in LSK cells
as well as myeloid progenitors. In search of the tribbles function in hematopoiesis, we havegenerated a novel Trib1 conditional knockout mouse by homologous recombination. The
Trib1 null homozygous mutants were viable but sterile, and no major defects were observed insystemic organs. Similar phenotypes were observed in the Trib2 null homozygous knockout
mouse that was created by Dr. Ryuichi Nishinakamura (Kumamoto University). However,significant increase of segmented granulocytes was observed in the Trib1 homozygous mutant,and polyI:polyC treatment of the Trib1flox/flox/Mx1-Cre mouse induced identical changes in bone

- 99 -

marrow (BM). The increase of mature granulocytes was associated with accumulation of the C/
EBPα protein and upregulation of C/EBPα target genes such as Il6r, Csf3r and Mpo. Interestingly,
neither increased granulocytes nor C/EBPα accumulation was observed in the Trib2 knockout
mouse.
To assess the role of Trib1 in leukemogenesis and Ras/MAPK signaling, Trib1 KO BM cells
were introduced with upstream gain-of-function mutants such as BCR-ABL, FLT3-ITD and
KIT DA. Wild type BM cells were immortalized by introduction of the mutants, however, theoncogenic effect of the mutants was abrogated when Trib1 KO BM cells were used. The result
suggests that Trib1 may be an important downstream effector to support leukemic cell growth
bearing mutations in RAS/MAPK signaling.
2. TRIB1 mutation in human leukemia
The Down syndrome (DS) patients are predisposed to developing myeloid leukemia, and thosepatients frequently exhibit GATA1 mutations. However, it is proposed that the GATA1 mutation
is important for transient leukemia in DS but not sufficient for full blown leukemia, suggestingthat additional genetic alterations are needed. Therefore, it is important to search the subsequent
genetic changes for DS-related leukemia (ML-DS) to predict malignant transformation andprognosis of the patients.
We identified a TRIB1 somatic mutation
in a human case of Down syndromerelated acute megakaryocytic leukemia(DS-AMKL) (Figure 1). The mutation
was observed at well conserved arginine

Figure 1. TRIB1 mutation in DS-AMKL.

107 residue in the pseudokinase domain.

This R107L mutation remained in leukocytes of the remission stage in which GATA1 mutation
disappeared, suggesting the TRIB1 mutation is an earlier genetic event in leukemogenesis.
The bone marrow transfer experiment showed that AML development was accelerated bytransducing murine bone marrow cells with the R107L mutant in which enhancement of ERK
phosphorylation and C/EBPα degradation by Trib1 expression was even greater than in thoseexpressing wild type. These results suggest that TRIB1 may be a novel important oncogene for
DS-AMKL.
3. Genetic interaction of Trib1 in leukemogenesis
Trib1 was identified as a cooperative gene for Hoxa9 and Meis1 in myeloid leukemogenesis.
We have recently found that Bcl11a encoding a C2H2 zinc finger transcription factor is anothercooperative gene in Trib1-induced leukemogenesis like Hoxa9/Meis1. Gene expression profiles
were compared between Trib1/Hoxa9/Meis1- and Trib1/Bcl11a-induced AML. Genes involvedin the nuclear co-repressor complex as well as cell cycle promoters/regulators are differentiallyexpressed, and the function of Bcl11a as an epigenetic modulator in leukemogenesis was
suggested.

- 100 -

Discussion & Conclusion
It was proposed that degradation of target proteins by tribbles is mediated by the E3 ubiquitin
ligase COP1. Trib3 promotes ubiquitination of acetyl-coenzyme A carboxylase (ACC) in adipose
tissue. Trib3 interacts with both ACC and COP1 using distinct domains, promoting COP1-dependentubiquitination of ACC. The COP1 binding consensus sequence [D/E]QXVP[D/E] has been wellconserved among the three tribbles during evolution, suggesting that COP1 binding by the tribbles
family of proteins is essential for their targets in protein degradation. Post-translational regulationof C/EBPα by Trib1 is thus one of important mechanisms to control differentiation and growth
suppression of myeloid cells.
Inhibition of cellular transformation by oncogenic signaling molecules including BCR-ABL and
FLT3-ITD in Trib1 deficient hematopoietic cells underscores the importance of Trib1 in the Ras/
MAPK pathway. Molecular targeted therapy using tyrosine kinase inhibitors (TKIs) has shown
great success in leukemia, however, specific inhibitors are required for each mutants and secondary
mutations make leukemic cells resistant to TKIs. Therefore Trib1 is an excellent candidate for thenovel molecular target not only in leukemia but also in cancer with Ras/MAPK abnormalities.

References
1. Jin G, Yamazaki Y, Takuwa M, Takahara T, Kaneko K, Kuwata T, Miyata S, Nakamura T. Trib1
and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood, 109, 3998-4005,
2007.
2. Yokoyama T, Kanno Y, Yamazaki Y, Takahara T, Miyata S, Nakamura T. Trib1 links the MEK1/
ERK pathway in myeloid leukemogenesis. Blood, 116, 2768-2775, 2010.
3. Yokoyama T, Nakamura T. Tribbles in disease: signaling pathways important for cellular function
and neoplastic transformation. Cancer Sci, 102: 1115-1122, 2011.
4. Yokoyama T, Toki T, Aoki Y, Kanezaki R, Park M, Kanno Y, Takahara T, Yamazaki Y, Ito E,
Hayashi Y, Nakamura T. Identification of TRIB1 R107L gain-of-function mutation in humanacute megakaryocytic leukemia. Blood, 199: 2608-2611, 2012.

一般の皆様へ
私たちは、マウスの白血病モデル系において Trib1 遺伝子を同定した。Trib1 は RAS/MAPK シグ
ナル系の活性化促進と C/EBP α転写因子の抑制の二つの機能をもつことから、強力な白血病誘導効果を持っていると考えられた。Trib1 遺伝子をノックアウトすると、C/EBPα蛋白量が骨髄で増加し、分化した好中球の数が増えた。したがって、Trib1 は正常骨髄でも C/EBP αを制御することで血球の分化に重要な働きをもつことが考えられた。これらの結果を合わせると、Trib1 はがん治療において新たな分子標的として有望である可能性が考えられた。

- 101 -

The roles of C-type lectin family in the maintenance of
immunological homeostasis.
Shinobu Saijo
Center for Medical Mycology, Chiba University
saijo@faculty.chiba-u.jp

Abstract
Dectin-1 and Dectin-2 are type II transmembrane proteins of the C-type lectin family withsingle carbohydrate-recognition domains (CRDs) in their extracellular region. They are expressed
mainly in dendritic cells (DCs) and macrophages. In this study, the functional roles of Dectin-1 andDectin-2 in host defense against fungal infection were examined, and it was elucidated that Dectin-1
is important in protection against P. carinii by inducing reactive oxygen species, whereas Dectin-2
plays important roles in host defense against C. albicans by preferentially inducing Th17 celldifferentiation.
Key Words : C-type lectin, Interleukin-17, Dendritic cell, fungal infection

Introduction
The C-type lectins are one of the pattern recognition receptors (PRRs) with lectin-like CRDs intheir extracellular carboxy-terminal domains. Some C-type lectin family members recognize thecarbohydrate structures of microbes as pathogen-associated molecular patterns (PAMPs), whereassome members on natural killer cells recognize endogenous ligands and discriminate self from nonself. Similar to other PRRs such as Toll-like receptors (TLRs), C-type lectins that recognize PAMPs
are also involved in host defense mechanisms against infection. However, different from TLRs,
which recognize various PAMPs such as lipopolysaccharides, proteoglycans, DNAs, and RNAs,
C-type lectins mostly recognize carbohydrate structures in pathogens (1).
Dectin-1 and Decin-2 are members of the C-type lectin family, whose genes are located in thetelomeric region of the mouse chromosome 6 and human chromosome 12q, where many C-type
lectin genes are located and form several clusters. Both Dectin-1 and Dectin-2 are glycosylated
type II transmembrane proteins with single CRDs, which are highly conserved in mice and humans(amino acid identities: Dectin-1 63%; and Dectin-2 75%). Whereas Dectin-1 has an ITAM-like motif
in its intracellular region, Dectin-2 has no known signaling motif in its shorter cytoplasmic region.
These structures are shared by mice and humans (2).
By using Dectin-1 and Dectin-2 deficient mice, we studied their roles in innate and acquired
immunity.

- 102 -

Results
The ligands for Dectin-1 and Dectin-2β-Glucans are an important cell-wall component of fungi; the backbone structure consists ofpolymerized β-1, 3-linked β-D-glucopyranosyl units with β-1, 6-linked side chains. β-Glucans
are found in a wide range of edible mushrooms, seaweeds, yeasts, and pathogenic fungi including
C. albicans and P. carinii, and various chain lengths and branchings are characteristics of eachfungal species. It is widely accepted that β-glucans are located in the inner layer between the
mannan and chitin layers as skeletal components of the candida cell wall, and they are exposedon the cell surface at budding sites.
Cytokine (e.g. TNF and IL-12) production occurred in bone marrow-derived DCs (BMDCs)
stimulated with β-glucans purified from edible mushroom (Sparassis crispa glucan) or with
NaClO-oxydized zymosan, was completely abolished when BMDCs or macrophages wereprepared from Dectin-1-deficient mice, indicating that Dectin-1 is the functional receptor for
β-glucans.
On the other hand, it was clearly shown that Dectin-2 is the functional receptor for α-mannans,because cytokine production was completely abolished in BMDCs from Dectin-2-deficient miceupon treatment with C. albicans cell-wall α-mannans.
The roles of Dectin-1 and Dectin-2 in host defense against fungal infection
Dectin-1-deficient mice were more susceptible to P. carinii. ROS production was abolished in
Dectin-1-deficient alveolar macrophages. On the other hand, production of proinflammatory
cytokines such as TNF or IL-12 was not affected by the Dectin-1 mutation upon treatment
with P. carinii, suggesting that the Dectin-1-induced oxidative burst is important for fungal
eradication. However, the mechanism of ROS production via activation of Dectin-1 remains tobe elucidated. ROS induces maturation of IL-1β through inflammasome-mediated activation of
Caspase-1, that is important for the development of inflammation and Th17 cell differentiation.
Dectin-2-deficient mice showed decreased survival of the infection of three different strains C.
albicans due to the increased fungal growth in the kidney. Thus, Dectin-2 seems to play more
important roles for the defense against C. albicans, probably because mannans, but not β-glucans,are exposed on the outer most layer of the fungal cell wall. Because human Dectin-2 also has
EPN motif which is responsible for mannose recognition, it is likely that Dectin-2 also plays animportant role for the anti-fungal immunity in humans.
Interestingly, it was shown that Dectin-2 in the differentiation of Th17 cells upon infection withthe yeast form of C. albicans; Th17 cells were preferentially induced by the C. albicans-treated
BMDC culture supernatant, whereas Th17 cell differentiation disappeared in Dectin-2-deficient
BMDCs.
The importance of IL-17A and/or IL-17F in host defense against C. albicans has been suggested
using IL-17RA-deficient mice and IL-23p19-deficient mice. We demonstrated that IL-17A-- 103 -

deficient mice, but not IL-17F-deficient mice, show increased susceptibility to systemic C.
albicans infection, indicating the importance of IL-17A for protection against this pathogen. The
importance of Th17 cells for the defense against fungal infection is also suggested in humans;
hyper-IgE syndrome patients with autosomal dominant mutations in the signal transducer andactivator of transcription 3 (STAT3) gene, by which Th17 cell differentiation is suppressed, areassociated with chronic mucocutaneous candidiasis (3).

Discussion & Conclusion
In this study, we have demonstrated that Dectin-1 is a functional β-glucan receptor and Dectin-2 isa functional α-mannan receptor to produce a large amount of cytokines. Although, it was suggested
that the receptors may contribute to host defense against C. albicans, because both carbohydrates
are important cell wall components of the fungal pathogen, Dectin-1 deficient mice showed normal
host defense against this fungus, whereas Dectin-2 deficient mice were more susceptible. Thismay be because of the structure of the cell wall, it is believed that β-glucan is located inner layer.
However, another group reported that Dectin-1-deficient mice also showed increased susceptibility
to intravenous C. albicans infection, with enhanced fungal dissemination in the gastrointestinal
tract and kidney using another fungal strain. Thus, the importance of Dectin-1 in the host defense
against C. albicans may differ depending on the strains.

References
1. Saijo S, Iwakura Y., Dectin-1 and Dectin-2 in innate immunity against fungi. Int Immunol. 2011,
23: 467-72
2. Drummond RA, Saijo S, Iwakura Y., Brown GD. The role of Syk/CARD9 coupled C-type lectins
in antifungal immunity. Eur J Immunol. 2011, 41:276-81
3. Iwakura Y, Ishigame H, Saijo S, Nakae S., Functional specialization of interleukin-17 family
members. Immunity. 2011, 34:149-62

一般の皆様へデクチン１とデクチン２は、C 型レクチンと呼ばれるファミリーに属する膜タンパク質で、糖鎖と結合することが知られていました。今回の研究で、デクチン１はβグルカンと呼ばれる真菌細胞壁を構成する糖鎖を、デクチン２はαマンナンと呼ばれる別の真菌細胞壁構成糖鎖と結合し、炎症性の液性分子を分泌させることで、感染防御に関与していることが明らかとなりました。

- 104 -

p53 targeted medicine against heart failure
Issei Komuro
Osaka University Graduate School of Medicine
komuro-tky@umin.ac.jp

Abstract
Mechanism of p53 elevation in the failing heart.
Key Words : Heart failure, p53, posttranslational modification

Introduction
p53 protein is a multifunctional protein that works as one of the most well-known tumor
suppressors. p53 protein is often called as ‘a guardian of the genome’ for its function to conserve
genomic stability and to prevent genomic mutation. The cellular level of p53 protein is usually kept
low but is increased when the cells are damaged or stressed. Protein level of p53 is also kept low inthe heart but is elevated when the cardiac cells are exposed to stresses including genotoxic stressafter adriamycin treatment and hypoxic stress after pressure overload and coronary artery ligation.

Results
The amount of p53 protein in cells is determined mainly by the rate of its degradation, rather than
the rate of transcription/translation. p53 protein is degraded through ubiquitin-proteasomal pathway,
which is mediated by E3 ubiquitin ligases such as MDM2. Importantly, the expression of MDM2
is positively regulated by p53, forming a negative-feedback loop and preventing constitutive p53
elevation.
Adriamycin is one of the chemotherapeutics against many cancers but also notorious for its
cardiotoxicity. Adriamycin is an anthracycline antibiotics and works by intercalating DNA.
Adriamycin also produces reactive oxygen species (ROS) and indirectly damages mitochondria
or genomic DNA. We identif ied that ROS-mediated indirect genomic DNA damage iscritically involved in the mechanism for p53 elevation in the heart after adriamycin treatment.
After intraperitoneal injection of adriamycin, p53 protein elevation was preceded by ROS
production, DNA damage and activation of DNA damage pathway, as evidenced by increased
DHE fluorescence, positive γ-H2AX staining, and increased phosphorylation of ATM (ataxia
telangiectasia mutated) kinase. ATM kinase is one of the kinases that phosphorylate p53 at its amino
terminus and stabilizes p53 protein by blocking MDM2 binding. ROS scavenger and inhibitor of
ATM kinase both prevented p53 accumulation after adriamycin treatment in vitro, underscoring
the importance of ROS-DNA damage-ATM kinase pathway on p53 accumulation in adriamycininduced cardiomyopathy.
Hypoxia is another stress that causes p53 accumulation in the heart [48] and cardiomyocytes.

- 105 -

Hypoxia also induces p53 accumulation in other cell types but the mechanism of p53 accumulation
was thought to be distinct from other types of stresses, such as DNA damaging reagent. Hypoxiainducible factor-1 (Hif-1) is a protein that becomes stabilized under hypoxic condition andinduces the transcription of various hypoxia-associated genes such as erythropoietin and vascularendothelial growth factor (VEGF) gene. Hif-1 is also known to be required for hypoxia-induced
p53 accumulation and potentiates p53-dependent transcription through direct binding. In the heart,
we identified that CHIP (carboxyl terminus of Hsp70-interacting protein) as one of the E3 ubiquitin
ligases that ubiquitinate p53 and induce its proteasomal degradation. Unlike other p53 ubiquitinating
enzymes, such as MDM2, CHIP expression is not induced by p53 to form a negative-feedback loop,
but rather inversely correlated with p53 expression in cardiomyocytes under hypoxic condition. We
further demonstrated that Hif-1-mediated transcriptional repression of CHIP gene is responsible forp53 accumulation under hypoxic condition in cardiomyocytes and after myocardial infarction in theheart, presenting a novel mechanism for hypoxia-induced p53 accumulation.
Stability and transcriptional activity of p53 is determined by various post-translational
modifications, such as phosphorylation, acetylation, and methylation. Phosphorylation of p53 affects
p53 stability through preventing and promoting ubiquitination by MDM2. Acetylation affects
transcriptional activity of p53 and methylation affects both stability and transcriptional activity of
p53. We found that phosphorylation and methylation, but not acetylation of p53 was increased in theheart of pressure-overloaded mice. We are currently investigating the mechanism why p53 become
phosphorylated and methylated during heart failure and identified a unique DNA damage response
pathway and protein lysine methylation enzyme which may end in phosphorylation and methylationof p53.

Discussion & Conclusion
Elevation of p53 is observed in the failing heart of various etiology such as adriamycin, coronary
artery ligation, and pressure-overload, suggesting that p53 elevation may become a common
therapeutic target against heart failure, irrespective of its etiology.
In the present study, we investigated the mechanism of p53 elevation during in the failing heartof various etiologies. We found that p53 protein level in the heart become elevated by manymechanisms and the mechanism varied depending on the etiology of heart failure.
Therefore, intervention against the mechanism of p53 elevation may not be suitable for the generaltreatment of heart failure. Rather, intervention against p53 per se, through modifying its posttranslational modification may be more suitable as a therapeutic strategy against heart failure.

一般の皆様へ
食生活の欧米化および高齢者の増加と共に日本でも心不全患者数は増加している。心不全に対して様々な薬物療法が開発されているものの、重症心不全患者の予後はきわめて不良であり、新しい治療法の開発が望まれている。我々はガン抑制遺伝子の一つである p53 が心不全で増えていることから、心不全に対する新たな治療法として p53 の増加を防ぐ、あるいはその作用を減らす、とい- 106 -

う戦略を考えている。p53 はガン抑制遺伝子でもあるため、p53 の作用を抑制してしまうことでガンを誘導してしまう可能性が我々の治療戦略の欠点であると考えており、この欠点を防ぐため今後は心臓で特異的に p53 の増加を防ぐ、p53 の作用を減らす手法を開発していく必要がある。

- 107 -

Investigation on chronic kidney disease through signal transduction
between vascular endothelial cells and podocytes.
Noriaki Emoto
Department of Clinical Pharmacy, Kobe Pharmaceutical University
noriaki.emoto@mac.com

Abstract
Diabetes has a constantly growing prevalence and leads to a number of complications including
diabetic nephropathy. In the present study, we aimed to investigate the role of cell-to-cellcommunication via the endothelin system on the development of diabetic nephropathy using
genetically modified mice. Although our study has not been completed yet, we could demonstrate
several results, suggesting that blocking specifically ET-1 actions in the podocytes from the renal
glomerulus should prevent diabetes-induced proteinuria.
Key Words : endothelin, podocyte, endothelial cells, chronic kidney disease

Introduction
Diabetes has a constantly growing prevalence and leads to a number of complications including
diabetic nephropathy. A novel therapeutic approach is needed to limit the renal and also thecardiovascular complications linked to diabetic nephropathy.
Endothelin-1 (ET-1) plays a major role in the development of DN. ET-1 antagonists reduce
proteinuria in DN patients but induce fluid retention.
We hypothesized that these adverse secondary effects are probably due to the diuretic function of
ET-1 in the renal tubular system. We believe that blocking specifically ET-1 actions in the podocytes
from the renal glomerulus should prevent diabetes-induced proteinuria without adverse effects.
In the present study, we aimed to investigate the role of cell-to-cell communication via theendothelin system on the development of diabetic nephropathy using genetically modified mice.

Results
1) Generation of podocyte-specific endothelin receptor A knockout mice
We h a ve t h e r e f o r e g e n e r a t e d m i c e
k n o c k- o u t f o r t h e E T-1 r e c e p t o r A(ETA) specifically in the podocytes, thePodoETAKO mice. I have achieved thisby crossing mice in which the ETA allele
was f loxed and mice expressing the Cre
recombinase under the promotor of the
podocin gene. The specific recombination of
ETA has been proven by PCR.

- 108 -

2) Generation of diabetic model mice
We induced type 1 diabetes in seven weeks old endothelial cell-specific endothelin-1 knockout(VEETKO) male mice, podocyte specific endothelin receptor A knockout (PodETAKO) malemice and wild type (WT) littermates using streptozotocin (i.p., 50mg/kg, five consecutive days).
Eight mice per group were analyzed.
Diabetes was defined as starving blood glucose level more than 300mg/dL. Body weight wasmonitored weekly.
3) Analysis of the phenotype of diabetic mice
We measured blood pressure in awaken mice using the tail cuff method at 8 (early stage
diabetes) and 28 weeks (late phase). Following this, we placed the animals in metabolic cages
in order to collect 24h urine sample, measured urine volume, and monitored food and water
consumption. At the end of the metabolic cages experiment, blood was withdrawn from the retroorbital sinus for creatinine and hematocrit measurement.
At week 22, mice were sacrificed. Kidneys and hearts were harvested. From the left kidney,cortex and medulla was separated and both were frozen for protein and mRNA extraction. Halfright kidneys were mounted in freezing medium or fixed in paraffin for immunofluorescenceand histology.
We found that WEETKO mice had lower blood pressure than WT mice with and without
diabetes. At base line, PodETAKO mice are similar to WT mice in terms of general appearance,kidney function and morphology. At the age of 28 weeks, the PodETAKO mice present a lower
diastolic blood pressure and a higher serum creatinine concentration for which the reason is still
unknown.
We have observed that after 8 weeks diabetes, proteinuria waslower in PodETAKO mice compared to WT mice, showing that ETA
on podocytes is responsible for hyperglycaemia-induced proteinuria
in vivo and participates in the development of DN. We are currently
analysing the data after 28 weeks diabetes.

Discussion & Conclusion
Analysis of the phenotypes of VEETKO mice and PodETAKO mice revealed that these mice areresistant to diabetes-induced renal damage. Although the data presented has not been completed
yet, currently available observations suggest that the communications between endothelial cells
and podocytes via ET-1–ETA receptor are involved in the development of diabetic nephropathy.
Targeting the endothelin system by specific antagonist in kidney may provide the novel therapeutic- 109 -

intervention towards diabetes-induced complications including diabetic nephropathy andcardiovascular disorders.
In cooperation with some pharmaceutical companies, we will test the efficacy of a new endothelin
antagonist in our model. This experiment will investigate the benefit of blocking specifically the
ETA on podocytes compared to a systemic unspecific blockade. Moreover, it will help determine
the way of action of endothelin receptor antagonist in experimental diabetic nephropathy.

References
1. Vignon-Zellweger N, Heiden S, EmotoN. Renal Function and Blood Pressure: Molecular Insights
into the Biology of Endothelin-1. (2011) Contributions to Nephrology 172, 18-34.
2. Vignon-Zellweger N, Heiden S, Miyauchi T, Emoto N. Molecular Biology of Endothelin-1 in the
Renal and Cardiovascular Systems. (2012) Life Sci. in press

一般の皆様へ
糖尿病の合併症のひとつである糖尿病性腎症は、わが国においても増加の一途をたどっており、有効な治療法の開発が社会から望まれています。今回、私たちはエンドセリンという分子が糖尿病性腎症の発症や進展に重要な役割を果たしていることを、遺伝子改変マウスを用いて明らかにし、エンドセリンの作用を抑制することが新しい治療法となることを示唆する成果を得ることができました。
エンドセリン作用を抑制する薬剤は肺高血圧症という疾患に対しすでに臨床応用されており、今後
糖尿病性腎症に対しても有効性を検討されることが期待されます。

- 110 -

Development of immunotherapy against
disseminated Candida infection
Yuki Kinjo
National Institute of Infectious Diseases
ykinjo@nih.go.jp

Abstract
Candida albicans is a major cause of invasive fungal infection. We studied if NKT cells play arole in the host defense against systemic C. albicans infection and if glycolipid mediated NKT cell
activation affect on the course of C. albicans infection in diabetic mice. Our data show that NKT
cells play a limited role in controlling systemic C. albicans infection and glycolipid mediated NKT
cell activation exacerbates C. albicans infection in the diabetic mice. These results suggest that theregulation of NKT cell function may be beneficial for controlling inflammation during systemic C.
albicans infection.
Key Words : NKT cell, Candida albicans, glycolipid

Introduction
Candida albicans is a major cause of invasive fungal infection. The mortality attributable tocandidemia is very high, despite of the use of antifungal agents. Therefore, it is important toinvestigate the mechanisms of the immune response to C. albicans and develop a new therapy.
NKT cells, innate lymphocytes that recognize glycolipid antigens, participate in the response tovarious microbes. We have shown that NKT cells play protective roles in the host defense against
certain microbial infection. However, it is not known if NKT cells play a role in controlling C.
albicans infection and if glycolipid mediated NKT cell activation affect on the course of C. albicans
infection. In this study, we addressed these points.

Results
1. The effect of glycolipid treatment on the course of Candida albicans infection in mice withdiabetes mellitus
In order to induce diabetes mellitus (DM), female C57BL/6 mice were injected intraperitoneallywith streptzotocin (STZ) at 210 mg/kg. The mice with 200 - 500 mg/dL of glucose level in blood(on six days after STZ injection) were selected as DM mice. The DM mice were treated with
antibiotics in drinking water (Gentamicin 0.1 mg/ml and Clindamycin 0.24 mg/ml) for more than
1 week in order to facilitate the colonization of Candida albicans in intestine.
The DM mice were inoculated intragastrically with C. albicans (2 x 10 8 cells) and 2 μgof α-galactosylceramide (α-GalCer), a glycolipid that stimulates NKT cells potently, wasintraperitoneally injected into these mice on either day 0, 1 or 2 after infection. The body weight- 111 -

and fungal burden in feces were measured once a week, and the survival was monitored daily for
25 days.
All the mice treated with α-GalCer (regardless of the time point of injection; day 0, 1 or 2 after
infection) lost their body weight up to 15%, whereas the body weight of control mice that hadreceived Vehicle (Tween 20 containing buffer, solvent without α-GalCer) was not significantly
changed. The fungal burden in feces was not significant different between the control miceand the α-GalCer treated mice. Although all of the control mice were survived, some mice that
had received α-GalCer on day 0 or 1, died within 25 days. Surprisingly, all of the mice that hadreceived α-GalCer on day 0 died.
2. The role for NKT cells in controlling systemic C. albicans infection
To determine if NKT cells play a role in the host defense against C. albicans, we employed NKT
deficient Jα18KO mice (provided by Dr. M. Taniguchi, RIKEN Research Center for Allergy
and Immunology, Yokohama, Japan) and control wild type (WT) mice. We first examined
the survival of Jα18KO mice and WT mice after intravenous infection with C. albicans. We
infected these mice with the different doses of C. albicans and monitored the survival in three
independent experiments. However, the mean survival time of WT mice and Jα18KO mice was
equivalent in all the experiments and there was no significant difference between the two groups.
We next examined the fungal burden in the mouse kidneys at two different time points afterC. albicans infection. The fungal burden in the kidneys was not significantly different between
Jα18KO mice and WT mice at both time points. We also examined fungal burden in the livers ofthese mice, but there was no difference between the two groups.

Discussion & Conclusion
These results suggest that glycolipid mediated NKT cell activation exacerbates C. albicans
infection in the DM mice. We speculate that NKT cell activation augments inflammatory response
during systemic C. albicans infection in the DM mice.
Our data show that NKT cells do not play a major role in the clearance of the fungal pathogen
in systemic C. albicans infection. It was reported that NKT cells did not contribute to microbial
clearance during Salmonella infection, although these cells produced IFNγ in response to thispathogen. Similarly, NKT cells may not stimulate major effector cells to enhance clearance of thepathogen during C. albicans infection.
In conclusion, our data show that NKT cells play a limited role in controlling systemic C. albicans
infection and glycolipid mediated NKT cell activation exacerbates C. albicans infection in the
DM mice. These results suggest that the regulation of NKT cell function may be beneficial forcontrolling inflammation during systemic C. albicans infection.

- 112 -

References
1. Pfaller, M.A. and Diekema DJ (2007): Epidemiology of invasive candidiasis:a persistent public health problem. Clin. Microbiol. Rev., 20, 133-163.
2. Kinjo, Y. and Ueno, K. (2011): iNKT cells in microbial immunity: recognition of
microbial glycolipids. Microbiol. Immunol., 55, 472-482.

一般の皆様へカンジダは、免疫力の低下した方において菌血症（病原微生物が血中に侵入）をおこす重要な真菌で、致死率が高いことから、その病態解析及び治療法の開発は重要です。私達は、特定の細菌や真菌の感染において、感染防御に関与する NKT 細胞というリンパ球に着目して、解析を行いました。その結果、カンジダ感染防御における NKT 細胞の役割は限定的であること、糖尿病マウスに NKT 細胞を活性化する糖脂質を投与すると病態が増悪することが分かりました。今後、NKT 細胞の機能を抑制することで、真菌感染の増悪を制御できるか検討する必要があると考えられました。

- 113 -

Construction of chemical library of calyculin A and development ofsubtype selective phosphatase inhibitor
Toshiyuki Wakimoto
Graduate School of Pharmaceutical Sciences, The University of Tokyo
wakimoto@mol.f.u-tokyo.ac.jp

Abstract
Calyculin A is a specific and potent inhibitor against protein phosphatases 1, 2A and 2B. We
therefore tried to develop selective inhibitors against these subtype taking advantage of the scaffoldof this natural product. Two different methods were applied to the synthesis of platform andfluorescent probe was also synthesized.
Key Words : calyculin A, marine sponge, protein phosphatase,

Introduction
Calyculin A is a major cytotoxic metabolite of a Japanese marine sponge Discodermia calyx. It
has been known that this marine natural product is specific and potent inhibitor against protein
phosphatase 1 and 2A as well as calcineurin (PP2B). These enzyme are potential targets ofdrug development for the purpose of antitumor and immunosuppressant. PP2A is the target
enzyme of antitumor fostriecin, and moreover PP2B is well known as the target molecule ofimmunosuppressants such as tacrolimus and cyclosporine. Therefore, we launched the developmentof subtype-selective inhibitor against PPs on the basis of calyculin A.

Results
1) Degradation of Calyculin A
We first attempted to transform natural calyculin A to a small fragment containing spiroketal
moiety as a platform of library construction. Taking advantage of olefins located at both sides of
spiroketal core fragment, ozonolysis after protection of 1,3-diol and phosphate group successfullyyielded the core fragment versatile for further introduction of side chains. However, the selective
protection or modification of each hydroxyl group in the core fragment (1) obtained as triol
was difficult. The selective modification of each terminal of core fragment is currently underinvestigation.

- 114 -

2) Chemical synthesis of calyculin mimics
Another approach is chemical synthesis of the platform of library construction. In order tosynthesize the platform easier, we designed the target molecule mimicking the partial structure ofcalyculin A corresponding to spiroketal moiety. Since the stereoselective synthesis of spiroketal
moiety would require the multi-step transformations, the tetrahydrofuran ring bearing phosphategroup was set as our target molecule (2). Starting from (R)-(-)-5-Oxotetrahydrofuran-2-carboxylicacid, diester generated from methanolysis was subjected to DIBAL reduction after protection of
secondary hydroxyl group. The resulting aldehyde was subjected to Indium-mediated alkylation withprenyl bromide to introduce geminal dimethyl group characteristic for calyculin A. This reaction
proceeded stereoselective manner and afforded desired alcohol, which will be phosphorylated inlater step. Further chemical synthesis will be performed in due course.

3) Fluorescent probe of calyculin A
In the course of chemical transformation of calyculin A, we synthesized new analog having
terminal aldehyde, which was versatile functionality for selective modification. In addition, thefluorescent probe of protein phosphatases had not been reported so far. Therefore, fluorescent probe
derive from calyculin A wasdesigned and synthesized (3). The aldehyde was ligated with ethylenediamine and succeeding
reductive amination successfully afford calyculin derivative bearing terminal amino group. Except
for newly introduced amino groups, there is no other amino groups in calyculin A. Therefore,
selective modification became possible despite of polyfunctional groups. Indeed, by the treatment
with NHS ester of TokyoGreen, TokyoGreen was consequently introduced into terminal aminogroup.

Discussion & Conclusion
We tried to synthesize the platform of chemical library of calyculin A by two different methods.
One was degradation of natural calyculin A and another was synthesis of calyculin mimic. Bothmethods are currently investigated and either of them will be applied to the construction of chemical
library. In addition, fluorescent probe of calyculin A was successfully synthesized from natural
calycuin A. In fact, this probe is the first fluorescent probe of protein phosphatases 1 and 2A. The- 115 -

efficiency to visualize the localization and function of protein phosphatases will be examined indetail.

References
1) Y. Kato, N. Fusetani, S. Matsunaga, K. Hashimoto, S. Fujita, T. Furuya, Bioactive marine
metabolites. Part 16. Calyculin A. A novel antitumor metabolite from the marine sponge
Discodermia calyx. J. Am. Chem. Soc. 1986, 108, 2780−2781.
2) T. Wakimoto, S. Matsunaga, A. Takai, N. Fusetani, Insight into Binding of Calyculin A to Protein
Phosphatase 1: Isolation of Hemicalyculin A and Chemical Transformation of Calyculin A. Chem.
Biol., 2002, 9, 309-319.
3) A. Kita, S. Matsunaga, A. Takai, H. Kataiwa, T. Wakimoto, N. Fusetani, M. Isobe, K. Miki,
Crystal Structure of the Complex between Calyculin A and the Catalytic Subunit of Protein
Phosphatase 1. Structure, 2002, 10, 715-724.

一般の皆様へ
海綿 Discodermia calyx に含まれる Calyculin A は極めて選択的かつ強力なタンパク質脱リン酸化酵素の阻害物質として知られている。タンパク質脱リン酸化酵素のサブタイプは抗がん剤や免疫抑制剤の標的分子として知られている。そこで、我々は Calyculin A をもとに新たな医薬品のリード化合物を見出すことを目的として、サブタイプ選択的な化合物の創製を目指した。実際に Calyculin
A の分解反応によって土台を合成するとともに、より簡略化した模倣分子の合成にも取り組んだ。
また、タンパク質脱リン酸化酵素を可視化する蛍光プローブの合成にも成功した。

- 116 -

Roles of axon guidance protein, draxin in
the corpus callosum formation
Yohei Shinmyo
Kumamoto University
shinmyo@kumamoto-u.ac.jp

Abstract
The correct selection of axonal path toward to their target is known accomplished by extracellular
guidance molecules. We previously found a novel axon guidance protein, draxin, which is essential
for the corpus callosum and thalamocortical projections. In this study, We addressed the importanceof draxin expression in neocortical neurons for corpus callosum formation and thalamocorticalprojections by rescue experiments using transgenic mice. We found that the thalamocorticalphenotype in draxin-/- mice is sufficiently rescued by transgenic expression of draxin in neocorticalneurons, suggesting that draxin from neocortical pioneer neurons is responsible for thalamocorticalprojections from the internal capsule to the neocortex.
Key Words : Axon guidance, draxin, corpus callosum, thalamocortical axon

Introduction
The correct wiring of the nervous system relies on the ability of axons and dendrites to locate
and recognize their appropriate synaptic partners. The correct selection of axonal path toward totheir target is known accomplished by extracellular guidance molecules such as the netrins, slits,
semaphorins and ephrins. We have identified a novel secreted protein, draxin (dorsal repulsive
axon guidance protein), which acts as a roof plate-derived chemorepellent for commissural axonsin chick spinal cord. In this study, we focus on draxin functions in corpus callosum formation andthalamocortical projections in mouse brains.

Results
We previously found that draxin deficient mice show severe defects in axonal projection of the
corpus callosum and thalamocortical axons. First, we checked the expression patterns of draxinby β-galactosidase staining of draxin+/- mice. We found that draxin is expressed in the neocorticalneurons and midline glial cells during corpus callosum formation. We also observed that draxin isstrongly expressed in the neocortex and weakly expressed in the ventral telencephalon and dorsal
thalamus during thalamocortical projections. Next, to examine the importance of draxin expressionin neocortical neurons for corpus callosum formation and thalamocortical projections, we performed
rescue experiments making use of transgenic mice (Z/draxin) in which Cre-mediated recombination
results in the stable expression of draxin and EGFP. Induction of draxin expression in the neocortex
of draxin-/- mice was achieved by crossing Z/draxin+/+; draxin-/- mice with Emx1Cre/+; draxin+/- mice,- 117 -

which show specific Cre expression in the dorsal telencephalon. Compared with draxin KO (Emx1+/+;
Z/draxin+/0; draxin-/-) mice, the neocortex of Emx1Cre/+; Z/draxin+/0; draxin-/- (Ctx-draxin) mice wasgreatly reduced in size, suggesting that proliferation and/or cell death of neocortical progenitors
might be affected. We examined the corpus callosum and thalamocortical projections in Ctx-draxin
mice. We could not observe the rescue of corpus callosum in the mice. Importantly, we found thatsome of the thalamocortical axons turned into the neocortex in the Ctx-draxin mice, even though thenumber of corticofugal axons was greatly reduced. In agreement with this observation, DiI injection
into the dorsal thalamus revealed that pathfinding errors of thalamocortical axons at the PSPB were
sufficiently rescued in Ctx-draxin mice. These results suggest that draxin from neocortical neurons
is critical for the guidance of thalamocortical axons into the neocortex.

Discussion & Conclusion
Our data demonstrate that draxin from neocortical neurons is critical for the guidance ofthalamocortical axons into the neocortex, suggesting that draxin is a responsible guidance moleculefrom the neocortical neurons for thalamocortical axons. These data offer important clues tounderstanding the molecular mechanisms underlying the interaction between neocortical pioneer
axons and thalamocortical axons, which is essential for thalamocortical projections. I believe that
this finding will not only deepen our understanding of thalamocortical projections but also provide
insights into axon guidance mechanisms by heterotypic axon interactions, which are necessary forthe formation of complex neural networks in the brain.

一般の皆様へ
脳では膨大な数の神経細胞がそれぞれ適切な位置に配置され、精密な神経回路網を形成しています。これらの神経回路形成には、発生過程に神経軸索ガイダンス分子が担う神経細胞の選択的な軸索形成が必須です。本研究では、我々が独自に発見したガイダンス分子 draxin に着目した脳神経回路形成メカニズムの解明を目指しています。特に、既知の軸索ガイダンス分子にはなく、draxin が特有の機能を持つと考えられる脳梁と視床皮質軸索投射の分子機構を調べています。こうした研究から複雑な脳回路がどのようにして形成されるかを理解したいと考えています。

- 118 -

III.
Reports from the Recipients of Grants
for International Meetings- 119 -

The 13th TNF International Conference
1. Representative
Shigekazu Nagata, Ph.D.
Professor, Kyoto University, the Graduate School of Medicine
2. Opening period and Place
May 15 (Sun) - 18 (Wed), 2011
3. Number of participants / Number of participating countries and areas
Participants: 208
Countries: 19 (Australia, Belgium, Canada, Czech Republic, France, Germany, Israel, Italy,
Japan, Romania, Russia, Singapore, Slovenia, Spain, Switzerland, Taiwan, The
Netherlands, United Kingdom, USA)
4. Total cost
JPY28,201,247
5. Main use of subsidy
Travel expenses for invited speakers from abroad
6. Result and Impression
208 scientists from 19 different countries attended the 13th International TNF Conference inspite of the challenging circumstances after the tragedy on May 11, 2011. As previous TNF
congresses, the discussion was very active. We were very glad to see many young scientists
including Japanese graduate students actively engaged in the discussion. We are sure all theparticipants have enjoyed Science, and this meeting would trigger a new collaboration or new
friendship among the participants.
7. Additional description- 120 -

10th International Family Nursing Conference
1. Representative
Kazuko Ishigaki
President of the Japanese Association for Research in Family Nursing
2. Opening period and Place
June 25-27, 2011
Kyoto International Conference Center
3. Number of participants / Number of participating countries and areas
1,007 individuals from 34 countries
4. Total cost
¥ 48,424,123
5. Main use of subsidy
International invitation & program printing
6. Result and Impression
Although we have agonized until the last minute in deciding whether we should go ahead andhave this conference after the Great East Japan Earthquake, the conference was a great successwith the total number of participants exceeding 1,000 from as many as 34 countries. We haveadded an educational session on “Family in Disaster Nursing.” We have received many positive
comments from the participants from Japan and overseas.
7. Additional description
Total cancellation from overseas due to earthquake and nuclear power plant accident was about
10% of the original applications.
We appreciate your generous grant for this conference.

- 121 -

XV International Congress of Molecular Plant-Microbe Interactions
1. Representative
Ko Shimamoto
Professor at Nara Institute of Science and Technology
2. Opening period and Place
July 29 to August 2, 2012
Kyoto International Conference Center
3. Number of participants / Number of participating countries and areas
993 participants from 42 countries
4. Total cost
JPY 69,232,990
5. Main use of subsidy
Printing and extra prize for poster awards
6. Result and Impression
XV IS-MPMI 2012 Kyoto was held as an interdisciplinary conference with attendance of anumber of scientists of related fields including biochemistry, molecular biology, cell biology andgenetics.
Research presentations have been made to find solutions to such problems as food shortage andenergy supply on a global scale. For stabilization of food production, discussions were made on
countermeasures against plant diseases that cause damage to various crops the world over. As
approaches to energy problems, presentations were made to discuss possibilities of improvementof production of such plants for bio-based fuels as corn and sugar cane.
In spite of importance and rapid growth of study of this field, population of researchers in thefield is very small in Japan compared to Europe and the United States. In addition, other Asian
nations have even smaller population of researchers in this field, because advanced method isrequired for research. Therefore, Japanese scientists are expected to play a leading role among
Asian countries in the coming future. As one of most advanced fields of study, our study would
have great influence on other scientific fields of plants, so it is meaningful to have aninternational meeting like this in this country.
For this conference, close to 1000 people from 42 countries gathered to Kyoto. Most ofparticipants were from abroad indicating that this field of study has importance on a global basis.
While this conference has been held so far in Europe or the United States, this time we held it for
the first time outside Europe and the United States. Characteristically, the number of participantsfrom China, Korea and Taiwan came close to 150, having increased significantly compared to the- 122 -

last meeting. This would create an opportunity for this field of study to make drastic progress inAsian region. Although this meeting was to be held in August 2011 originally, we postponed it by
one year due to the Great East Japan Earthquake. Despite concern for a decrease in participants,
we had as many participants as ever before.
7. Additional description
To encourage active participation of young researchers, we discounted students’ registration fee
as well as offered travel awards for students. On the other hand, in an effort to foster researchersin future generations we had workshops chaired by young researchers on the first day ofconference.

- 123 -

The 6th International Conference of Neurons and Brain Diseases (ICNBD)(by Association for Neuron and Diseases)
1. Representative
Dr. Kaoru Inokuchi(Professor; University of Toyama, Graduate School of Medicine & Pharmaceutical Sciences)
2. Opening period and Place
3th August - 5th August 2011
ANA Crowne Plaza Toyama
3. Number of participants / Number of participating countries and areas
121 / 8
4. Total cost
9,650,636 JPY
5. Main use of subsidy
Conference room charge
6. Result and Impression
ICNBD Toyama, the joint conference of the 6th International Conference of Neurons and Brain
Diseases and Japan Science and Technology Agency, JST, was held in the city of Toyama, Japan.
AND has been established as a nonprofit organization to promote scientific exchange amongus. ICNBD Toyama was the first annual meeting of AND since the establishment of AND. In thismemorable conference, we have an excellent program of 47 talks and 53 poster exhibitions. All
the attendees developed new understanding and insight that would lead to the creation of newconcept in the neuroscience field. Attendees were highly interactive both in the formal scientificsessions and in the informal social events. That we hold an international conference such as
ICNBD Toyama in recent adverse circumstances in Japan caused by the huge earthquake inNorth East region of Japan on March 11, 2011 would, I believe, has encouraged Japanesescientists, students, and postdoctoral fellows.
Finally, I would like to express our sincere thanks to The NOVARTIS Foundation (Japan) for the
Promotion of Science for financial support.
7. Additional description
This conference, ICNBD, will be annually held, and next year venue will be Montreal, Canada.

- 124 -

XXV Symposium of the International Association for Comparative Research on
Leukemia and Related Diseases (IACRLRD)
1. Representative
Watanabe Toshiki
The University of Tokyo

Professor

2. Opening period and Place
September 15 (Thu)-17 (Sat), 2011
3. Number of participants / Number of participating countries and areas
184 participants / 14 countries and areas
4. Total cost
31,530,332 Yen
5. Main use of subsidy
The cost of conference website production
6. Result and Impression
This was the jubilee symposium for the 50 years anniversary of the IACRLRD. Although thenumber of participants was not so large, all of them agreed that this symposium was a great
success. The speakers were the leaders of the hematology/oncology in the world. Lectures were
all those that report the “state of arts” of the diagnosis and treatments of leukemias andlymphomas, thus this symposium was an exceptional opportunity for the participants to update
their knowledge in the field. In addition, on September 17th, the symposium co-organized aninternational symposium of the HTLV-1 and related diseases. This was also an exceptionalchance to learn the recent achievements in the HTLV-1 and related diseases covering both basic
and clinical studies.
7. Additional description
For the 50th anniversary, 5 special lectures were programmed, in addition to John Moloney
Memorial Lecture and Yohei Ito Memorial Lecture. These lectures covered the areas of basic
sciences in the oncology such as oncogenic retroviruses and the most recent achievements in thetreatment of acute and chronic myelogenous leukemias. Thus, this symposium provided a rareopportunity to study both the history and most updated information of basic and clinical sciencesof hematology and oncology.

- 125 -

8th AFMC International Medicinal Chemistry Symposium (AIMECS11)
1. Representative
Masakatsu Shibasaki
Symposium Chairperson. Institute of Microbial Chemistry, Tokyo, Japan
2. Opening period and Place
29 November- 2 December, KEIO PLAZA HOTEL TOKYO
3. Number of participants / Number of participating countries and areas
1100 participants, 23 countries
4. Total cost
¥66,000,000
5. Main use of subsidy
Printing – Program & Abstract book
6. Result and Impression
The eighth AFMC international medical chemistry symposium (AIMECS11) was held from
Tuesday, November 29 to Friday, December 3 at Keio Plaza Hotel (Shinjuku). Dr. Masakatsu
Shibasaki (Emeritus Professor of University of Tokyo and Director of Microbial Chemistry
Research Center) was a symposium chairperson. This symposium is organized jointly by the
Asian federation for Medicinal Chemistry (AFMC) and the Pharmaceutical Society of Japan(PSJ) in collaboration with the Medicinal Chemistry Division of the America Chemical Society(ACS-MEDI) and the European Federation for Medicinal Chemistry (EFMC).
Emphasis of this symposium is focused on the “Frontier of Medicinal Science”, and there are 6
plenary lecturers by globally distinguished scientist, 27 invited lectures in 21 sessions, and 578
poster presentations along with 1,125 participants. The numbers of foreign people were 174 from22 countries.The number of participants and presentations of this symposium was highest among
the past of this symposium.
7. Additional description
The most important result is that this symposium could be shown the high scientific level andpossibility of drug discovery on Japanese pharmaceutical industry even after the earthquake on
March, 2011.

- 126 -

25th Grant Report (FY2011)
The foundation has been conducting public interest activities such as research grant, meeting
grant and international exchange program since its establishment on Sep. 4, 1987 in Japan underauthorization of the Ministry of Education, Science, Sports and Culture. The grants conducted in FY
2011 are as follows.
25th Novartis Research Grant: 41 Researchers (JPY 1 mil.),

Subtotal JPY 41 mil.

Research Meeting Grant:

Subtotal JPY

2.4 mil.

Total JPY

43.4 mil.

6 Meetings (JPY 0.4 mil.),		

25th Novartis Research Grant (FY2011)
The grant is to aim supporting creative research in Japan in the field of bio, life science and relevant
chemistry.
(Order received, Honorifics omitted, * Great East Japan Earthquake supporting)#Name

4 Takayuki Shindo*

Institution
School of Medicine,
Fukushima Medical
University
Faculty of Pharmaceutical
Sciences, Tokyo Universityof Science
Graduate School of Scienceand Technology, Kumamoto
University
Shinshu University Graduate
School of Medicine

5 Hideaki Kano

School of Science, The
University of Tokyo

Associate
Professor

6 Masatake Osawa

Professor
Professor

Analysis for the molecular mechanisms
causing paroxysmal cough in pertussis

Professor

Analysis of mice deficient in molecules
involved in intracellular polarized transport

Assistant
Professor

Investigation of molecular signal output
from a dividing nucleus to cell cortex

Assistant
Professor

The Role of transcription factor Iκβ-ζ in
immunity homeostasis

Assistant
Professor

Study of dense-core vesicle synthesis on
the membrane of Golgi complex

Assistant
Professor
Associate
Professor

Stress response, homeostasis and cancer

13 Hidenori Suzuki

Gifu University, Graduate
School of Medicine
Research Institute forMicrobial Diseases, Osaka
University
Graduate School of
Medicine, Osaka University
Graduate School of Life andEnvironmental Sciences,
University of Tsukuba
Graduate School of Life
Sciences, Tohoku University
Advanced Scientific
Research Leaders
Development Unit, Gunma
University
Kinki University, Faculty of
Medicine
Mie University Hospital,
Department of Neurosurgery

Synthetic Study of Polymeric
Pyrrolidinoindoline Alkaloids via
Biomimetic RouteRegulation of vascular integrity by AMRAMP system and its application
Development of novel molecular imaging
method for visualization of clinicalcondition of intravital lipids
Role of autophagy in the induction ofcornification of epidermal cells

14 Daiju Kitagawa

National Institute of Genetics

Associate
Professor

15 Akinori Akaike

Graduate School of
Pharmaceutical Sciences,
Kyoto University

Professor

1 Yoshikazu Ugawa*2 Takahiro Suzuki
3 Hayato Ishikawa

7 Yasuhiko Horiguchi
8 Akihiro Harada
9 Kentaro Nakano*
10 Takashi Maruyama*
11 Tetsushi Sadakata*
12 Toshiharu Sakurai

Title

Research Project

Professor

Ageing effects on the neuroplasticity ofhuman brain and Alzheimer’s disease

Assistant
Professor

Synthetic study of non-alkaloidal diterpene
isolated from the genus Aconitum

Associate
Professor
Professor- 127 -

Regulation of cerebral vasospasm by
growth factors and matricellular proteins
Towards elucidating the mechanisms of thestep-wise formation of centrioles by using
AID system
The role of specific cell adhesion molecules
in dopaminergic innervation of striatal
neurons#Name

16 Satoshi Nishimura*
17 Hitoshi Kurumizaka

Institution
Department of
Cardiovascular Medicine,
The University of Tokyo
Waseda University, Graduate
School of Advanced Science& Engineering

Title
Assistant
Professor

Research ProjectIn vivo imaging reveals molecularmechanisms of adult common diseases
based on chronic inflammation

Professor

Structural study of the human centromericchromatin
An intrinsic molecular mechanism
governing the development of root nodule
primordia
Identification and characterization of novel
skeletal muscle-derived angiogenesis
growth factor
Molecular mechanism of self-renewal andproliferation of a hematopoietic cell due to
HMGA2 expression

18 Takuya Suzaki

National Institute for Basic
Biology

Assistant
Professor

19 Yasuhiro Izumiya

Faculty of Life Sciences,
Kumamoto University

Assistant
Professor

20 Kazuhiko Ikeda*
21 Keizo Kanasaki
22 Tomoe Nishitani
23 Masayo Kagami
24 Hiroyuki Niida
25 Kentaro Nakagawa
26 Shu Shimada

27 Kenji Osafune

28 Kuninori Suzuki

Department of Cardiology
Assistantand Hematology, Fukushima
Professor
Medical University
Kanazawa Medical
Seniorbiological and pathological
University, Diabetes &Assistant The
Endocrinology
Professor significance of Stox1 transcriptional factor
National Cerebral andLaboratory Novel role of neuronal Ca2+ sensor-1 as a
Cardiovascular Center
Chiefcardioprotective factor in stressed heart
The National Research
SeniorElucidation of the physiological function of
Institute for Child Health and Investigator
imprinted genes on human chromosome 14
Development
Hamamatsu University
Associate Mechanism of dNTPs supply at beginning
School of Medicine
Professor of DNA replication
Tokyo Medical and Dental
Assistant Characterization of mammalian homologue
University
Professor of Unc119 as a tumor suppressor
Graduate School of Medicalof the mechanism andand Dental Sciences,
Assistant Clarification
developmentof the treatment of diffuseTokyo Medical and Dental
Professor type gastric cancer
using our mouse model
University
and generation of organCenter for iPS Cell Research Associate Characterization
specific vascular cells from human iPS
and Application, Kyoto
Professor cells towards development of novel in vitro
University
models for intractable vascular diseases
Frontier Research Center,
Associate Role of lipid droplets during autophagy inTokyo Institute ofProfessor Saccharomyces cerevisiae
Technology

29 Takanori Iwasaki

Graduate School ofEngineering, Osaka
University

Assistant
Professor

30 Hisao Tsukamoto

National Institute for
Molecular Sciences

Research
Assistant
Professor

31 Naoto Ishii*

Tohoku University Graduate
School of Medicine

32 Takaya Satoh

Graduate School of Science,
Osaka Prefecture University

33 Yuichiro Mishima

Graduate School of Science,
Kobe University
RIKEN Research Center forAllergy and Immunology
Immunology Frontier
Research Center, Osaka
University

Hashimoto34 Akiko
Tane
35 Wataru Ise

Synthesis of fatty acids having various
carbon frameworks

Analyses of structural dynamics of a G
protein-coupled receptor using site-directed
fluorescent labelingof the generation andProfessor Regulation
maintenance of memory T cells
Studies on the regulatory mechanisms
Professor underlying cell cycle-dependent
centrosome replication
Research microRNA-mediated regulation of
Scientist vasculogenesisrole of molecular motor for regulating
Researcher The
T cell activation
Associate
Professor

36 Yuzuru Imai*

Juntendo University
Graduate School of Medicine

Associate
Professor

37 Tomoaki Tanaka

Chiba University Graduate
School of Medicine

Assistant
Professor

38 Takaaki Abe*

Tohoku University Graduate
School of Biomedical
Engineering

Professor- 128 -

Regulation of humoral immune responseby the transcription factor BATF
Study on the molecular mechanisms of
mitochondrial regulation by the genes
responsible for early-onset familial formsof Parkinson’s disease
Fundamental study for long intergenic
RNA (linc RNA) and epigenetic regulation
by tumor suppressor p53 using ES/iPS cells
to control cancer stem cells
Drugs discovery for CKD patients usingtransporter manipulation

#

Name

39 Terukazu Nogi

40 Masakiyo Sakaguchi

41 Yoshihiro Kawasaki

Institution
Association of International
Arts and Science, Yokohama
City University
Okayama University
Graduate School of
Medicine, Dentistry, andPharmaceutical Sciences
Institute of Molecular andCellular Biosciences, The
University of Tokyo

Title
Associate
Professor

Research Project
Molecular mechanism of semaphorin
receptor activation implicated in axonpathfinding

Associate
Professor

Promoter-based super improvement of gene
expression in an antibody production

Lecturer

Analysis of a novel mechanism oftumorigenesis involving c-Myc protooncogene product

FY 2011 Research Meeting Grant
The grant is to aim supporting international research meetings in Japan in the field of bio, life
science and relevant chemistry.
#

Meeting

1 The 13th TNF International Conference
10th International Family Nursing
2 Conference Making Family Nursing
VisibleThe
15th Congress on Molecular Plant3 Microbe
Interactions
6th International Conference of
4 The
Neurons and Brain Diseases
XXV Symposium of the International
5 Association for Comparative Researchon Leukemia and Related Diseases
AFMC International Medicinal
6 8th
Chemistry Symposium

Representative
Institution / Title
Name
Graduate School of
2011.5.15 ～ 5.18 Medicine, Kyoto Univ.
Shigekazu Nagata(Awaji)Prof.
Prefectural Univ.
2011.6.25 ～ 6.27 Chiba
of Health Sciences
Kazuko Ishigami(Kyoto)Prof.
2011.8.2 ～ 8.6 Nara Institute of Science
Ko Shimamoto(Kyoto)and Technology
of Medicine,2011.8.3 ～ 8.5 Faculty
Univ.
of
ToyamaKaoru Inokuchi(Toyama)Prof.
Graduate School of
2011.9.15 ～ 9.17 Frontier Sciences, Univ.
Toshiki Watanabe(Tokyo)of TokyoProf.
2011.11.29 ～ 12.2 Toho Univ.
Yusaku Yokoyama(Tokyo)Prof.
Date(Place)- 129 -

第 25 期（2011 年度）助成事業報告
当財団は、文部大臣の認可を得て 1987 年 9 月 4 日に設立されて以降、研究助成を中心とした公益事業を行っております。2011 年度は、下記の総額 4,340 万円の助成事業を実施しました。
第 25 回ノバルティス研究奨励金
研究集会助成41 件 （1 件 100 万円）4,100 万円
6 件 （1 件 40 万円） 240 万円
総額4,340 万円

第 25 回ノバルティス研究奨励金 (2011 年度 )この事業は、生物・生命科学および関連する化学の領域において、我が国で行われる創造的な研究の助成を目的としています。
（受付順 ・ 敬称略 ､ 所属 ・ 職位は申請時、 贈呈額は 1 件 100 万円、 * は震災支援 10 件）
No

氏名

所属

1

宇川 義一 * 福島県立医科大学

2

鈴 木 孝 洋 東京理科大学薬学部

3
4
5
6
7
8

職位

熊本大学大学院自然科学研究科
信州大学大学院
新藤 隆行 *
医学系研究科東京大学大学院
加納 英明
理学系研究科岐阜大学大学院
大沢 匡毅
医学系研究科大阪大学
堀口 安彦
微生物病研究所
石川 勇人

原 田 彰 宏 大阪大学医学系研究科

筑波大学大学院
生命環境科学研究科
東北大学大学院
10 丸山 貴司 *生命科学研究科
群馬大学先端科学研究指導者
11 定方 哲史 *育成ユニット9中野 賢太郎*

12 櫻 井 俊 治 近畿大学医学部
三重大学
医学部附属病院
国立遺伝学研究所
14 北 川 大 樹
新分野創造センター
京都大学大学院
15 赤 池 昭 紀
薬学研究科
13 鈴 木 秀 謙

16 西 村智 * 東京大学医学系研究科

17 胡桃坂 仁志

早稲田大学理工学術院先進理
工学部

研究課題
ヒト中枢神経可塑性に対する加齢の影響
教授とアルツハイマー病
新規骨格を有するトリカブト属由来の非ア
助教
ルカロイド性ジテルペンの全合成研究
多量体型ピロリジノインドリンアルカロイド
准教授
類の生合成模擬的全合成研究
AM-RAMP システムによる血管制御機構
教授の解明と応用展開
生体内脂肪の病態を可視化する新しい分
准教授子イメージング法の開発
皮膚上皮角質層形成の分子的機構の解教授
明
百日咳における発作性咳嗽の発症メカニ教授
ズムの解析
細胞内の極性輸送を司る蛋白のノックア
教授
ウトマウスの分子細胞生物学的解析
細胞表層と分裂核を結びつける分子シグ
講師
ナルの解明
免疫恒常性における転写因子 I κβ 助教
ζの役割
有芯小胞はゴルジ体にてどのように生ま
助教
れるか？
ストレス応答蛋白による恒常性維持及び講師
発癌制御機構の解明
増殖因子とマトリックス細胞間蛋白に着目
講師した脳血管攣縮の病態解明
特任 AID 法を用いた中心小体の段階的構築
准教授 原理の解明
ドパミンニューロンによる線条体神経支配
教授における特異的細胞接着因子の役割
特任 生体分子イメージングを用いた慢性炎症
准教授 を背景とする生活習慣病の病態解明
染色体の均等分配を保証しているセントロメ
教授
ア領域の高次クロマチンの立体構造解析- 130 -

No

氏名

所属
自然科学研究機構
18 寿 崎 拓 哉
基礎生物学研究所
熊本大学大学院
19 泉 家 康 宏
生命科学研究部

職位
助教

骨格筋由来の新規血管新生因子の同定とその機能解析
HMGA2 発現による造血細胞の自己複
助教
製 ・ 増殖における分子機構の解明
転写因子 Stox1 の生物学的 ・ 病理学的講師
意義の検討
新たな心筋保護因子としての Ca2+ セン
室長
サー NCS-1 の役割とその調節
上級 14 番染色体インプリンティング遺伝子の研究員 生理学的機能の解明

21 金 崎 啓 造 金沢医科大学
国立循環器病研究センター
国立成育医療雅 代
研究センター研究所

22 西 谷 友 重

24 丹伊田 浩行 浜松医科大学

准教授 DNA 複製開始時における dNTPs 供給機構

25 中川 健太郎 東京医科歯科大学

26 島 田周

27 長 船 健 二

29
30
31
32
33
34
35

京都大学
iPS 細胞研究所

東京工業大学
フロンティア研究機構
大阪大学大学院
岩崎 孝紀
工学研究科
自然科学研究機構
塚本 寿夫
分子科学研究所
東北大学大学院
石井 直人 *
医学系研究科大阪府立大学大学院
佐藤 孝哉
理学系研究科神戸大学大学院
三嶋 雄一郎
理学研究科
理化学研究所免疫 ・ アレルギ
多根 彰子
ー科学総合研究センター
大阪大学免疫学フロンティア研
伊 勢
渉
究センター

36 今 居譲 * 順天堂大学医学研究科

37 田 中 知 明

千葉大学大学院
医学研究院

東北大学大学院
医工学研究科
横浜市立大学学術院
39 禾
晃 和
国際総合科学群
岡山大学大学院
40 阪 口 政 清
医歯薬学総合研究科
東京大学
41 川 崎 善 博
分子細胞生物学研究所
38 阿部 高明 *網膜色素変性症原因遺伝子産物、 線虫
Unc119 哺乳類ホモログの腫瘍抑制機能の解析
胃がんマウスモデルを利用した未分化型
特任
胃がんの発症機構の解明と新規治療方
助教
法の開発
難治性血管疾患に対する新規疾患モデ
准教授 ル開発を目指した臓器特異的血管細胞の同定とヒト iPS 細胞からの分化誘導
特任 出芽酵母のオートファジーにおける脂肪助教 滴の役割
多様な炭素骨格を有する脂肪酸類の合助教
成
特任 部位特異的蛍光標識を用いた G タンパク
助教 質共役受容体の動的構造変化の解析
記憶 T 細胞の産生と維持の制御機構の教授
解明
細胞周期に同調した中心体複製機構の教授
解明
学術 microRNA による血管形成制御機構の研研究員 究
細胞内分子モーターによる T 細胞抗原応
研究員
答制御メカニズムの解明
特任 転写因子 BATF による抗体産生応答の准教授 制御若年性パーキンソン病原因遺伝子による専任
ミトコンドリア機能制御の分子メカニズムの准教授
解明
がん幹細胞制御を目的にしたヒト ES/iPS
講師 における linc RNA 探索と p53 によるエピ
ゲノム制御機構の解析
トランスポーターを介した腎不全治療薬開教授
発
神経軸索の伸長をガイドするセマフォリン
准教授
受容体活性化の分子機構
抗体大量産生用超高効率遺伝子発現ベ准教授
クターの開発癌原遺伝子産物 c-Myc による新たな発講師
癌機構の解明助教

東京医科歯科大学大学院医歯学総合研究科28 鈴 木 邦 律

根粒原基形成を司る生体内分子機構

助教

20 池田 和彦 * 福島県立医科大学

23 鏡

研究課題

- 131 -

2011 年度 研究集会助成
この事業は、生物・生命化学および関連する化学の領域において、我が国で開催される国際色豊かな研究集会の助成を目的としています。
（受付順・敬称略、所属・職位は申請時、贈呈額は 1 件 40 万円）
No

研究集会名

1

第 13 回 TNF 国際会議

2

第 10 回国際家族看護学会

3

第 15 回国際分子植物微生物
相互作用学会

4

第 6 回ニューロンと脳疾患
国際カンファレンス

5

第 25 回国際比較白血病学会・
国際シンポジウム

6

第 8 回 AFMC 国際医薬化学
シンポジウム代表者
所属・職位
京都大学大学院
2011.5.15 ～ 5.18
医学系研究科
（淡路）教授
千葉県立2011.6.25 ～ 6.27
保健医療大学（京都）教授
奈良先端科学技術
2011.8.2 ～ 8.6
大学院大学
（京都）
教授
富山大学大学院
2011.8.3 ～ 8.5
医学薬学研究部（富山）教授
東京大学大学院
2011.9.15 ～ 9.17
新領域創成科学研究科（東京）教授
2011.11.29 ～ 12.2 東邦大学薬学部
（東京）
教授
開催日
( 開催地 )- 132 -

氏名
長田

重一

石垣

和子

島本

功

井ノ口

馨

渡邉

俊樹

横山

祐作

25th Financial Report

Balance Sheet

As of March 31, 2012

Income & Expenditure Statement(Unit: JP Yen)

Account
AmountI Assets
1. Current Assets
Total Current Assets
66,425,041
2. Fixed Assets (Long-term)(1) Fundamental Property
Investments in Securities (Designated)
1,000,000,000
Investments in Securities (General)
100,000,000
Total Fundamental Property
1,100,000,000(2) Other Long-term Assets
Total Other Long-term Assets
39,893,756
Total Long-term Assets
1,139,893,756
Total Assets
1,206,318,797
II Liabilities
1. Current Liabilities
Total Current Liabilities
41,093,720
Total Liabilities
41,093,720
III Equity (Net Assets)
1. Designated Net Assets
Total Designated Net Assets
1,000,000,000(Amount appropriating to Fundamental Property) (1,000,000,000)
2. General Net Assets
165,225,077(Amount appropriating to Fundamental Property) (100,000,000)
Total Equity (Net Assets)
1,165,225,077
Total Liabilities & Equity
1,206,318,797- 133 -

April 1, 2011 - March 31, 2012
(Unit: JP Yen)

Account
I Business Activity
1. Business Activity Income
Donation
Business Activity Income Total
2. Business Activity Expenditure
Project Expense
Grant Expense
Administrative Expense
Business Activity Expenditure Total
Business Activity Balance
II Investment Activity
1. Investment Activity Income
Investment Activity Income Total
2. Investment Activity Expenditure
Investment Activity Expenditure Total
Investment Activity Balance
III Financial Activity
1. Financial Activity Income
Financial Activity Income Total
2. Financial Activity Expenditure
Financial Activity Expenditure Total
Financial Activity Balance
Balance of Current Period
Balance brought from Previous Period
Balance to be carried to Next Period

Amount40,048,000
75,376,374
54,377,469
43,400,000
4,691,785
59,069,254
16,307,120

10,070,000
9,830,294
239,70600
0
16,546,826
8,784,495
25,331,321

第 25 期（2011 年度）財務報告

貸借対照表

収支計算書

2012 年 3 月 31 日現在（単位：円）

科目
Ⅰ資産の部
１． 流動資産
流動資産合計
２． 固定資産(1) 基本財産
投資有価証券 （指定）投資有価証券 （一般）
基本財産合計(2) その他固定資産
その他固定資産合計
固定資産合計資産合計
Ⅱ負債の部
１． 流動負債
流動負債合計
負債合計
Ⅲ正味財産の部
１． 指定正味財産
指定正味財産合計（うち基本財産への充当額）
２．一般正味財産（うち基本財産への充当額）
正味財産合計
負債及び正味財産合計

金額66,425,041

1,000,000,000
100,000,000
1,100,000,000
39,893,756
1,139,893,756
1,206,318,797

41,093,720
41,093,720

1,000,000,000(1,000,000,000)
165,225,077(100,000,000)
1,165,225,077
1,206,318,797- 134 -

2011 年 4 月 1 日～ 2012 年 3 月 31 日
（単位：円）

科
目
Ⅰ事業活動収支の部
１． 事業活動収入
寄付金収入
事業活動収入計
２． 事業活動支出
事業費支出
助成金支出
管理費支出
事業活動支出計
事業活動収支差額
Ⅱ投資活動収支の部
１． 投資活動収入
投資活動収入計
２． 投資活動支出
投資活動支出計
投資活動収支差額
Ⅲ財務活動収支の部
１． 財務活動収入
財務活動収入計
２． 財務活動支出
財務活動支出計
財務活動収支差額
当期収支差額
前期繰越収支差額
次期繰越収支差額

決算額

40,048,000
75,376,374
54,377,469
43,400,000
4,691,785
59,069,254
16,307,120

10,070,000
9,830,294
239,70600
0
16,546,826
8,784,495
25,331,321

List of Board Members[Board of Trustees]

As of Oct. 1, 2012

Post

Name

Chairman

Akimichi KANEKO

Dean, Prof., MD, Grad. School of Health Science, Kio Univ.,
Emer. Prof., Keio Univ.

Shigetaka ASANO

Prof., MD, School of Science & Engineering, Waseda Univ.,
Emer. Prof., Univ. of Tokyo

Masao ENDOH

Emer. Prof., MD, Yamagata Univ.

Hiroko ISHIKAWA

Managing Director, Novartis Pharma K.K.

Toshio SUDA

Prof., MD, Keio Univ., School of Medicine

Tokuzo NAKAJIMA

Certified Public Accountant

Masanori FUSE

Head, Accounting Dept., Novartis Pharma K.K.

Trustee

Auditor

Title[Board of Councilors]
Post

Name

Chairman Tsuneyoshi KUROIWA

Title
Director, Research Information Center of Extremophile, Prof.,
Grad. School of Science, Rikkyo Univ., Emer. Prof., Univ. of
Tokyo

Norio AKAIKE

Director, Kumamoto Health Science Univ., Emer. Prof., Kyushu
Univ.

Max M. BURGER

Vice Chairman, Novartis Science Board
Prof., MD, Univ. of Basel

Hiroyuki KAWASHIMA

Former Prof., Grad. School of Medical & Dental Sciences,
Niigata Univ.

Shigeo KOYASU

Prof., Keio Univ., School of Medicine

Tadanori MAYUMI

Univ. Emer. Prof., Osaka Univ.

Councilor Hiroyuki MITANI

President & CEO, Novartis Pharma K.K.

Miwako MORI

Prof., Health Sciences Univ. of Hokkaido, Emer. Prof., Hokkaido
Univ.

Akihiko NAKANO

Prof., Univ. of Tokyo, Science Dept., Team Leader, RIKEN (Inst.
of Physical & Chemical Research)

Masakatsu SHIBASAKI

Director, Microbial Chemistry Research Center, Microbial
Chemistry Research Foundation

Takao SHIMIZU

Prof., Univ. of Tokyo, School of Medicine

Toshifumi WATANABE

Corporate Officer, Head, Scientific Affairs Division, Novartis
Pharma K.K.

- 135 -

[Grantee Selection Committee]
Post

Name

Chairman Masataka SATA

Prof., MD, Inst. of Health Biosciences, Univ. of Tokushima

Hidenori ICHIJO

Prof., Dentist, Grad. School of Pharmaceutical Sciences, Univ. ofTokyo

Nobuya INAGAKI

Prof., MD, Grad. School of Medicine, Kyoto Univ.

Akihiro UMEZAWA

Director, MD, National Inst. for Child Health & Development

Member Shinichi OKA

MemberTitle

Director, MD, Aids Clinical Center, National Center for Global
Health & Medicine

Kozo KAIBUCHI

Prof., MD, Grad. School of Medicine, Nagoya Univ.

Masanobu KANO

Prof., MD, Grad. School of Medicine, Univ. of Tokyo

Takeo KISHIMOTO

Prof., Grad. School of Bioscience & Biotechnology, Tokyo Inst.
of Technology

Hiroaki SASAI

Prof., Inst. of Scientific & Industrial Research, Osaka Univ.

Makoto SASAKI

Prof., Grad. School of Life Sciences, Tohoku Univ.

Toshiharu SHIKANAI

Prof., Grad. School of Science, Kyoto Univ.

Hiroshi TAKAYANAGI

Prof., MD, Grad. School of Medical & Dental Sciences, Tokyo
Medical & Dental Univ.

Tsutomu TAKEUCHI

Prof., MD, School of Medicine, Keio Univ.

Hiroyuki TSUTSUIProf., MD, School of Medicine, Hokkaido Univ.

Atsushi NISHIDA

Prof., Grad. School of Pharmaceutical Sciences, Chiba Univ.

Mitsuyasu HASEBE

Prof., National Inst. for Basic Biology

Masabumi MINAMI

Prof., Grad. School of Pharmaceutical Sciences, Hokkaido Univ.

Takashi MINEGISHI

Prof., MD, Grad. School of Medicine, Gunma Univ.

Kohei MIYAZONO

Prof., MD, Grad. School of Medicine, Univ. of Tokyo

Toyoaki MUROHARA

Prof., MD, Grad. School of Medicine, Nagoya Univ.

- 136 -

公益財団法人ノバルティス科学振興財団

役 員 名 簿2012 年 10 月 1 日現在 ( 順不同、 敬称略 )
職

名

氏

名

現

職

就任年月日

常勤･非常勤代表理事 金 子 章 道

畿央大学大学院健康科学研究科教授
慶應義塾大学名誉教授

1997 年 6 月 2 日

非常勤理早稲田大学先端科学・健康医療融合研究機構長
1997 年 6 月 2 日
東京大学名誉教授

非常勤

ノバルティス ファーマ株式会社
常務取締役 人事・コミュニケーション本部長

2004 年 6 月 7 日

非常勤

遠 藤 政 夫 山形大学名誉教授

1997 年 6 月 2 日

非常勤

須 田 年 生 慶應義塾大学医学部教授

2012 年 4 月 1 日

非常勤

事 浅野 茂隆
石川 裕子

監事 中嶋 德三

中嶋德三公認会計士事務所
公認会計士

2006 年 6 月 5 日

非常勤

布施 正則

ノバルティス ファーマ株式会社
経理部長

2012 年 4 月 1 日

非常勤

評議員名簿
2012 年 10 月 1 日現在 ( 順不同、敬称略 )
職

名

氏

名

就任年月日

常勤･非常勤2002年2月7日

非常勤

熊本保健科学大学リハビリテーション学科教授
評 議 員 赤池 紀扶 銀杏学園理事 ・ 副学長
1999 年 6月4日
九州大学名誉教授

非常勤

評議員長 黒岩 常祥

現職

立教大学極限生命情報センター長
東京大学名誉教授

川島 博行 元新潟大学大学院医歯学総合研究科教授

2001年 6月1日

非常勤

小安 重夫 慶應義塾大学医学部教授

2012年 4月1日

非常勤2005 年 6月13日

非常勤

清水 孝雄 東京大学大学院医学系研究科特任教授

2012年 4月1日

非常勤

中野 明彦 東京大学大学院理学系研究科教授

2012年 4月1日

非常勤

マックス ・ ノバルティス サイエンスボード副議長
ブルガー バーゼル大学教授

1987年9月16日

非常勤

眞弓 忠範 大阪大学名誉教授

2004 年 6月7日

非常勤

2007年9月5日

非常勤

柴崎 正勝

三谷 宏幸

公益財団法人微生物化学研究会
微生物化学研究所長

ノバルティス ファーマ株式会社
代表取締役社長- 137 -

職

名

氏

名

現

評 議 員 森 美和子
渡邉 敏文

職

就任年月日

常勤･非常勤2005 年 6月13日

非常勤

ノバルティス ファーマ株式会社
2012年 4月1日
執行役員 サイエンティフィック アフェアーズ本部長

非常勤

北海道医療大学客員教授
北海道大学名誉教授

選考委員名簿2012 年 10 月 1 日現在 ( 順不同、敬称略 )
職 名

氏 名

現

就任年月日

常勤･非常勤

徳島大学大学院
ヘルスバイオサイエンス研究部教授

2009 年 6月19日

非常勤

選考委員 一 條 秀 憲 東京大学大学院薬学系研究科教授

2011年 6月17日

非常勤

2012年 6月15日

非常勤

選考委員長 佐 田 政 隆

職

稲 垣 暢 也 京都大学大学院医学研究科教授
梅澤 明弘

国立成育医療研究センター
再生医療センター長

2012年 6月15日

非常勤

岡国立国際医療センター
エイズ治療 ・ 研究開発センター長

2011年 6月17日

非常勤

貝 淵 弘 三 名古屋大学大学院医学系研究科教授

2009 年 6月19日

非常勤

狩 野 方 伸 東京大学大学院医学系研究科教授

2009 年 6月19日

非常勤

岸 本 健 雄 東京工業大学大学院生命理工学研究科教授 2011年 6月17日

非常勤

笹 井 宏 明 大阪大学産業科学研究所教授

2010 年 6月18日

非常勤

佐々木 誠 東北大学大学院生命科学研究科教授

2012年 6月15日

非常勤

鹿 内 利 治 京都大学大学院理学研究科教授

2011年 6月17日

非常勤

高 柳

広 東京大学大学院医学系研究科教授

2011年 6月17日

非常勤

竹 内

勤 慶應義塾大学医学部教授

2009 年 6月19日

非常勤

筒 井 裕 之 北海道大学大学院医学研究科教授

2012年 6月15日

非常勤

西 田 篤 司 千葉大学大学院薬学研究科教授

2009 年 6月19日

非常勤

長谷部 光泰 自然科学研究機構 基礎生物学研究所教授

2009 年 6月19日

非常勤

南2011年 6月17日

非常勤

敬 群馬大学大学院医学系研究科教授

2010 年 6月18日

非常勤

宮 園 浩 平 東京大学大学院医学系研究科教授

2009 年 6月19日

非常勤

室 原 豊 明 名古屋大学大学院医学系研究科教授

2011年 6月17日

非常勤

慎 一

雅 文 北海道大学大学院薬学研究院教授

峯 岸- 138 -

事務局便りご寄附のお願い
当財団は、 自然科学における創造的な研究の奨励等を行うことにより、 学術の振興を図り、 国民の健康と福祉の向上に寄与することを目的にしております。
当財団の事業は、 基本財産の運用益並びに寄付金によって賄われており、 財団では趣旨にご賛同いただける皆様からのご寄付を募っております。
なお、 当財団は、 その事業が広く社会一般の公益に資するとの認定を内閣府より受け、2012 年 4 月 1 日付で公益財団法人へと移行しました。 当財団へのご寄付には、 下記の税法上の優遇措置が適用されます。
優遇措置の概略
個人 ： 年間寄付金の合計額もしくは年間所得の 40％相当額のいずれか低い方から 2 千円を引いた金額が、 所得税の寄付金控除額となります。
法人 ： 支出した寄附金は、 通常一般の寄附金の損金算入限度額と同額まで、別枠で損金に算入できます。
ご寄附は、 随時受付けております。
詳しくは、 財団事務局までお問合せ下さい。
（電話 ： 03-5464-1460、 E メール ： novartisfound.japan@novartis.com）

事務局より
本年度もお陰様で、 財団年報を発行できる運びとなりました。 これも偏に、 助成を受けられた皆様および財団関係者の皆様のご尽力の賜物と感謝申し上げます。
助成事業は財団設立以来、 総数で 1,460 件、 総額 17 億 6 千 8 百万円余りに達しました。
公益法人の制度改革につきましては、 当財団は内閣府より、 事業が社会一般の公益に資するとの認定を受け、2012 年 4 月1日付で公益財団法人へ移行いたしました。
新しい公益を担う財団として、 今後とも事務局は学術の進展に寄与するべく、 公益事業の遂行に邁進いたします。
引き続きご指導、 ご支援の程よろしくお願い申し上げます。
事務局長 松田光陽〒 106-0031 東京都港区西麻布 4-16-13
西麻布 28 森ビル 2F
Tel:03-5464-1460 Fax:03-5467-3055
E- メール ： novartisfound.japan@novartis.com
ホームページ :http://www.novartisfound.or.jp- 139 -